ES2294820T3 - DECLARATION DEVICE FOR CONSTRUCTION CONDUCTED BY PERCUTANEOUS CATETER - Google Patents
DECLARATION DEVICE FOR CONSTRUCTION CONDUCTED BY PERCUTANEOUS CATETER Download PDFInfo
- Publication number
- ES2294820T3 ES2294820T3 ES98953347T ES98953347T ES2294820T3 ES 2294820 T3 ES2294820 T3 ES 2294820T3 ES 98953347 T ES98953347 T ES 98953347T ES 98953347 T ES98953347 T ES 98953347T ES 2294820 T3 ES2294820 T3 ES 2294820T3
- Authority
- ES
- Spain
- Prior art keywords
- medical device
- catheter
- transport
- expanded diameter
- fabric
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 238000010276 construction Methods 0.000 title 1
- 239000004744 fabric Substances 0.000 claims abstract description 46
- 229910052751 metal Inorganic materials 0.000 claims abstract description 23
- 239000002184 metal Substances 0.000 claims abstract description 23
- 238000000034 method Methods 0.000 abstract description 17
- 230000002159 abnormal effect Effects 0.000 abstract description 10
- 210000000056 organ Anatomy 0.000 abstract description 3
- 238000000465 moulding Methods 0.000 description 39
- 230000007547 defect Effects 0.000 description 28
- 229910001000 nickel titanium Inorganic materials 0.000 description 21
- 238000010438 heat treatment Methods 0.000 description 18
- 239000000463 material Substances 0.000 description 18
- 229910045601 alloy Inorganic materials 0.000 description 16
- 239000000956 alloy Substances 0.000 description 16
- HLXZNVUGXRDIFK-UHFFFAOYSA-N nickel titanium Chemical compound [Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni] HLXZNVUGXRDIFK-UHFFFAOYSA-N 0.000 description 13
- 238000005192 partition Methods 0.000 description 12
- PXHVJJICTQNCMI-UHFFFAOYSA-N Nickel Chemical compound [Ni] PXHVJJICTQNCMI-UHFFFAOYSA-N 0.000 description 8
- 230000000694 effects Effects 0.000 description 6
- 238000004891 communication Methods 0.000 description 5
- 239000011521 glass Substances 0.000 description 5
- 230000036961 partial effect Effects 0.000 description 5
- 230000015572 biosynthetic process Effects 0.000 description 4
- 210000004491 foramen ovale Anatomy 0.000 description 4
- 210000002837 heart atrium Anatomy 0.000 description 4
- 230000008569 process Effects 0.000 description 4
- 241000153246 Anteros Species 0.000 description 3
- 208000032170 Congenital Abnormalities Diseases 0.000 description 3
- 230000008859 change Effects 0.000 description 3
- 230000004927 fusion Effects 0.000 description 3
- 230000014759 maintenance of location Effects 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 238000002844 melting Methods 0.000 description 3
- 230000008018 melting Effects 0.000 description 3
- 229910052759 nickel Inorganic materials 0.000 description 3
- 230000007704 transition Effects 0.000 description 3
- 238000003466 welding Methods 0.000 description 3
- 229910000990 Ni alloy Inorganic materials 0.000 description 2
- 229910001069 Ti alloy Inorganic materials 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 239000011248 coating agent Substances 0.000 description 2
- 238000000576 coating method Methods 0.000 description 2
- 239000000835 fiber Substances 0.000 description 2
- 239000012530 fluid Substances 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- RVTZCBVAJQQJTK-UHFFFAOYSA-N oxygen(2-);zirconium(4+) Chemical compound [O-2].[O-2].[Zr+4] RVTZCBVAJQQJTK-UHFFFAOYSA-N 0.000 description 2
- 239000011347 resin Substances 0.000 description 2
- 229920005989 resin Polymers 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- 230000002792 vascular Effects 0.000 description 2
- 238000011265 2D-echocardiography Methods 0.000 description 1
- NLHHRLWOUZZQLW-UHFFFAOYSA-N Acrylonitrile Chemical compound C=CC#N NLHHRLWOUZZQLW-UHFFFAOYSA-N 0.000 description 1
- 240000007124 Brassica oleracea Species 0.000 description 1
- 235000003899 Brassica oleracea var acephala Nutrition 0.000 description 1
- 235000011301 Brassica oleracea var capitata Nutrition 0.000 description 1
- 235000001169 Brassica oleracea var oleracea Nutrition 0.000 description 1
- 206010008088 Cerebral artery embolism Diseases 0.000 description 1
- 229910000531 Co alloy Inorganic materials 0.000 description 1
- 206010010356 Congenital anomaly Diseases 0.000 description 1
- 239000004677 Nylon Substances 0.000 description 1
- 208000007536 Thrombosis Diseases 0.000 description 1
- 240000007313 Tilia cordata Species 0.000 description 1
- RTAQQCXQSZGOHL-UHFFFAOYSA-N Titanium Chemical compound [Ti] RTAQQCXQSZGOHL-UHFFFAOYSA-N 0.000 description 1
- 206010053648 Vascular occlusion Diseases 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 230000002965 anti-thrombogenic effect Effects 0.000 description 1
- 239000003146 anticoagulant agent Substances 0.000 description 1
- 210000000709 aorta Anatomy 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 206010003664 atrial septal defect Diseases 0.000 description 1
- 230000007698 birth defect Effects 0.000 description 1
- 230000000903 blocking effect Effects 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 239000004568 cement Substances 0.000 description 1
- 239000013043 chemical agent Substances 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 208000028831 congenital heart disease Diseases 0.000 description 1
- 210000004351 coronary vessel Anatomy 0.000 description 1
- 230000008878 coupling Effects 0.000 description 1
- 238000010168 coupling process Methods 0.000 description 1
- 238000005859 coupling reaction Methods 0.000 description 1
- 238000005520 cutting process Methods 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 238000006073 displacement reaction Methods 0.000 description 1
- 210000003191 femoral vein Anatomy 0.000 description 1
- 239000012634 fragment Substances 0.000 description 1
- 229910000856 hastalloy Inorganic materials 0.000 description 1
- 238000002513 implantation Methods 0.000 description 1
- 229910001293 incoloy Inorganic materials 0.000 description 1
- 238000003780 insertion Methods 0.000 description 1
- 230000037431 insertion Effects 0.000 description 1
- 201000010849 intracranial embolism Diseases 0.000 description 1
- 210000005246 left atrium Anatomy 0.000 description 1
- 239000000314 lubricant Substances 0.000 description 1
- 238000013507 mapping Methods 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 150000002739 metals Chemical class 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012148 non-surgical treatment Methods 0.000 description 1
- 229920001778 nylon Polymers 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 230000000803 paradoxical effect Effects 0.000 description 1
- 230000008375 physiological alteration Effects 0.000 description 1
- 239000000088 plastic resin Substances 0.000 description 1
- 229920000728 polyester Polymers 0.000 description 1
- 230000036316 preload Effects 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000002829 reductive effect Effects 0.000 description 1
- 230000002040 relaxant effect Effects 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 238000012552 review Methods 0.000 description 1
- 210000005245 right atrium Anatomy 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 239000010935 stainless steel Substances 0.000 description 1
- 229910001220 stainless steel Inorganic materials 0.000 description 1
- 229910000601 superalloy Inorganic materials 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 230000002537 thrombolytic effect Effects 0.000 description 1
- 230000001732 thrombotic effect Effects 0.000 description 1
- 239000010936 titanium Substances 0.000 description 1
- 208000021331 vascular occlusion disease Diseases 0.000 description 1
- 210000001835 viscera Anatomy 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods
- A61B17/08—Wound clamps or clips, i.e. not or only partly penetrating the tissue ; Devices for bringing together the edges of a wound
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods
- A61B17/0057—Implements for plugging an opening in the wall of a hollow or tubular organ, e.g. for sealing a vessel puncture or closing a cardiac septal defect
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods
- A61B17/0057—Implements for plugging an opening in the wall of a hollow or tubular organ, e.g. for sealing a vessel puncture or closing a cardiac septal defect
- A61B2017/00575—Implements for plugging an opening in the wall of a hollow or tubular organ, e.g. for sealing a vessel puncture or closing a cardiac septal defect for closure at remote site, e.g. closing atrial septum defects
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods
- A61B17/0057—Implements for plugging an opening in the wall of a hollow or tubular organ, e.g. for sealing a vessel puncture or closing a cardiac septal defect
- A61B2017/00575—Implements for plugging an opening in the wall of a hollow or tubular organ, e.g. for sealing a vessel puncture or closing a cardiac septal defect for closure at remote site, e.g. closing atrial septum defects
- A61B2017/00592—Elastic or resilient implements
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods
- A61B17/0057—Implements for plugging an opening in the wall of a hollow or tubular organ, e.g. for sealing a vessel puncture or closing a cardiac septal defect
- A61B2017/00575—Implements for plugging an opening in the wall of a hollow or tubular organ, e.g. for sealing a vessel puncture or closing a cardiac septal defect for closure at remote site, e.g. closing atrial septum defects
- A61B2017/00597—Implements comprising a membrane
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods
- A61B17/0057—Implements for plugging an opening in the wall of a hollow or tubular organ, e.g. for sealing a vessel puncture or closing a cardiac septal defect
- A61B2017/00575—Implements for plugging an opening in the wall of a hollow or tubular organ, e.g. for sealing a vessel puncture or closing a cardiac septal defect for closure at remote site, e.g. closing atrial septum defects
- A61B2017/00606—Implements H-shaped in cross-section, i.e. with occluders on both sides of the opening
Landscapes
- Health & Medical Sciences (AREA)
- Surgery (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Medical Informatics (AREA)
- Molecular Biology (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Cardiology (AREA)
- Surgical Instruments (AREA)
- Media Introduction/Drainage Providing Device (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Materials For Medical Uses (AREA)
- Disintegrating Or Milling (AREA)
- Train Traffic Observation, Control, And Security (AREA)
- Alarm Systems (AREA)
- Prostheses (AREA)
Abstract
Description
Dispositivo de oclusión por constricción conducido por catéter percutáneo.Constriction occlusion device Percutaneous catheter driven.
La presente invención en términos generales se refiere a un dispositivo y un método no quirúrgico para tratar algunos defectos cardíacos. Más particularmente, la presente invención se refiere a un dispositivo de oclusión de perfil bajo para el tratamiento no quirúrgico de un paciente con Foramen Ovale Perforado (FOP) que tiene como resultado embolismo cerebral paradójico. El dispositivo hecho de acuerdo con la invención es capaz de ajustar automáticamente un defecto del septo o tabique con aberturas excéntricas y se adapta particularmente bien para el transporte a través de un catéter o localizado en una posición distante en el corazón de un paciente o en un vaso análogo u órgano dentro del cuerpo de un paciente.The present invention in general terms is refers to a device and a non-surgical method to treat some heart defects More particularly, the present invention relates to a low profile occlusion device for the non-surgical treatment of a patient with Foramen Ovale Perforated (FOP) resulting in cerebral embolism paradoxical. The device made according to the invention is capable of automatically adjusting a septum or septum defect with eccentric openings and fits particularly well for the transport through a catheter or located in a position distant in the heart of a patient or in an analogous vessel or organ inside a patient's body.
Una variedad amplia de dispositivos intracardíacos se utilizan en varios procedimientos médicos. Algunos dispositivos intravasculares tales como catéteres y cables guía, pueden usarse para transportar fluidos u otros dispositivos médicos a una localización específica dentro del corazón de un paciente. Por ejemplo, un catéter puede usarse para alcanzar una arteria coronaria selectiva dentro del sistema vascular, o el catéter y/o el cable guía pueden utilizarse para colocar un dispositivo en una cavidad interna del corazón del paciente. Dispositivos complejos pueden colocarse y utilizarse para tratar condiciones anormales específicas, como los dispositivos utilizados para eliminar oclusiones vasculares o los dispositivos utilizados para tratar defectos de la pared y otros similares.A wide variety of devices Intracardiacs are used in various medical procedures. Some intravascular devices such as catheters and guide wires, can be used to transport fluids or other devices doctors to a specific location within the heart of a patient. For example, a catheter can be used to achieve a selective coronary artery within the vascular system, or the catheter and / or guide wire can be used to place a device in an internal cavity of the patient's heart. Complex devices can be placed and used to treat specific abnormal conditions, such as the devices used to eliminate vascular occlusions or the devices used to treat wall and other similar defects.
Los catéteres de balón y los dispositivos poliméricos prefabricados de forma plegable parecidos a aquel descubierto por Landymore y colaboradores en la patente estadounidense No. 4.836.204 y a la de Linden y colaboradores en la patente estadounidense No. 5.634.936 respectivamente se han utilizado para ocluir el defecto del tabique. Al usar un catéter de balón similar al descrito en la patente '204, se lleva un balón expandible en el extremo distal de dicho catéter. Cuando el catéter se guía al sitio deseado, el balón se llena con un fluido hasta que ocupa el vaso considerablemente y permanece colocado en el lugar. Las resinas que endurecerán el interior del balón, como acrilonitrilo, pueden emplearse para fijar permanentemente el tamaño y la forma del balón. El balón puede desacoplarse entonces del extremo del catéter y dejarse en el lugar. El dispositivo '936 se expande y se endurece por un sistema ternario que modifica el pH y la afinidad del dispositivo por el agua (véase patente '936, col. 6, en 40-45). Si estos dispositivos no se expanden completamente no pueden colocarse firmemente en el defecto del tabique y pueden rotar y soltarse de la pared del septo, liberándose por tanto al torrente sanguíneo. El sobrellenando del dispositivo '204 es un incidente igualmente indeseable que puede llevar a la ruptura del balón y a la descarga de las resinas en el torrente sanguíneo del paciente.Balloon catheters and devices prefabricated polymeric folding form similar to that discovered by Landymore and collaborators in the patent No. 4,836,204 and Linden et al. U.S. Patent No. 5,634,936 respectively have used to occlude the partition defect. When using a catheter ball similar to that described in the '204 patent, a ball is carried expandable at the distal end of said catheter. When the catheter is guided to the desired site, the ball is filled with a fluid until It occupies the glass considerably and remains in place. The resins that will harden the inside of the ball, such as acrylonitrile, can be used to permanently fix the size and shape of the ball. The ball can be uncoupled then from the end of the catheter and left in place. The device '936 it expands and hardens by a ternary system that modifies the pH and the affinity of the device for water (see patent '936, cabbage. 6, in 40-45). If these devices are not fully expand cannot be firmly placed in the defect of the septum and can rotate and release from the wall of the septum, thus freeing the bloodstream. Overfilling device '204 is an equally undesirable incident that can lead to the rupture of the ball and the discharge of the resins in the patient's bloodstream
Los dispositivos de émbolos mecánicos se han propuesto en el pasado para ocluir los defectos en el sistema intravascular de un paciente. Los dispositivos incluyen típicamente un par de parches separados cada uno con una estructura interior plegable (similar a la estructura y tela exterior de un paraguas), en donde el parche opuesto y la estructura se interconectan por una pieza conjunta. Los parches están típicamente alineados y acoplados al eje común de la pieza conjunta. La pieza conjunta puede ser un cilindro rígido o semirígido que minimiza el movimiento de uno y otro parche en sentido lateral y antero posterior, de tal modo retiene los parches firmemente contra la pared septal adyacente al defecto. Los parches que se acoplan al eje común del cilindro pueden causar dificultades cuando el defecto del tabique a ser ocluido tiene aberturas excéntricas. Dado que los parches se acoplan a un eje rígido común, por lo menos una de las aberturas excéntricas no puede ser cubierta completamente por el parche respectivo. El cubo rígido o semirígido impide el ajuste de los parches para compensar la excentricidad de las aberturas.The mechanical piston devices have proposed in the past to occlude defects in the system intravascular of a patient. The devices typically include a pair of separate patches each with an internal structure folding (similar to the structure and outer fabric of an umbrella), where the opposite patch and structure are interconnected by a joint piece The patches are typically aligned and coupled. to the common axis of the joint piece. The joint piece can be a rigid or semi-rigid cylinder that minimizes the movement of one and another patch in the lateral direction and posterior antero, thereby holds the patches firmly against the septal wall adjacent to the default. Patches that attach to the common axis of the cylinder they can cause difficulties when the defect of the septum to be occluded has eccentric openings. Since the patches are they attach to a common rigid shaft, at least one of the openings Eccentric cannot be completely covered by the patch respective. The rigid or semi-rigid hub prevents the adjustment of the patches to compensate for the eccentricity of the openings.
Ejemplos representativos de tales dispositivos mecánicos se exponen en King y cols., patente estadounidense No. 3.874.388 (patente '388), Das, patente estadounidense No. 5.334.217 (patente '217), la solicitud europea No. 0541.063 A2 (solicitud '063), Sideris, patente estadounidense No. 4.917.089 (patente '089), y Marks, patente estadounidense No. 5.108.420 (patente '420). Estos dispositivos están comúnmente precargados en un introductor o catéter de transporte previo al procedimiento de implantación y normalmente no se colocan por el médico durante la intervención. Durante el despliegue de tales dispositivos, la recuperación en el catéter de transporte es difícil si no imposible, de tal modo se limita su efectividad.Representative examples of such devices mechanics are set forth in King et al., U.S. Patent No. 3,874,388 ('388 patent), Das, U.S. Patent No. 5,334,217 (patent '217), European application No. 0541.063 A2 (application '063), Sideris, U.S. Patent No. 4,917,089 (' 089 Patent), and Marks, U.S. Patent No. 5,108,420 ('420 patent). These devices are commonly preloaded in an introducer or transport catheter prior to the implantation procedure and Normally they are not placed by the doctor during the intervention. During the deployment of such devices, recovery in the transport catheter is difficult if not impossible, thereby Limit its effectiveness.
Antes de la implantación de estos dispositivos, deben determinarse el espesor de la pared del tabique cerca del defecto y la amplitud aproximada del defecto para que pueda suministrarse un dispositivo con el tamaño apropiado. Un catéter de balón y un cable guía calibrado con zonas radio opacas de longitud conocida, pueden utilizarse por el médico durante un procedimiento fluoroscópico preliminar para estimar el tamaño del defecto, forma y espesor de la pared del tabique cercana al defecto. Aunque de utilidad, el tamaño exacto y la forma de los defectos no pueden determinarse, por tanto se incrementa la posibilidad de fuga alrededor del dispositivo de oclusión. A causa de esto podría requerirse un dispositivo con la propiedad inherente de ajustarse a la forma y grosor del defecto.Before the implementation of these devices, the thickness of the partition wall must be determined near the defect and the approximate extent of the defect so you can Provide a device with the appropriate size. A catheter of balloon and a calibrated guide wire with opaque radius zones in length known, can be used by the doctor during a procedure preliminary fluoroscopic to estimate defect size, shape and wall thickness of the partition near the defect. Although of utility, exact size and shape of defects can not determined, therefore the possibility of leakage is increased around the occlusion device. Because of this I could a device with the inherent property of adjusting is required to the shape and thickness of the defect.
Significativamente, el tamaño de los
dispositivos anteriores está inherentemente limitado por la
estructura y forma del dispositivo. También, al usar dispositivos
oclusivos como aquéllos expuestos en las patentes '089, '388, '217,
o '420 para ocluir el defecto del tabique, la presión y por
consiguiente la probabilidad de desplazamiento del dispositivo
aumenta al aumentar el tamaño del defecto. Por consiguiente, los
dispositivos anteriores requieren una cubierta de retención de
mayor tamaño localizadas en cada lado del defecto. A menudo, la
posición del defecto del tabique sugiere el tamaño de la cubierta
de retención. En un defecto del septo de tipo membranoso es difícil
si no improbable ser capaz de posicionar los dispositivos '388,
'217, '089, ó '420 eficazmente sin bloquear la aorta por lo menos
parcialmente. También, los dispositivos expuestos tienden a ser
bastante caros y requieren gran consumo de tiempo en su
fabricación.Significantly, the size of the previous devices is inherently limited by the structure and shape of the device. Also, when using occlusive devices such as those set forth in the '089,' 388, '217, or' 420 patents to occlude the partition defect, the pressure and consequently the probability of displacement of the device increases as the defect size increases. Therefore, the above devices require a larger retention cover located on each side of the defect. Often, the position of the septum defect suggests the size of the retention cover. In a defect of the membranous septum it is difficult if not unlikely to be able to position the '388,' 217, '089, or' 420 devices effectively without at least partially blocking the aorta. Also, the exposed devices tend to be quite expensive and require great time consumption in their
manufacturing.
Además, la forma de los dispositivos anteriores (por ejemplo cuadrados, triángulos, pentágonos, hexágonos y octágonos) requiere una zona de contacto con mayor superficie y tiene esquinas que pueden extenderse a la pared libre de las aurículas. Cada vez que la aurícula se contrae (aproximadamente 100,000 veces por día) las esquinas que se extienden a las paredes auriculares se tuercen, creando grietas de fatiga estructural en 30 por ciento de todos los casos aproximadamente. Además, los dispositivos previos requieren un catéter introductor de 14-16 French, lo que hace imposible el tratamiento de niños afectados por defectos congénitos con estos dispositivos. Por tal motivo sería ventajoso proporcionar un dispositivo de oclusión fiable que sea fácil de desplegar a través de un catéter de 6-7 French así como que automáticamente se ajuste a la forma y al grosor del defecto. La presente invención se dirige a éstas y otras desventajas de la técnica anterior.In addition, the shape of the previous devices (for example squares, triangles, pentagons, hexagons and octagons) requires a contact area with greater surface area and it has corners that can extend to the free wall of the atria Each time the atrium contracts (approximately 100,000 times per day) the corners that extend to the walls headphones twist, creating structural fatigue cracks in 30 percent of all cases approximately. In addition, the previous devices require an introducer catheter of 14-16 French, which makes treatment impossible of children affected by birth defects with these devices. For this reason it would be advantageous to provide a device for Reliable occlusion that is easy to deploy through a catheter from 6-7 French as well as automatically adjusting to the shape and thickness of the defect. The present invention is addresses these and other disadvantages of the prior art.
El documento VVO 97/42878 en la cual se basan las dos partes de la reivindicación 1, describe un dispositivo de oclusión intravascular moldeado a partir de un tejido metálico elástico, capaz de adoptar tanto la forma expandida como la forma colapsada. La forma expandida generalmente tiene la configuración de la barra de ejercicios con dos partes extendidas en los extremos separadas por un tubo en la parte media.Document VVO 97/42878 on which they are based the two parts of claim 1 describe a device of intravascular occlusion molded from a metallic tissue elastic, capable of adopting both the expanded form and the form collapsed The expanded form generally has the configuration of the exercise bar with two parts extended at the ends separated by a tube in the middle part.
La invención proporciona un dispositivo médico, plegable, según la reivindicación 1. El objeto principal de la presente invención es proporcionar un dispositivo fiable, de bajo perfil, dispositivo de oclusión intracardíaca, capaz de ajustar automáticamente la alineación dentro de un defecto del tabique con aberturas excéntricas, donde el dispositivo es adecuado para tratar los defectos del septo, incluso el Foramen Oval Perforado (FOP). El FOP es esencialmente una condición caracterizada por una abertura anormal, ancha, en la pared del septo, entre las dos aurículas del corazón. La sangre puede fluir directamente entre las dos cavidades, comprometiendo el flujo normal de la circulación, y la eficiencia del corazón del paciente. La abertura anormal o defecto del tabique puede que no se extienda perpendicularmente a través de la pared del septo. Más bien, el centro de la abertura en la pared del tabique en la aurícula izquierda puede ser excéntrico en relación con el centro de la abertura en la pared del septo de la aurícula derecha, a causa de esto se requieren "parches" colocados excéntricamente para ocluir el defecto eficazmente. También, la pared del tabique puede ser muy delgada y requerir una distancia de separación mínima entre los dos "parches" oclusivos. El dispositivo de la presente invención se forma preferentemente de un tejido metálico de forma tubular continua e incluye dos "discos", parches, o cubiertas de retención opuestas, separadas e interconectadas por una pieza central flexible o elástica. La pieza central se flexiona tanto en dirección lateral como antero posterior y así proporciona una tensión interior contra cada uno de los discos.The invention provides a medical device, folding according to claim 1. The main object of the present invention is to provide a reliable, low device profile, intracardiac occlusion device, able to adjust automatically alignment within a partition wall defect with eccentric openings, where the device is suitable for treating the defects of the septum, including the perforated oval foramen (FOP). FOP is essentially a condition characterized by an opening abnormal, wide, in the wall of the septum, between the two atria of the heart. Blood can flow directly between the two cavities, compromising the normal flow of circulation, and the efficiency of the patient's heart. Abnormal opening or defect of the septum may not extend perpendicularly through from the wall of the septum. Rather, the center of the opening in the septum wall in the left atrium can be eccentric in relationship with the center of the opening in the wall of the septum of the right atrium, because of this "patches" are required placed eccentrically to occlude the defect effectively. Also, the wall of the septum can be very thin and require a minimum separation distance between the two "patches" occlusive The device of the present invention is formed preferably of a continuous tubular metal fabric and includes two "disks", patches, or retention covers opposite, separated and interconnected by a flexible centerpiece or elastic The centerpiece flexes both in the direction lateral as antero posterior and thus provides a tension inside against each of the discs.
Cuando estos dispositivos intravasculares se forman a partir de una malla metálica elástica, se suministra un número de hilos elásticos o cables, el tejido metálico se forma por trenzado de los hilos elásticas para crear un material resistente. Este tejido trenzado se deforma entonces para adaptarse por lo general a la superficie de moldeo de un molde y dicha malla trenzada se somete al calor en contacto con la superficie del molde a temperatura elevada. El tiempo y la temperatura del tratamiento térmico se seleccionan esencialmente para lograr la deformación del tejido trenzado. Después del tratamiento térmico, la malla se retira del contacto con el molde y retendrá substancialmente su estado de deformación. El tejido trenzado así tratado caracteriza el estado de relajamiento del dispositivo médico que puede estirarse o expandirse y desplegarse a través de un catéter en un conducto en el cuerpo de un paciente. Los expertos en la técnica apreciarán que las cavidades de los moldes deben reproducir la forma deseada del dispositivo y además las piezas de molde se describen en la solicitud estadounidense pendiente 5725552 presentada el 14 de mayo de 1996, y titulada "Dispositivo de oclusión dirigido por cateter intravascular percutaneo" la cual se designa al mismo beneficiario que la presente invención.When these intravascular devices are formed from an elastic metal mesh, a number of elastic wires or cables, the metallic fabric is formed by braided elastic threads to create a resistant material. This braided fabric is then deformed to adapt so general to the mold surface of a mold and said mesh braided is subjected to heat in contact with the mold surface at high temperature. The time and temperature of the treatment thermal are essentially selected to achieve deformation of the braided fabric After heat treatment, the mesh is removed of contact with the mold and will substantially retain its state of deformation. The braided fabric thus treated characterizes the state of relaxing the medical device that can stretch or expand and deploy through a catheter in a duct in The body of a patient. Those skilled in the art will appreciate that the mold cavities should reproduce the desired shape of the device and also the mold pieces are described in the U.S. application pending 5725552 filed May 14 1996, entitled "Occlusion device directed by catheter intravascular percutaneous "which is designated the same beneficiary than the present invention.
El dispositivo de la presente invención tiene una forma específica particularmente satisfactoria para ocluir el FOP. El dispositivo tiene una configuración de bajo perfil plegada e incluye anillos que permiten su acople al extremo de un dispositivo de transporte o cable guía (lo cual permite recuperar el dispositivo después de la colocación). Durante la utilización, un catéter guía se posiciona y se introduce en el cuerpo de un paciente, de manera tal que el extremo distal del catéter es adyacente a la zona donde se requiere el tratamiento de la alteración fisiológica. El dispositivo médico de la presente invención con una forma predeterminada se estira entonces y se inserta en la luz del catéter. El dispositivo se libera a través del catéter y fuera del extremo distal, después de lo cual, debido a su propiedad de memoria de forma tenderá a recobrar, en esencia, su estado de relajación, adyacente a la zona de tratamiento. El cable guía o el catéter de transporte se suelta entonces del anillo y se retira.The device of the present invention has a specific way particularly satisfactory to occlude the FOP The device has a folded low profile configuration and includes rings that allow its coupling to the end of a transport device or guide wire (which allows you to recover the device after placement). During use, a guide catheter is positioned and inserted into the body of a patient, so that the distal end of the catheter is adjacent to the area where the treatment of the physiological alteration The medical device of the present invention with a predetermined form is then stretched and inserted into catheter light. The device is released through the catheter and outside the distal end, after which, due to its form memory property will tend to recover, in essence, its state of relaxation, adjacent to the treatment area. He guide wire or the transport catheter is then released from the ring and withdraws.
Un objeto principal de la presente invención es, por consiguiente, disponer de un dispositivo adecuado para la oclusión del defecto del septo, capaz de ajustarse automáticamente a las aberturas excéntricas del defecto del tabique mientras proporciona una tensión interior en los parches oclusivos del dispositivo.A main object of the present invention is, therefore, have a suitable device for occlusion of the septum defect, capable of automatically adjusting to eccentric septum defect openings while provides internal tension in the occlusive patches of the device.
Otro objeto de la presente invención es proporcionar un dispositivo adecuado para ocluir defectos del tabique con aberturas excéntricas, en donde el dispositivo está particularmente bien configurado para su transporte a través de un catéter o a una zona distante en el corazón de un paciente o en un vaso análogo u órgano interno en el cuerpo del paciente.Another object of the present invention is provide a suitable device to occlude defects of the partition with eccentric openings, where the device is particularly well configured for transport through a catheter or to a distant area in the heart of a patient or in a Analog vessel or internal organ in the patient's body.
Un objeto adicional de la presente invención es proporcionar un dispositivo oclusivo con partes oclusivas exteriores y una pieza central elástica flexible que estabiliza las porciones oclusivas exteriores.A further object of the present invention is provide an occlusive device with occlusive parts exteriors and a flexible elastic centerpiece that stabilizes the outer occlusive portions.
Estos y otros objetos, así como éstas y otras características y ventajas de la presente invención se harán evidentes con prontitud para los expertos en la técnica, a partir de una revisión de la descripción detallada que sigue de la realización preferente, junto con las reivindicaciones y dibujos en los cuales los números en las diversas vistas se refieren a las partes correspondientes.These and other objects, as well as these and others Features and advantages of the present invention will be made readily apparent to those skilled in the art, from a review of the detailed description that follows from the preferred embodiment, together with the claims and drawings in which the numbers in the various views refer to the corresponding parts.
La figura 1 es una vista en perspectiva de un dispositivo de oclusión de foramen oval permeable de acuerdo con la presente invención;Figure 1 is a perspective view of a permeable oval foramen occlusion device according to the present invention;
La figura 2 es una vista lateral en elevación del dispositivo médico del tipo mostrado en la figura 1;Figure 2 is a side elevation view of the medical device of the type shown in Figure 1;
La figura 3 es una vista parcial lateral en elevación del dispositivo médico que se muestra en la figura 2, se muestra parcialmente estirado a lo largo de su eje longitudinal;Figure 3 is a partial side view in elevation of the medical device shown in figure 2, is shows partially stretched along its longitudinal axis;
La figura 4 es una vista lateral en elevación del dispositivo médico del tipo mostrado en la figura 3, ligeramente más estirado a lo largo de su eje longitudinal que en la figura 3;Figure 4 is a side elevation view of the medical device of the type shown in Figure 3, slightly more stretched along its longitudinal axis than in the figure 3;
La figura 5 es una vista lateral en elevación del dispositivo médico del tipo mostrado en la figura 4, que se muestra ligeramente más estirado a lo largo de su eje longitudinal que en la figura 4;Figure 5 is a side elevation view of the medical device of the type shown in Figure 4, which shows slightly more stretched along its longitudinal axis that in figure 4;
La figura 6 es una vista lateral en elevación del dispositivo médico del tipo mostrado en la figura 1, se muestra parcialmente estirado, donde se compensa el perímetro exterior de los discos separados;Figure 6 is a side elevation view of the medical device of the type shown in figure 1, is shown partially stretched, where the outer perimeter of the disks separated;
La figura 7 es una vista lateral parcial en elevación del dispositivo médico del tipo mostrado en la figura 1, y se representa parcialmente estirado por su eje longitudinal;Figure 7 is a partial side view in elevation of the medical device of the type shown in figure 1, and is represented partially stretched by its longitudinal axis;
La figura 8 es una vista lateral en elevación de otra realización de la presente invención que lo muestra parcialmente estirado por su eje longitudinal;Figure 8 is a side elevation view of another embodiment of the present invention showing it partially stretched by its longitudinal axis;
La figura 9 es una vista lateral en elevación de otra realización de la presente invención en la cual se muestra parcialmente estirado en su eje longitudinal;Figure 9 is a side elevation view of another embodiment of the present invention in which it is shown partially stretched along its longitudinal axis;
La figura 10 es una vista lateral en elevación de otra realización de la presente invención en la cual se muestra extendida parcialmente a lo largo de su eje longitudinal;Figure 10 is a side elevation view of another embodiment of the present invention in which it is shown partially extended along its longitudinal axis;
La figura 11 es una vista lateral parcial en elevación de la realización de la figura 8 mostrada cuando ocluye un FOP del tabique;Figure 11 is a partial side view in elevation of the embodiment of figure 8 shown when it occludes a FOP of the partition;
La figura 12 es una vista lateral parcial en elevación que muestra de la realización de la figura 8 en la oclusión del FOP del tabique; yFigure 12 is a partial side view in elevation showing the embodiment of figure 8 in the FOP occlusion of the septum; Y
La figura 13 es una vista parcial lateral de sección en elevación de la realización de la figura 1 que muestra la oclusión del defecto del tabique auricular.Figure 13 is a partial side view of elevation section of the embodiment of figure 1 showing occlusion of the atrial septum defect.
La presente invención proporciona un dispositivo de oclusión conducido por un catéter percutáneo para usar en el cierre de una abertura anormal en el cuerpo de un paciente, apropiado particularmente para ocluir un FOP (véanse figuras 11-13). El dispositivo de oclusión incluye dos piezas separadas, interconectadas por una parte central flexible y elástica. Un anillo se fija al extremo exterior de cada pieza de oclusión, donde dichos anillos se adaptan para acoplarse al extremo de un cable guía o catéter para el transporte al sitio previamente seleccionado dentro del paciente. En la realización preferente, el dispositivo de oclusión se forma a partir de un solo tejido metálico tubular continuo.The present invention provides a device of occlusion driven by a percutaneous catheter for use in the closure of an abnormal opening in a patient's body, particularly suitable to occlude a FOP (see figures 11-13). The occlusion device includes two separate parts, interconnected by a flexible central part and elastic. A ring is fixed to the outer end of each piece of occlusion, where said rings adapt to fit the end of a guide wire or catheter for transport to the site previously selected within the patient. In the realization Preferably, the occlusion device is formed from a single continuous tubular metal fabric.
El tejido tubular se forma por una pluralidad de hilos de alambre con una orientación relativa predeterminada entre ellas. Los expertos en la técnica apreciarán que la tensión y distancia de los alambres trenzados pueden variarse en dependencia del grosor del tejido que se requiere. El tejido tubular tiene filamentos metálicos los cuales definen dos juegos de hilos, esencialmente paralelos que por lo general se entrecruzan en espiral y se solapan alternativamente los hilos de un juego por una parte en dirección de rotación contraria a las del otro juego. Este tejido tubular se conoce en la industria como trenza o cordón tubular.The tubular tissue is formed by a plurality of wire wires with a predetermined relative orientation between they. Those skilled in the art will appreciate that the tension and Distance of twisted wires can be varied depending of the thickness of the tissue that is required. The tubular tissue has metallic filaments which define two sets of threads, essentially parallel that usually intersect in a spiral and alternately overlap the threads of a game on the one hand in the direction of rotation contrary to those of the other game. This tubular fabric is known in the industry as braid or cord tubular.
El grado de inclinación de los hilos del alambre (o sea, el ángulo definido entre los giros del alambre y el eje de la trenza) y la tracción o tensión del tejido (es decir, el número de giros o cruces alternos por la longitud de la unidad) así como algunos otros factores, como el número de alambres empleados en un cordón tubular, el tamaño o diámetro de cada alambre en el cordón y el diámetro del cordón son todos de importancia para determinar varias propiedades importantes del dispositivo. Por ejemplo, cuanto mayor frecuencia de giros y de inclinación de los hilos del tejido, tanto más será la densidad de los hilos de alambre en dicho tejido, y mayor la rigidez del dispositivo. También, a mayor diámetro de cada alambre de la trenza, más rigidez en el dispositivo. El tener mayor grosor de alambre también provee al dispositivo con un área de superficie de alambre mayor, la cual, por lo general, elevará la tendencia del dispositivo a bloquear el área en la cual se despliega. Esta trombogenicidad puede aumentarse, o puede disminuirse por el revestimiento con una capa de un agente trombolítico, o por el revestimiento con una capa de un compuesto lubricante antitrombogénico. Al usar un cordón tubular para formar el dispositivo de la presente invención, es adecuado una hilo tubular de aproximadamente 4 mm de diámetro que tenga aproximadamente 72 alambres trenzados, para fabricar dispositivos capaces de ocluir aberturas anormales, defectos del tabique o ambos.The degree of inclination of the wire threads (that is, the defined angle between the turns of the wire and the axis of the braid) and the tension or tension of the fabric (i.e. the number of turns or alternate crossings by the length of the unit) as well as some other factors, such as the number of wires used in a tubular cord, the size or diameter of each wire in the cord and The diameter of the cord are all of importance to determine Several important properties of the device. For example, how much greater frequency of turns and inclination of the threads of the fabric, the more the density of the wire wires in said fabric will be, and greater the rigidity of the device. Also, a larger diameter of Each braid wire, more rigidity in the device. To have Higher wire thickness also provides the device with an area of larger wire surface, which will generally raise the tendency of the device to block the area in which it display This thrombogenicity can be increased, or it can be reduced by coating with a layer of an agent thrombolytic, or by coating with a layer of a compound antithrombogenic lubricant. When using a tubular cord to form the device of the present invention, a thread is suitable tubular approximately 4 mm in diameter that has approximately 72 twisted wires, to manufacture devices able to occlude abnormal openings, septum defects or both of them.
Las hebras o filamentos de alambre del tejido metálico tubular se fabrican preferentemente a partir de aleaciones con la llamada memoria de forma. Tales aleaciones tienden a tener un cambio de fase inducido por la temperatura la cual causará que el material tenga una configuración de preferencia que puede fijarse calentando el material por encima de cierta temperatura de transición para inducir un cambio en la fase del material. Cuando la aleación se enfría por debajo de la temperatura de transición, la aleación "recordará" la forma que tenía durante el tratamiento térmico y tenderá a asumir esa configuración a menos que se limite para que lo haga así.The strands or filaments of tissue wire Tubular metallic are preferably manufactured from alloys with the so-called shape memory. Such alloys tend to have a temperature induced phase change which will cause the material has a preference setting that can be set by heating the material above a certain temperature of transition to induce a change in the phase of the material. When the alloy cools below the transition temperature, the alloy will "remember" the shape it had during treatment thermal and will tend to assume that configuration unless it is limited To do so.
Sin cualquier intención de limitarlo, los materiales adecuados para el hilo pueden seleccionarse de un grupo que consiste en la aleación de cobalto basada en baja expansión térmica descrita en el campo como ELGELOY®, "superaleaciones" de níquel de alta fortaleza a temperatura elevada (incluso nitinol) comercialmente disponible por ejemplo, en Haynes International bajo el nombre comercial HASTELLOY®, aleaciones con base de níquel tratables al calor, vendidas bajo el nombre INCOLOY® por Internacional Nickel, y acero inoxidable de diversos grados. El factor importante en la selección del material adecuado para los hilos del alambre es que los alambres retengan la cantidad adecuado de la deformación inducida por la superficie de moldeo (como se describe más adelante), cuando se someten a un tratamiento de calor predeterminado.Without any intention to limit it, the suitable materials for the thread can be selected from a group consisting of cobalt alloy based on low expansion thermal described in the field as ELGELOY®, "superalloys" high strength nickel at high temperature (including nitinol) commercially available for example, at Haynes International under the trade name HASTELLOY®, nickel based alloys heat treatable, sold under the name INCOLOY® by International Nickel, and stainless steel of various grades. He important factor in selecting the right material for wire threads is that the wires retain the right amount of the deformation induced by the molding surface (as described below), when subjected to heat treatment predetermined.
En la realización preferente, los hilos de alambre se hacen de una aleación con memoria de forma, NiTi (conocido como nitinol) el cual es una aleación de níquel y titanio aproximadamente estequiométrica y también puede incluir cantidades menores de otros metales para lograr las propiedades deseadas. Los requisitos de tratamiento y variaciones en la composición de la aleación NiTi se conocen en la técnica, por consiguiente no es necesario que se discutan aquí en detalle. Las patentes de Estados Unidos 5.067.489 (Lind) y 4.991.602 (Amplatz y colaboradores), los métodos de las cuales se citan aquí como referencia, discuten el uso de aleaciones NiTi con memoria de forma, en alambres guía. Se prefieren tales aleaciones de NiTi, por lo menos en parte, porque están comercialmente disponibles y se conoce más sobre el tratamiento de tales aleaciones que de otras aleaciones con la propiedad de memoria de forma. Las aleaciones de NiTi también son muy elásticas y se dice que son "superelásticas" o "seudoplásticas." Esta elasticidad permite al dispositivo de la invención volver a la configuración prefijada después del despliegue.In the preferred embodiment, the threads of wire are made of an alloy with shape memory, NiTi (known as nitinol) which is a nickel and titanium alloy approximately stoichiometric and may also include quantities minors of other metals to achieve the desired properties. The treatment requirements and variations in the composition of the NiTi alloy are known in the art, therefore it is not They need to be discussed here in detail. State patents United 5,067,489 (Lind) and 4,991,602 (Amplatz et al.), the methods of which are cited here for reference, discuss the use of NiTi alloys with shape memory, in guide wires. Such NiTi alloys are preferred, at least in part, because they are commercially available and more is known about the treatment of such alloys than of other alloys with the shape memory property. NiTi alloys are also very elastic and they are said to be "super elastic" or "pseudoplastic." This elasticity allows the device to the invention return to the default setting after deployment.
Al moldear el dispositivo médico de acuerdo con la presente invención, una pieza tubular de tejido metálico de tamaño apropiado se inserta en el molde, por medio del cual, el tejido se deforma para conseguir, en términos generales, la forma de las cavidades dentro del molde. La forma de las cavidades es tal, que el tejido metálico cambia substancialmente a la forma del dispositivo médico deseado. Los centros dentro de las cavidades pueden usarse para moldear la forma del tejido dentro de dichas cavidades. Los extremos de los hilos de alambre del tejido metálico tubular deben fijarse para prevenir que el tejido metálico pierda la trama. Un anillo o soldadura, como se describe adelante, puede usarse para fijar los extremos de los hilos del alambre.When molding the medical device according to the present invention, a tubular piece of metallic fabric of appropriate size is inserted into the mold, by means of which, the fabric deforms to get, in general terms, the shape of the cavities inside the mold. The shape of the cavities is such that the metallic fabric changes substantially to the shape of the desired medical device. The centers inside the cavities they can be used to mold the shape of the tissue within said cavities The ends of wire wires of metallic fabric Tubular should be fixed to prevent the metallic tissue from losing the plot. A ring or weld, as described below, can used to fix the ends of the wire threads.
Durante el procedimiento de moldeo, un elemento de moldeo puede colocarse dentro de la luz de la trenza tubular antes de la inserción en el molde para así además determinar la superficie de moldeo. Si los extremos del tejido metálico tubular ya se han fijado por un anillo o soldadura, el elemento de moldeo puede insertarse en la luz al mover los hilos de alambre del tejido manualmente y por separado e insertando el elemento de moldeo en la luz del tejido tubular. Por la utilización de un elemento de moldeo, pueden controlarse con justa precisión las dimensiones y la forma del dispositivo médico terminado y se asegura que el tejido se conforme a la cavidad del molde.During the molding procedure, an element molding can be placed inside the light of the tubular braid before insertion into the mold to further determine the molding surface If the ends of the tubular metallic fabric have already been fixed by a ring or weld, the molding element can be inserted into the light when moving the wire strands of the fabric manually and separately and inserting the molding element into the tubular tissue light. For the use of an element of molding, dimensions and dimensions can be precisely controlled shape of the finished medical device and ensures that the tissue is according to the mold cavity.
El elemento de moldeo puede formarse de un material seleccionado que permita destruir o retirar dicho elemento de moldeo del interior del tejido metálico. Por ejemplo, el elemento de moldeo puede formarse de un material quebradizo o friable. Una vez el material se ha tratado con calor en contacto con las cavidades del molde y el elemento de moldeo, dicho elemento puede romperse en piezas más pequeñas y retirarse fácilmente desde el interior del metal tejido. Por ejemplo, si este material es vidrio, el elemento de moldeo y el tejido metálico pueden golpearse contra una superficie dura, que haga pedazos el vidrio. Los fragmentos de vidrio pueden quitarse entonces del cercado adjunto del metal tejido.The molding element can be formed of a selected material that allows to destroy or remove said molding element inside the metal fabric. For example, The molding element can be formed of a brittle material or friable. Once the material has been heat treated in contact with the mold cavities and the molding element, said element can be broken into smaller pieces and easily removed from The interior of the woven metal. For example, if this material is glass, molding element and metallic fabric can bang against a hard surface, which shatters the glass. The glass fragments can then be removed from the fence Attached woven metal.
De modo alternativo, el elemento de moldeo puede formarse por un material que pueda disolverse con facilidad o de lo contrario, alterarse químicamente por un agente químico que no afecte substancial y adversamente las propiedades de los hilos de alambre metálico. Por ejemplo, el elemento de moldeo puede hacerse con una resina plástica resistente a la temperatura, capaz de disolverse con el solvente orgánico apropiado. En este caso, el tejido metálico y el elemento de moldeo pueden someterse a un tratamiento de calor para configurar substancialmente la forma del tejido en conformidad con la cavidad del molde y el elemento de moldeo, después de lo cual, el elemento de moldeo y el tejido metálico pueden colocarse en la superficie del solvente. Una vez el elemento de moldeo se ha disuelto substancialmente, el tejido metálico puede retirarse del solvente.Alternatively, the molding element it can be formed by a material that can dissolve easily or otherwise, chemically altered by a chemical agent that does not substantially and adversely affect the properties of the threads of metallic wire For example, the molding element can be made with a temperature resistant plastic resin, capable of dissolve with the appropriate organic solvent. In this case, the metallic fabric and the molding element can undergo a heat treatment to substantially configure the shape of the fabric in accordance with the mold cavity and the element of molding, after which, the molding element and tissue Metallic can be placed on the surface of the solvent. Once the molding element has substantially dissolved, the tissue Metallic can be removed from the solvent.
Debe tenerse cuidado para asegurar que los materiales seleccionados para formar el elemento de moldeo sean capaces de resistir el tratamiento de calor sin perder su forma, por lo menos hasta que se haya configurado la forma del tejido. Por ejemplo, el elemento de moldeo podría formarse de un material con un punto de fusión por encima de la temperatura necesaria para lograr la forma de los hilos de alambre, pero por debajo del punto de fusión del metal que forma los hilos. El elemento de moldeo y el tejido metálico podrían tratarse entonces con calor para dar forma al tejido metálico, después de lo cual, la temperatura se aumentaría hasta completar esencialmente la fusión del elemento de moldeo, mientras se removería el elemento de moldeo desde el interior del tejido metálico.Care must be taken to ensure that materials selected to form the molding element be capable of resisting heat treatment without losing its shape, by at least until the shape of the tissue has been configured. By For example, the molding element could be formed of a material with a melting point above the temperature needed to achieve the shape of the wire wires, but below the point of fusion of the metal that forms the threads. The molding element and the metallic tissue could then be heat treated to shape to the metallic fabric, after which, the temperature is would increase until essentially the fusion of the element of molding, while the molding element would be removed from the inside the metal fabric.
Los expertos en la técnica apreciarán que la forma específica del elemento de moldeo produce la forma específica del dispositivo amoldado. Si se desea una forma más compleja, el elemento de moldeo y el molde pueden tener piezas adicionales incluso agregados que transmitan movimiento (tipo cam), pero si la forma es más simple, el molde puede tener pocas piezas. El número de piezas en un molde dado y las formas de esas partes será determinado casi completamente por la forma del dispositivo médico deseado para el que, por lo general, el tejido metálico se conformará.Those skilled in the art will appreciate that the specific form of the molding element produces the specific form of the molded device. If a more complex form is desired, the Molding element and mold may have additional parts even aggregates that transmit movement (cam type), but if the Shape is simpler, the mold may have few pieces. The number of pieces in a given mold and the shapes of those parts will be determined almost completely by the shape of the medical device desired for which, generally, the metallic tissue is conform to.
Cuando la trenza tubular, por ejemplo, está plegada en su configuración laxa preformada, cada una de los hilos de alambre que forman la trenza tubular tendrá, con respecto a las otras, la orientación relativa predeterminada primero. Como la trenza tubular está comprimida a lo largo de su eje, el tejido tenderá a ampliarse fuera del eje para configurase con la forma del molde. Cuando el tejido se deforma así, cambiará la orientación relativa de los hilos de alambre del propio tejido metálico. Cuando el molde se ensambla, el tejido metálico por lo general se conformará a la superficie de moldeo del interior de la cavidad. Después de sufrir el proceso de memoria de forma, el dispositivo médico resultante tiene una configuración relajada o laxa prefijada y una configuración plegada o extendida que permite pasar el dispositivo a través de un catéter u otro dispositivo de transporte similar. La configuración relajada por lo general se define por la forma del tejido cuando está deformado para en términos generales conformarse a la superficie de moldeo del molde.When the tubular braid, for example, is folded in its preformed lax configuration, each of the threads of wire that form the tubular braid will have, with respect to the others, the default relative orientation first. As the tubular braid is compressed along its axis, the tissue will tend to expand outside the axis to configure with the shape of the mold. When the fabric deforms like this, the orientation will change relative of the wire wires of the metallic fabric itself. When the mold is assembled, the metal fabric is usually will conform to the molding surface inside the cavity. After suffering the shape memory process, the device resulting doctor has a relaxed or lax setting preset and a folded or extended configuration that allows to pass the device through a catheter or other transport device Similary. The relaxed configuration is usually defined by the tissue shape when deformed in general terms conform to the mold molding surface.
Una vez el tejido metálico plano o tubular se posiciona apropiadamente dentro de un molde preseleccionado con el tejido metálico por lo general ajustado a la superficie de moldeo de las cavidades de que se trata, el tejido puede someterse a un tratamiento térmico mientras permanece en contacto con la superficie de moldeo. El proceso del tratamiento térmico adecuado para configurar el alambre de nitinol en la forma deseada se conoce bien en la técnica. Las trenzas de nitinol enrolladas en forma de espiral por ejemplo, se usan en un número de dispositivos médicos, tal como en la formación de anillos comúnmente portados alrededor de las uniones distales de los alambres guías. Existe amplio conocimiento en la formación de nitinol en tales dispositivos, así no es necesario tratar minuciosamente los parámetros del tratamiento térmico para el tejido de nitinol seleccionado para el uso en la presente invención. Brevemente, sin embargo, se ha demostrado que el sometimiento del tejido de nitinol a temperatura aproximadamente de 500 a 550 grados centígrados por un período aproximado de 1 a 30 minutos y en dependencia de la suavidad o la dureza del dispositivo que se requiere hacer, tenderá a configurar el tejido en su estado de deformidad, es decir, como se conforma en la superficie de moldeo de las cavidades del molde. A temperaturas más bajas, el tiempo de tratamiento térmico tenderá a ser mayor (por ejemplo, cerca de 1 hora a aproximadamente 350 grados centígrados) y a temperaturas más altas el tiempo propenderá a ser más corto (por ejemplo, aproximadamente 30 segundos a temperatura cercana a 900 grados centígrados). Estas condiciones pueden variarse como sea necesario para ajustar las variaciones en la composición exacta del nitinol, previo a su tratamiento térmico, las propiedades del nitinol que se desean en el artículo acabado y otros factores conocidos por los expertos en este campo.Once the flat or tubular metallic fabric is properly positioned inside a pre-selected mold with the metal fabric usually adjusted to the molding surface of the cavities in question, the tissue can undergo a heat treatment while remaining in contact with the molding surface The proper heat treatment process to configure the nitinol wire in the desired way it is known Fine in the art. Nitinol braids rolled in the form of spiral for example, are used in a number of medical devices, such as in the formation of commonly carried rings around the distal junctions of the guide wires. There is ample knowledge in nitinol formation in such devices as well it is not necessary to treat treatment parameters thoroughly thermal for nitinol tissue selected for use in the present invention Briefly, however, it has been shown that subjecting the nitinol tissue at approximately temperature from 500 to 550 degrees Celsius for an approximate period of 1 to 30 minutes and depending on the softness or hardness of the device that needs to be done, will tend to configure the tissue in its state of deformity, that is, as conformed in the Molding surface of mold cavities. At more temperatures low, the heat treatment time will tend to be longer (for example, about 1 hour at about 350 degrees Celsius) and at higher temperatures the weather will tend to be shorter (for example, approximately 30 seconds at a temperature close to 900 degrees Celsius). These conditions can be varied as necessary to adjust the variations in the exact composition of the Nitinol, prior to its heat treatment, the properties of Nitinol desired in the finished article and other factors known by experts in this field.
En vez de depender de la convección térmica o de métodos similares también se conoce en la técnica la aplicación de una corriente eléctrica al nitinol para calentarlo. En la presente invención, esto puede conseguirse por ejemplo, al conectar electrodos en cada extremo del tejido metálico. El alambre puede entonces calentarse por la resistencia al calentamiento de dichos alambres para lograr el tratamiento térmico deseado, lo cual propenderá a eliminar la necesidad de aplicar calor al molde entero en la magnitud requerida para calentar el tejido metálico como se desea. Los materiales, elementos de moldeo y métodos de moldeo un dispositivo médico a partir de un tejido metálico tubular o plano se describen además en el documento U.S. Patent Application Serial No. 08/647.712, presentado el 14 de mayo de 1996 y asignado al mismo cesionario que la presente invención, y publicado como US-A-5725552.Instead of relying on thermal convection or similar methods are also known in the art the application of an electric current to nitinol to heat it. At the moment invention, this can be achieved for example by connecting electrodes at each end of the metallic tissue. Wire can then be heated by the heating resistance of said wires to achieve the desired heat treatment, which will tend to eliminate the need to apply heat to the entire mold in the magnitude required to heat the metallic fabric as want. Materials, molding elements and molding methods a medical device from a tubular or flat metallic tissue They are further described in U.S. Patent Application Serial No. 08 / 647,712, filed on May 14, 1996 and assigned to it assignee than the present invention, and published as US-A-5725552.
El tratamiento térmico del tejido metálico a temperaturas que oscilan entre 500-550 grados centígrados configura esencialmente las formas de los hilos de alambre en una posición relativa reorientada que ajusta la forma del tejido a la superficie de moldeo. Cuando el tejido metálico se retira del molde, el tejido mantiene la forma de las superficies de moldeo de las cavidades del molde para así definir un dispositivo médico con forma determinada. Después del tratamiento térmico, el tejido se retira del contacto con la cavidad de moldeo y esencialmente conservará su estado deforme. Si se utiliza un elemento de moldeo, dicho elemento de moldeo puede retirarse como se ha descrito anteriormente.The heat treatment of the metallic fabric a temperatures ranging between 500-550 degrees centigrade essentially configures the shapes of the threads of wire in a reoriented relative position that adjusts the shape from the fabric to the molding surface. When the metallic fabric gets removed from the mold, the fabric maintains the shape of the surfaces of molding of the mold cavities to define a device doctor with certain form. After heat treatment, the tissue is removed from contact with the molding cavity and It will essentially retain its deformed state. If a molding element, said molding element can be removed as described above
El tiempo requerido para el proceso de tratamiento térmico dependerá principalmente del material del que se forman los hilos de alambre, del tejido metálico y la masa del molde, pero el tiempo y la temperatura del tratamiento térmico deben seleccionarse para configurar substancialmente el tejido en su estado de deformidad, es decir, donde los hilos de alambre están reorientadas en su configuración relativa y el tejido generalmente se conforma a la superficie de moldeo. El tiempo requerido y la temperatura del tratamiento térmico pueden variar grandemente y dependen del material utilizado para formar los hilos de alambre. Como se ha mencionado anteriormente, la clase de materiales que se prefieren para formar los hilos de alambre son aleaciones con memoria de forma como nitinol, una aleación de titanio y níquel, que particularmente se prefiere. Si el nitinol se usa para hacer los hilos de alambre del tejido, éstas tenderán a ser muy elásticas cuando el metal está en su fase austenítica; a esta fase tan elástica frecuentemente se le ha dado a conocer como fase superelástica o seudoplástica. Calentando el nitinol por encima de la temperatura de transición de cierta fase, la estructura cristalina del metal nitinol, tenderá a "tomar" la forma del tejido y la configuración relativa de los hilos de alambre en las posiciones en las cuales se les mantiene durante el tratamiento térmico.The time required for the process of heat treatment will depend mainly on the material from which they form the wires of wire, of the metallic fabric and the mass of the mold, but the time and temperature of the heat treatment must be selected to substantially configure the tissue in your state of deformity, that is, where the wire wires are reoriented in their relative configuration and generally tissue It conforms to the molding surface. The time required and the heat treatment temperature can vary greatly and They depend on the material used to form the wire wires. As mentioned above, the kind of materials that are prefer to form wire strands are alloys with shape memory like nitinol, a titanium and nickel alloy, which particularly preferred. If nitinol is used to make woven wire threads, these will tend to be very elastic when the metal is in its austenitic phase; to this phase so elastic has frequently been known as a phase superelastic or pseudoplastic. Heating the nitinol above the transition temperature of a certain phase, the structure crystalline nitinol metal, will tend to "take" the shape of the fabric and the relative configuration of the wire strands in the positions in which they are maintained during treatment thermal.
Una vez que se ha formado el dispositivo con una forma predeterminada, dicho dispositivo puede utilizarse para tratar el estado disfuncional de un paciente. Se selecciona un dispositivo médico adecuado para tratar la condición. Una vez el dispositivo médico apropiado se selecciona, un catéter u otro dispositivo igualmente adecuado para el transporte puede posicionarse dentro de un conducto en el cuerpo del paciente para colocar el extremo distal del dispositivo de transporte adyacente a la zona de tratamiento citada, tal como la comunicación de una abertura anormal inmediatamente adyacente (o incluso dentro) en el órgano del paciente, por ejemplo.Once the device has been formed with a by default, said device can be used to treat the dysfunctional state of a patient. A Medical device suitable to treat the condition. Once the appropriate medical device is selected, a catheter or other device equally suitable for transport can position itself inside a duct in the patient's body to place the distal end of the adjacent transport device to the aforementioned treatment zone, such as the communication of a Abnormal opening immediately adjacent (or even inside) in the patient organ, for example.
El dispositivo de transporte (no mostrado) puede tomar una forma adecuada indeterminada, pero deseablemente consta de un eje metálico alargado y flexible con un extremo distal roscado. El instrumento de transporte puede usarse para conducir el dispositivo médico a través de la luz de un catéter para el despliegue en el conducto del cuerpo de un paciente. Cuando el dispositivo se despliega fuera del extremo distal del catéter, el dispositivo aún se retendrá por el instrumento de transporte. Una vez el dispositivo médico se posiciona adecuadamente dentro de la comunicación de la abertura anormal, el extremo distal del catéter puede presionarse contra el dispositivo médico y el cuerpo metálico o cable guía puede hacerse girar sobre su eje para desenroscar el dispositivo médico desde el extremo distal roscado del eje. Entonces el catéter y el cable guía se retiran.The transport device (not shown) can take a proper indeterminate form, but desirably consists of an elongated and flexible metal shaft with a distal end screwed. The transport instrument can be used to drive the medical device through the light of a catheter for the deployment in the duct of a patient's body. When he device is deployed outside the distal end of the catheter, the device will still be retained by the transport instrument. A Once the medical device is properly positioned within the abnormal opening communication, the distal end of the catheter can be pressed against the medical device and the metal body or guide wire can be rotated on its axis to unscrew the medical device from the threaded distal end of the shaft. So the catheter and guide wire are removed.
Al mantener el dispositivo médico acoplado a los medios de transporte significa que el operador puede retraer el dispositivo para reubicarlo en relación con la abertura anormal, si se determina que el dispositivo no está adecuadamente colocado dentro de la comunicación. Un anillo roscado acoplado al dispositivo médico le permite al operador controlar la manera en que el dispositivo médico se despliega fuera del extremo distal del catéter. Cuando el dispositivo sale del catéter, tenderá a recobrar, por elasticidad, la forma relajada elegida. Cuando el dispositivo adopta su forma anterior, puede tender a tocar contra el extremo distal del catéter y conducirse eficazmente a sí mismo más allá del extremo del catéter. Este efecto de muelle probablemente podría producir el posicionamiento impropio del dispositivo si la localización del dispositivo dentro del conducto está en un punto crítico, como cuando se posiciona en una comunicación entre dos vasos. Dado que el anillo enroscado puede permitir al operador mantener el dispositivo sostenido durante el despliegue, el efecto de muelle del dispositivo puede controlarse por el operador para asegurar el posicionamiento apropiado durante el despliegue.By keeping the medical device attached to the means of transport means that the operator can retract the device to relocate it in relation to the abnormal opening, if it is determined that the device is not properly placed within the communication A threaded ring coupled to the device doctor allows the operator to control the way in which the medical device is deployed outside the distal end of the catheter. When the device leaves the catheter, it will tend to recover, by elasticity, the relaxed form chosen. When the device It adopts its previous form, it can tend to touch against the end distal catheter and effectively lead yourself beyond the catheter end This spring effect could probably produce improper positioning of the device if the location of the device inside the duct is at one point critical, such as when it is positioned in a communication between two glasses. Since the threaded ring can allow the operator keep the device held during deployment, the effect device spring can be controlled by the operator to ensure proper positioning during deployment.
El dispositivo médico puede plegarse a su configuración plegada e insertarse en la luz del catéter. La configuración plegada del dispositivo puede ser de cualquier forma, la adecuado para el pasaje fácil a través de la luz de un catéter y el despliegue apropiado fuera del extremo distal del catéter. Por ejemplo, el dispositivo oclusivo para FOP puede tener una configuración plegada relativamente alargada en donde el dispositivo se estira a lo largo de su eje longitudinal (véase Figura 5). Esta configuración plegada puede lograrse simplemente por estiramiento del dispositivo generalmente a lo largo de su eje, por ejemplo tomando con las manos los anillos y tirando de ellos por separado, lo cual tenderá a plegar las partes relajadas del diámetro del dispositivo interiormente hacia el eje de dicho dispositivo. El cargar tal dispositivo en un catéter puede hacerse en el momento de la implantación lo que hace que no se requiera cargar previamente el introductor o catéter.The medical device can be folded to your folded configuration and inserted into catheter light. The Folded device configuration can be any way, suitable for easy passage through the light of a catheter and proper deployment outside the distal end of the catheter. By for example, the occlusive device for FOP may have a relatively elongated folded configuration where the device stretches along its longitudinal axis (see Figure 5). This folded configuration can be achieved simply by stretching the device generally along its axis, for example, taking the rings with your hands and pulling them separately, which will tend to fold the relaxed parts of the diameter of the device internally towards the axis of said device. Loading such a device into a catheter can be done. at the time of implementation what does not require preload the introducer or catheter.
Si el dispositivo se usará para ocluir permanentemente un conducto en el cuerpo del paciente, simplemente puede retraerse el catéter y retirarlo del cuerpo del paciente. Esto deja el dispositivo médico desplegado en el sistema vascular del paciente para que pueda ocluir el vaso sanguíneo u otro conducto en el cuerpo del paciente. En algunas circunstancias, el dispositivo médico puede acoplarse a un sistema de transportación, de manera tal que se asegure el dispositivo al extremo de los medios de transporte. Antes de retirar el catéter en tal sistema, puede ser necesario separar el dispositivo médico de los medios de transporte antes de retirar el catéter y los medios de transporte.If the device will be used to occlude permanently a duct in the patient's body, simply The catheter can be retracted and removed from the patient's body. This leaves the medical device deployed in the vascular system. of the patient so that he can occlude the blood vessel or other duct in the patient's body. In some circumstances, the medical device can be coupled to a transportation system, in such a way that the device is secured to the end of the transport. Before removing the catheter in such a system, it may be necessary to separate the medical device from the means of transport before removing the catheter and the means of transport.
Cuando el dispositivo se despliega en un paciente, habrá tendencia a la formación de trombos en la superficie de los alambres. Al tener los alambres mayor grosor, el área total de la superficie de los alambres aumentará, incrementando así la actividad trombótica del dispositivo lo que le permite relativamente de manera rápida ocluir el vaso en que se despliega. Se piensa que al formar el dispositivo de oclusión a partir de una trenza tubular con diámetro de 4 mm con una cantidad de giros de 40 por lo menos y un ángulo de inclinación de al menos 30º aproximadamente, se proporcionará el área de superficie suficiente para ocluir esencial y completamente la abertura anormal del tabique. Si se desea aumentar la proporción a que el dispositivo ocluye, pueden aplicarse al dispositivo cualquiera de una variedad amplia de agentes de oclusión conocidos. Los expertos en la técnica apreciarán que una membrana oclusiva, fibra, o malla puede posicionarse dentro de cualquiera de los discos 12 y 14 o en ambos, para mejorar además la característica oclusiva de cada disco (véase Figura 3).When the device is deployed in a patient, there will be a tendency to thrombus formation in the wire surface. By having the wires thicker, the total surface area of the wires will increase, thus increasing the thrombotic activity of the device which it allows you relatively quickly to occlude the vessel in which it display It is thought that by forming the occlusion device a from a tubular braid with a diameter of 4 mm with an amount of turns of at least 40 and an inclination angle of at least 30º approximately, the surface area will be provided enough to essentially and completely occlude the abnormal opening of the partition. If you want to increase the proportion to which the device occludes, any of a variety can be applied to the device wide of known occlusion agents. Those skilled in the art they will appreciate that an occlusive membrane, fiber, or mesh can position within any of discs 12 and 14 or both, to further improve the occlusive characteristic of each disc (see Figure 3).
Terminada la descripción detallada de la invención, la referencia específica a las figuras se presentará a continuación. Las diversas figuras ilustran varias realizaciones de la invención donde la parte central es elástica y tira de los discos exteriores, del uno hacia el otro. En relación primero con las figuras 1 y 2, se muestra por lo general el dispositivo 10 adecuado para ocluir el Foramen Oval Permeable (FOP). En estado de relajación, no extendido (véase Figura 2), el dispositivo 10 generalmente incluye dos discos 12 y 14 alineados unido uno al otro por una porción central elástica 16. El número de alambres trenzados forman la superficie externa 18 y la interna 20 de cada disco. La superficie 20 interna de cada disco puede ser cóncava o en forma de copa (también véase Figura 7) para asegurar que el borde del perímetro exterior 22 y 24 de cada disco 12 y 14 se ponga en contacto con la pared del tabique correspondiente 40.Finished the detailed description of the invention, the specific reference to the figures will be presented to continuation. The various figures illustrate various embodiments of the invention where the central part is elastic and pulls the outer disks, from one to the other. In relation first to Figures 1 and 2, the device 10 is generally shown suitable to occlude the Permeable Oval Foramen (FOP). In state of relaxation, not extended (see Figure 2), device 10 generally includes two aligned 12 and 14 discs attached to each other another for an elastic central portion 16. The number of wires braided form the outer surface 18 and inner 20 of each disk. The inner surface 20 of each disk can be concave or cup-shaped (also see Figure 7) to ensure that the edge of the outer perimeter 22 and 24 of each disk 12 and 14 be put in contact with the wall of the corresponding partition 40.
Cuando el dispositivo 10 está en estado de relajación, los discos 12 y 14 tienden a solaparse y la porción central 16 se extiende en el vacío formado por la superficie interna de los discos 12 y 14. De esta manera, cuando los discos 12 y 14 se separan (véase Figura 3) el efecto muelle de la porción 16 central causará que el borde del perímetro 22 y 24 del disco correspondiente cierre totalmente la pared lateral del tabique (véase Figura 11 y 12). Las Figuras 3-5 ilustran de modo secuencial el estiramiento por el efecto muelle de la porción 16 central curvada. Sin limitaciones intencionales, durante la formación del dispositivo 10, se allana parcialmente la trenza tubular (en la región que forma la porción central 16) para mejorar el efecto muelle en dicha porción central16. La figura 6 ilustra que los discos 12 y 14 pueden equilibrarse lateralmente por estiramiento de la porción central 16.When device 10 is in the state of relaxation, discs 12 and 14 tend to overlap and the portion central 16 extends in the vacuum formed by the internal surface of disks 12 and 14. Thus, when disks 12 and 14 are separate (see Figure 3) the spring effect of the central portion 16 will cause the edge of perimeter 22 and 24 of the disk corresponding fully close the side wall of the partition (see Figure 11 and 12). Figures 3-5 illustrate of sequential mode stretching by the spring effect of the portion 16 central curved. Without intentional limitations, during the formation of device 10, the braid is partially flattened tubular (in the region that forms the central portion 16) to improve the spring effect in said central portion16. Figure 6 illustrates that discs 12 and 14 can be balanced laterally by stretching of the central portion 16.
Los extremos 26 y 28 del tejido metálico tubular trenzado del dispositivo 10 se sueldan o sujetan juntos con los correspondientes anillos 30 y 32 para evitar la deshiladura. Por supuesto, alternativamente, los extremos pueden unirse sin dificultad por otros medios que se conocen por los expertos en la técnica. Además, se comprende que otros medios de fijación adecuados pueden acoplarse a los extremos 26 y 28 de otras maneras, como soldadura por calor, soldadura con una aleación de punto de fusión bajo, o alto, o con el uso de material de cemento biocompatible, o de cualquier otro modo útil. Los anillos 30 y 32 que mantienen juntos los hilos de alambre en los extremos correspondientes 26 y 28 también sirven para conectar el dispositivo a un sistema de transporte. En la realización que se ha mostrado, los anillos 30 y 32 son generalmente de forma cilíndrica y tienen un diámetro interno 34 roscado (véase Figura 7) para recibir los extremos 26 y 28 del tejido metálico y prevenir esencialmente el movimiento relativo de unos alambres con otros. El interior 34 roscado se adapta para recibir y trabar el extremo distal también roscado de un dispositivo de transporte.The ends 26 and 28 of the tubular metal fabric twisted device 10 are welded or held together with the corresponding rings 30 and 32 to prevent fraying. By course, alternatively, the ends can be joined without difficulty by other means that are known by experts in the technique. In addition, it is understood that other fixing means suitable can be coupled to ends 26 and 28 in other ways, as heat welding, welding with a point alloy low, or high melting, or with the use of cement material biocompatible, or in any other useful way. Rings 30 and 32 that hold wire wires together at the ends corresponding 26 and 28 also serve to connect the device to a transport system. In the realization that has been shown, rings 30 and 32 are generally cylindrical in shape and have an internal diameter 34 threaded (see Figure 7) to receive the ends 26 and 28 of the metallic fabric and essentially prevent the relative movement of some wires with others. The interior 34 threaded adapts to receive and lock the distal end as well Threading of a transport device.
Las figuras 8-10 muestran realizaciones adicionales del dispositivo 10 donde la forma de la porción elástica central 16 es variada. La parte central 16 es flexible en ambas direcciones, lateral y antero posterior. Esta flexibilidad proporciona al dispositivo la característica de centrarse a sí mismo, por la que, los discos 12 y 14 tienden a centrarse automáticamente ellos mismos alrededor de la abertura adyacente del defecto (véanse las figuras 11 y 12) mientras tiende a tirar los discos, el uno hacia el otro. La porción 16 central puede incluir una forma helicoidal semejante a un muelle (véase figura 9), una forma en espiral (véase la figura 10), o una forma curvada (véase figura 2).Figures 8-10 show additional embodiments of device 10 where the shape of the central elastic portion 16 is varied. The central part 16 is flexible in both directions, lateral and antero posterior. This flexibility gives the device the characteristic of focus on yourself, whereby, disks 12 and 14 tend to automatically center themselves around the opening adjacent to the defect (see Figures 11 and 12) while tending to throw the discs, towards each other. The central portion 16 may include a coil-like helical shape (see figure 9), a spiral shape (see figure 10), or a shape curved (see figure 2).
Los expertos en la técnica apreciarán que el dispositivo 10 se clasifica según el tamaño de la comunicación interauricular a ser ocluida. El diámetro de cada disco 12 y 14 puede variarse como se desee para las aberturas de la pared del tabique clasificadas de manera diferente según el tamaño. Además, la longitud de la porción central elástica puede variarse también en dependencia del espesor de la pared del tabique, y puede ir desde 4 a 40 mm.Those skilled in the art will appreciate that the device 10 is classified according to the size of the communication interatrial to be occluded. The diameter of each disc 12 and 14 can be varied as desired for the wall openings of the septum classified differently according to size. Besides, the length of the central elastic portion can also be varied in Dependence on the wall thickness of the partition, and can range from 4 to 40 mm
El dispositivo 10 para la oclusión de FOP puede hacerse ventajosamente de acuerdo con el método resumido anteriormente. El dispositivo se hace preferentemente de una malla de alambre de nitinol de 0,013 cm. El trenzado de la malla de alambre puede llevarse a cabo con 28 cruces alternos por pulgada con un ángulo de inclinación de aproximadamente 64 grados cuando se utiliza un trenzador Maypole con 72 filamentos de alambre. La rigidez del dispositivo 10 para FOP puede aumentarse o disminuirse al cambiar el tamaño del alambre, el ángulo de inclinación, el número de entrecruzamientos alternos, el diámetro de la trenza, el número de filamentos de alambre, o el proceso del tratamiento térmico. Los expertos en la técnica reconocerán de la discusión precedente que las cavidades del molde deben configurarse en correspondencia con la forma del dispositivo para FOP que se desea.The device 10 for FOP occlusion can be advantageously done according to the summarized method previously. The device is preferably made of a mesh 0.013 cm nitinol wire. The braided mesh wire can be carried out with 28 alternate crosses per inch with an inclination angle of approximately 64 degrees when Use a Maypole braider with 72 wire strands. The rigidity of the device 10 for FOP can be increased or decreased when changing the wire size, the angle of inclination, the number of alternate crosslinks, the diameter of the braid, the number of wire filaments, or the treatment process thermal. Those skilled in the art will recognize the discussion precedent that the mold cavities must be configured in correspondence with the form of the device for FOP that want.
Al usar tejidos de NiTi no tratados, los hilos tenderán a volver a su configuración no trenzada y el cordón puede desenredarse bastante rápidamente a menos que los extremos de la longitud de la trenza sean constreñidos entre sí. Los anillos 30 y 32 son útiles para prevenir que la trenza se desteja en cualquiera de los extremos, así definen eficazmente un espacio vacío dentro del extremo sellado del tejido. Estos anillos, 30 y 32, mantienen los extremos de los cortes de trenza unidos y previenen que dicha trenza se deshaga. Aunque la soldadura con bajo y alto punto de fusión de aleaciones de NiTi ha demostrado ser bastante difícil, los extremos pueden soldarse juntos, tanto por fusión de los hilos o con un soldador de láser. Al cortar el tejido a las dimensiones deseadas, debe tenerse cuidado para asegurar que el tejido no se deshaga. En el caso de trenzas tubulares por ejemplo, formadas de aleaciones de NiTi, los hilos individuales tenderán a volver a su configuración obtenida por la acción del calor a menos que se constriñan. Si la trenza se somete al calor para configurar los hilos en forma trenzada, éstas tenderán a permanecer en la forma trenzada y sólo los extremos se deshilarán. Sin embargo, puede ser más económico simplemente formar la trenza sin tratamiento térmico de dicha trenza, ya que el tejido se tratará de nuevo con calor para formar el dispositivo médico.When using untreated NiTi fabrics, the threads they will tend to return to their unbraided configuration and the cord can untangle fairly quickly unless the ends of the Braid length be constrained to each other. Rings 30 and 32 are useful to prevent the braid from unraveling in any of the ends, thus effectively define an empty space inside of the sealed end of the fabric. These rings, 30 and 32, keep the ends of the braid cuts attached and prevent that said Braid falls apart. Although welding with low and high point of NiTi alloy fusion has proven to be quite difficult, the ends can be welded together, both by melting the wires or with a laser welder. When cutting the fabric to the dimensions desired, care should be taken to ensure that the tissue is not undo In the case of tubular braids for example, formed of NiTi alloys, the individual threads will tend to return to their configuration obtained by the action of heat unless it they constrain. If the braid is subjected to heat to configure the braided strands, these will tend to remain in the form braided and only the ends will fray. However, it can be cheaper to simply form the braid without heat treatment of said braid, since the fabric will be treated again with heat to form the medical device.
El uso del dispositivo 10 de la presente invención se discutirá ahora con mayor detalle en relación con la oclusión de un FOP. El dispositivo puede transportarse y colocarse adecuadamente con la utilización de ecocardiografía bidimensional y un mapeo de flujo Doppler en color. Como se ha indicado anteriormente, el instrumento de transporte puede tomar la forma adecuada, cualquiera que sea, preferentemente que conste de un eje metálico flexible estirado similar a un cable guía convencional. El instrumento de transporte se usa para llevar el dispositivo de oclusión de FOP a través de la luz del tubo cilíndrico de diámetro pequeño, tal cual un catéter de transporte, para el despliegue de dicho dispositivo. El dispositivo 10 de FOP se coloca en el tubo cilíndrico de diámetro pequeño utilizando una funda de carga para estirar el dispositivo y ponerlo en su configuración alargada o estirada. El dispositivo puede insertarse en la luz del tubo durante el procedimiento o puede montarse previamente como una facilidad de la manufactura, en la cual los dispositivos de la presente invención no permanecen colocados cuando se mantienen en estado comprimido.The use of the device 10 of the present invention will now be discussed in greater detail in relation to the occlusion of a FOP. The device can be transported and placed adequately with the use of two-dimensional echocardiography and a color Doppler flow mapping. As indicated previously, the transport instrument can take the form suitable, whatever, preferably consisting of an axis stretched flexible metal similar to a conventional guide wire. He transport instrument is used to carry the device FOP occlusion through the diameter cylindrical tube light small, as is a transport catheter, for the deployment of said device. The FOP device 10 is placed in the tube Small diameter cylindrical using a charging case to stretch the device and put it in its elongated configuration or stretched out The device can be inserted into the tube light during the procedure or can be pre-assembled as a facility for the manufacture, in which the devices of the present invention they do not remain placed when they are kept in state compressed.
Desde la aproximación por la vena femoral, el catéter o tubo de transporte se pasa por el FOP. El dispositivo 10 se hace avanzar a través del catéter de transporte hasta el extremo distal, vuelve al estado no constreñido para salir al extremo del catéter, después de lo cual asume su forma de disco en la aurícula izquierda (véase figura 13). El catéter de transporte se tira entonces atrás en dirección proximal a través del FOP y el instrumento de transporte se tira igualmente en dirección proximal, empujando al disco distal contra el tabique. El catéter de transporte se tira entonces más afuera desde el tabique, permitiendo que el disco proximal se extienda fuera del catéter de transporte donde por resiliencia retorna a su forma prefijada de disco laxo. De esta manera, el dispositivo de FOP se posiciona de forma tal que el disco distal presione contra un lado del tabique mientras que el disco proximal presiona contra el otro lado del tabique. Para aumentar su capacidad de oclusión, el dispositivo puede contener fibras de poliéster o tejido de nailon (véase figura 3). En los casos donde el dispositivo se despliega inadecuadamente en una primera prueba, se puede recuperar al tirar del dispositivo de transporte en dirección proximal, para retraer al dispositivo 10 dentro del catéter de transporte previo a un segundo intento para posicionar el dispositivo en relación con el defecto.From the approach through the femoral vein, the catheter or transport tube is passed through the FOP. Device 10 is advanced through the transport catheter to the end distal, return to the unconstrained state to exit to the end of the catheter, after which it assumes its disk shape in the atrium left (see figure 13). The transport catheter is pulled then back in the proximal direction through the FOP and the transport instrument is also pulled proximally, pushing the distal disc against the septum. Catheter of transport is then pulled further out from the partition, allowing that the proximal disc extends outside the transport catheter where by resilience it returns to its default form of loose disk. From In this way, the FOP device is positioned such that the distal disc presses against the side of the septum while the Proximal disc presses against the other side of the septum. For increase its occlusion capacity, the device may contain polyester fibers or nylon fabric (see figure 3). In the cases where the device is improperly deployed in a First test, can be recovered by pulling the device transport in the proximal direction, to retract the device 10 inside the transport catheter prior to a second attempt to position the device in relation to the defect.
Cuando el dispositivo de oclusión de FOP se coloca adecuadamente, el médico gira el cable guía, para separar el extremo distal de dicho cable guía del anillo 30 ó 32 del dispositivo de oclusión 10. Las roscas en el anillo son tales que la rotación del alambre guía desenrosca el alambre guía del anillo del dispositivo de oclusión 10, en lugar de girar simplemente el dispositivo de oclusión. Como se ha notado anteriormente, el anillo roscado también puede permitir al operador mantener sostenido el dispositivo durante el despliegue, o le permite al operador que controle el efecto muelle durante el despliegue del dispositivo para asegurar el posicionamiento adecuado.When the FOP occlusion device is placed properly, the doctor turns the guide wire, to separate the distal end of said guide wire of ring 30 or 32 of the occlusion device 10. The threads in the ring are such that the guide wire rotation unscrews the ring guide wire of occlusion device 10, instead of simply rotating the occlusion device As noted previously, the ring threaded can also allow the operator to hold the device during deployment, or allows the operator to control the spring effect during device deployment to ensure proper positioning.
Esta invención se ha descrito en este documento con detalle suficiente para cumplir el EPC y para proporcionar a los expertos en la técnica la información que necesitan para aplicar los nuevos principios y construir y usar realizaciones del ejemplo como se requiera. Sin embargo, se entenderá que la invención puede realizarse en dispositivos específicamente diferentes y que varias modificaciones se pueden llevar a cabo sin desviarse del alcance de dicha invención como se define por las siguientes reivindicaciones.This invention has been described in this document. in sufficient detail to comply with the EPC and to provide those skilled in the art the information they need to apply the new principles and build and use realizations of example as required. However, it will be understood that the invention can be performed on specifically different devices and that several modifications can be carried out without deviating from the scope of said invention as defined by the following claims.
\vskip1.000000\baselineskip\ vskip1.000000 \ baselineskip
Esta lista de referencias citadas por el solicitante es sólo para la conveniencia del lector. No forma parte del documento de la Patente Europea. Aún cuando se ha tenido gran cuidado en la compilación de las referencias, los errores u omisiones no pueden ser excluidos y la OEP niega toda responsabilidad a este respecto.This list of references cited by the Applicant is only for the convenience of the reader. Not a part of the European Patent document. Even when you have had great Be careful when compiling references, errors or omissions cannot be excluded and the EPO denies all Responsibility in this regard.
- \bullet US 4836204 A, Landymore [0003]US 4836204 A, Landymore [0003]
- \bullet US 5108420 A [0005]US 5108420 A [0005]
- \bullet US 5634936 A, Linde [0003]US 5634936 A, Linde [0003]
- \bullet US 5725552 A, [0011][0032]US 5725552 A, [0011] [0032]
- \bullet US 3874388 A, King [0005]US 3874388 A, King [0005]
- \bullet US 5067489 A, Lind [0023]US 5067489 A, Lind [0023]
- \bullet US 5334217 A [0005]US 5334217 A [0005]
- \bullet US 4991602 A, Amplatz [0023]US 4991602 A, Amplatz [0023]
- \bullet EP 0541063 A2 [0005]EP 0541063 A2 [0005]
- \bullet US 64771296 A [0032]US 64771296 A [0032]
\bullet US 4917089 A [0005]US 4917089 A [0005]
Claims (6)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US09/019,620 US5944738A (en) | 1998-02-06 | 1998-02-06 | Percutaneous catheter directed constricting occlusion device |
| US19620 | 1998-02-06 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ES2294820T3 true ES2294820T3 (en) | 2008-04-01 |
Family
ID=21794150
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES07014279T Expired - Lifetime ES2431563T3 (en) | 1998-02-06 | 1998-10-12 | Constrictive occlusion device directed by percutaneous catheter |
| ES98953347T Expired - Lifetime ES2294820T3 (en) | 1998-02-06 | 1998-10-12 | DECLARATION DEVICE FOR CONSTRUCTION CONDUCTED BY PERCUTANEOUS CATETER |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES07014279T Expired - Lifetime ES2431563T3 (en) | 1998-02-06 | 1998-10-12 | Constrictive occlusion device directed by percutaneous catheter |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US5944738A (en) |
| EP (3) | EP1052944B1 (en) |
| JP (1) | JP3524494B2 (en) |
| KR (1) | KR100400506B1 (en) |
| CN (1) | CN1102373C (en) |
| AT (1) | ATE372727T1 (en) |
| CA (1) | CA2319521C (en) |
| DE (1) | DE69838436T2 (en) |
| DK (1) | DK1052944T3 (en) |
| EA (1) | EA002106B1 (en) |
| ES (2) | ES2431563T3 (en) |
| PT (1) | PT1052944E (en) |
| WO (1) | WO1999039646A1 (en) |
Families Citing this family (757)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5879366A (en) * | 1996-12-20 | 1999-03-09 | W.L. Gore & Associates, Inc. | Self-expanding defect closure device and method of making and using |
| US6168622B1 (en) * | 1996-01-24 | 2001-01-02 | Microvena Corporation | Method and apparatus for occluding aneurysms |
| US6006134A (en) * | 1998-04-30 | 1999-12-21 | Medtronic, Inc. | Method and device for electronically controlling the beating of a heart using venous electrical stimulation of nerve fibers |
| US6217585B1 (en) | 1996-08-16 | 2001-04-17 | Converge Medical, Inc. | Mechanical stent and graft delivery system |
| AU4082497A (en) | 1996-08-22 | 1998-03-06 | Trustees Of Columbia University, The | Endovascular flexible stapling device |
| US6293955B1 (en) | 1996-09-20 | 2001-09-25 | Converge Medical, Inc. | Percutaneous bypass graft and securing system |
| AU4489197A (en) * | 1996-09-20 | 1998-04-14 | Sid D. Fleischman | Radially expanding prostheses and systems for their deployment |
| US5989276A (en) * | 1996-11-08 | 1999-11-23 | Advanced Bypass Technologies, Inc. | Percutaneous bypass graft and securing system |
| US6050936A (en) | 1997-01-02 | 2000-04-18 | Myocor, Inc. | Heart wall tension reduction apparatus |
| US6406420B1 (en) | 1997-01-02 | 2002-06-18 | Myocor, Inc. | Methods and devices for improving cardiac function in hearts |
| US6183411B1 (en) | 1998-09-21 | 2001-02-06 | Myocor, Inc. | External stress reduction device and method |
| US7883539B2 (en) | 1997-01-02 | 2011-02-08 | Edwards Lifesciences Llc | Heart wall tension reduction apparatus and method |
| US20030045771A1 (en) * | 1997-01-02 | 2003-03-06 | Schweich Cyril J. | Heart wall tension reduction devices and methods |
| US6077214A (en) * | 1998-07-29 | 2000-06-20 | Myocor, Inc. | Stress reduction apparatus and method |
| US7569066B2 (en) | 1997-07-10 | 2009-08-04 | Boston Scientific Scimed, Inc. | Methods and devices for the treatment of aneurysms |
| FR2767672B1 (en) * | 1997-08-27 | 1999-11-26 | Ethnor | PROSTHESES FOR SEALING HERNIA CANALS |
| US5954766A (en) * | 1997-09-16 | 1999-09-21 | Zadno-Azizi; Gholam-Reza | Body fluid flow control device |
| US6332893B1 (en) | 1997-12-17 | 2001-12-25 | Myocor, Inc. | Valve to myocardium tension members device and method |
| EP1051128B1 (en) | 1998-01-30 | 2006-03-15 | St. Jude Medical ATG, Inc. | Medical graft connector or plug structures, and methods of making |
| JP3799810B2 (en) * | 1998-03-30 | 2006-07-19 | ニプロ株式会社 | Transcatheter surgery closure plug and catheter assembly |
| AU761192B2 (en) | 1998-06-10 | 2003-05-29 | Converge Medical, Inc. | Sutureless anastomosis systems |
| US6260552B1 (en) | 1998-07-29 | 2001-07-17 | Myocor, Inc. | Transventricular implant tools and devices |
| US6183496B1 (en) * | 1998-11-02 | 2001-02-06 | Datascope Investment Corp. | Collapsible hemostatic plug |
| US7044134B2 (en) * | 1999-11-08 | 2006-05-16 | Ev3 Sunnyvale, Inc | Method of implanting a device in the left atrial appendage |
| DE60024592T2 (en) * | 1999-02-01 | 2006-07-20 | Board of Regents, The University of Texas System, Austin | WOVEN INTRAVASCULAR DEVICE AND METHOD OF MANUFACTURING |
| ES2313882T3 (en) | 1999-02-01 | 2009-03-16 | Board Of Regents, The University Of Texas System | ENDOVASCULAR PROTESTS FORKED AND FORKED FABRICS AND PROCEDURE FOR MANUFACTURING THE SAME. |
| US7018401B1 (en) | 1999-02-01 | 2006-03-28 | Board Of Regents, The University Of Texas System | Woven intravascular devices and methods for making the same and apparatus for delivery of the same |
| AU2004200062B2 (en) * | 1999-02-01 | 2007-09-06 | Board Of Regents, The University Of Texas System | Woven intravascular devices and methods for making the same and apparatus for delivery of the same |
| EP1576937B1 (en) * | 1999-02-01 | 2012-10-31 | Board Of Regents, The University Of Texas System | Woven intravascular devices and methods for making the same and apparatus for delvery of the same |
| US6206907B1 (en) * | 1999-05-07 | 2001-03-27 | Cardia, Inc. | Occlusion device with stranded wire support arms |
| US7416554B2 (en) | 2002-12-11 | 2008-08-26 | Usgi Medical Inc | Apparatus and methods for forming and securing gastrointestinal tissue folds |
| US7637905B2 (en) | 2003-01-15 | 2009-12-29 | Usgi Medical, Inc. | Endoluminal tool deployment system |
| US6626899B2 (en) | 1999-06-25 | 2003-09-30 | Nidus Medical, Llc | Apparatus and methods for treating tissue |
| US7744613B2 (en) | 1999-06-25 | 2010-06-29 | Usgi Medical, Inc. | Apparatus and methods for forming and securing gastrointestinal tissue folds |
| US7618426B2 (en) | 2002-12-11 | 2009-11-17 | Usgi Medical, Inc. | Apparatus and methods for forming gastrointestinal tissue approximations |
| US6293951B1 (en) * | 1999-08-24 | 2001-09-25 | Spiration, Inc. | Lung reduction device, system, and method |
| US20020173809A1 (en) * | 1999-09-01 | 2002-11-21 | Fleischman Sidney D. | Sutureless anastomosis system deployment concepts |
| US6494889B1 (en) | 1999-09-01 | 2002-12-17 | Converge Medical, Inc. | Additional sutureless anastomosis embodiments |
| WO2001017435A1 (en) | 1999-09-07 | 2001-03-15 | Microvena Corporation | Retrievable septal defect closure device |
| US8083766B2 (en) | 1999-09-13 | 2011-12-27 | Rex Medical, Lp | Septal defect closure device |
| US6939361B1 (en) | 1999-09-22 | 2005-09-06 | Nmt Medical, Inc. | Guidewire for a free standing intervascular device having an integral stop mechanism |
| US7951201B2 (en) | 1999-10-20 | 2011-05-31 | Anulex Technologies, Inc. | Method and apparatus for the treatment of the intervertebral disc annulus |
| US6592625B2 (en) | 1999-10-20 | 2003-07-15 | Anulex Technologies, Inc. | Spinal disc annulus reconstruction method and spinal disc annulus stent |
| US7004970B2 (en) | 1999-10-20 | 2006-02-28 | Anulex Technologies, Inc. | Methods and devices for spinal disc annulus reconstruction and repair |
| US8632590B2 (en) | 1999-10-20 | 2014-01-21 | Anulex Technologies, Inc. | Apparatus and methods for the treatment of the intervertebral disc |
| US8128698B2 (en) | 1999-10-20 | 2012-03-06 | Anulex Technologies, Inc. | Method and apparatus for the treatment of the intervertebral disc annulus |
| US7615076B2 (en) | 1999-10-20 | 2009-11-10 | Anulex Technologies, Inc. | Method and apparatus for the treatment of the intervertebral disc annulus |
| US7935147B2 (en) | 1999-10-20 | 2011-05-03 | Anulex Technologies, Inc. | Method and apparatus for enhanced delivery of treatment device to the intervertebral disc annulus |
| US7052516B2 (en) | 1999-10-20 | 2006-05-30 | Anulex Technologies, Inc. | Spinal disc annulus reconstruction method and deformable spinal disc annulus stent |
| US6994092B2 (en) * | 1999-11-08 | 2006-02-07 | Ev3 Sunnyvale, Inc. | Device for containing embolic material in the LAA having a plurality of tissue retention structures |
| KR100349803B1 (en) * | 1999-11-10 | 2002-08-22 | 원용순 | A Device for Closing the Loss part of Heart, and a Pipe for moving that |
| US7018406B2 (en) | 1999-11-17 | 2006-03-28 | Corevalve Sa | Prosthetic valve for transluminal delivery |
| US8579966B2 (en) | 1999-11-17 | 2013-11-12 | Medtronic Corevalve Llc | Prosthetic valve for transluminal delivery |
| US8016877B2 (en) | 1999-11-17 | 2011-09-13 | Medtronic Corevalve Llc | Prosthetic valve for transluminal delivery |
| US20040068278A1 (en) * | 1999-12-06 | 2004-04-08 | Converge Medical Inc. | Anastomosis systems |
| US8241274B2 (en) | 2000-01-19 | 2012-08-14 | Medtronic, Inc. | Method for guiding a medical device |
| US6623492B1 (en) * | 2000-01-25 | 2003-09-23 | Smith & Nephew, Inc. | Tissue fastener |
| US7749245B2 (en) | 2000-01-27 | 2010-07-06 | Medtronic, Inc. | Cardiac valve procedure methods and devices |
| US6904909B2 (en) | 2000-03-04 | 2005-06-14 | Emphasys Medical, Inc. | Methods and devices for use in performing pulmonary procedures |
| US8474460B2 (en) | 2000-03-04 | 2013-07-02 | Pulmonx Corporation | Implanted bronchial isolation devices and methods |
| US6679264B1 (en) | 2000-03-04 | 2004-01-20 | Emphasys Medical, Inc. | Methods and devices for use in performing pulmonary procedures |
| US6537198B1 (en) | 2000-03-21 | 2003-03-25 | Myocor, Inc. | Splint assembly for improving cardiac function in hearts, and method for implanting the splint assembly |
| DE60128663T2 (en) | 2000-03-23 | 2008-01-31 | Cook Inc., Bloomington | CATHETER INTRODUCTION SLEEVE |
| US6468303B1 (en) * | 2000-03-27 | 2002-10-22 | Aga Medical Corporation | Retrievable self expanding shunt |
| US6425924B1 (en) * | 2000-03-31 | 2002-07-30 | Ethicon, Inc. | Hernia repair prosthesis |
| US6805695B2 (en) | 2000-04-04 | 2004-10-19 | Spinalabs, Llc | Devices and methods for annular repair of intervertebral discs |
| US6551344B2 (en) | 2000-04-26 | 2003-04-22 | Ev3 Inc. | Septal defect occluder |
| EP1284670B1 (en) * | 2000-05-03 | 2009-06-03 | C.R. Bard, Inc. | Apparatus for mapping and ablation in electrophysiology procedures |
| US6334864B1 (en) | 2000-05-17 | 2002-01-01 | Aga Medical Corp. | Alignment member for delivering a non-symmetric device with a predefined orientation |
| WO2002005888A1 (en) | 2000-06-30 | 2002-01-24 | Viacor Incorporated | Intravascular filter with debris entrapment mechanism |
| US6440152B1 (en) | 2000-07-28 | 2002-08-27 | Microvena Corporation | Defect occluder release assembly and method |
| WO2002015793A2 (en) | 2000-08-18 | 2002-02-28 | Atritech, Inc. | Expandable implant devices for filtering blood flow from atrial appendages |
| MXPA03002015A (en) * | 2000-09-07 | 2003-07-24 | Synthes Ag | Device for fixing surgical implants. |
| CA2423360A1 (en) | 2000-09-21 | 2002-03-28 | Atritech, Inc. | Apparatus for implanting devices in atrial appendages |
| US6616684B1 (en) * | 2000-10-06 | 2003-09-09 | Myocor, Inc. | Endovascular splinting devices and methods |
| US6723038B1 (en) | 2000-10-06 | 2004-04-20 | Myocor, Inc. | Methods and devices for improving mitral valve function |
| US8083768B2 (en) | 2000-12-14 | 2011-12-27 | Ensure Medical, Inc. | Vascular plug having composite construction |
| US6846319B2 (en) | 2000-12-14 | 2005-01-25 | Core Medical, Inc. | Devices for sealing openings through tissue and apparatus and methods for delivering them |
| US6890343B2 (en) | 2000-12-14 | 2005-05-10 | Ensure Medical, Inc. | Plug with detachable guidewire element and methods for use |
| US6623509B2 (en) | 2000-12-14 | 2003-09-23 | Core Medical, Inc. | Apparatus and methods for sealing vascular punctures |
| US6896692B2 (en) | 2000-12-14 | 2005-05-24 | Ensure Medical, Inc. | Plug with collet and apparatus and method for delivering such plugs |
| US6681773B2 (en) | 2001-02-28 | 2004-01-27 | Chase Medical, Inc. | Kit and method for use during ventricular restoration |
| US20020133227A1 (en) * | 2001-02-28 | 2002-09-19 | Gregory Murphy | Ventricular restoration patch apparatus and method of use |
| US20040074491A1 (en) * | 2001-03-02 | 2004-04-22 | Michael Hendricksen | Delivery methods and devices for implantable bronchial isolation devices |
| US7011094B2 (en) | 2001-03-02 | 2006-03-14 | Emphasys Medical, Inc. | Bronchial flow control devices and methods of use |
| US7798147B2 (en) | 2001-03-02 | 2010-09-21 | Pulmonx Corporation | Bronchial flow control devices with membrane seal |
| IL157732A0 (en) * | 2001-03-08 | 2004-03-28 | Atritech Inc | Atrial filter implants |
| US6923646B2 (en) * | 2001-04-18 | 2005-08-02 | Air Techniques, Inc. | Process and apparatus for treating an exhaust stream from a dental operatory |
| US6619291B2 (en) * | 2001-04-24 | 2003-09-16 | Edwin J. Hlavka | Method and apparatus for catheter-based annuloplasty |
| US20060069429A1 (en) * | 2001-04-24 | 2006-03-30 | Spence Paul A | Tissue fastening systems and methods utilizing magnetic guidance |
| US8202315B2 (en) | 2001-04-24 | 2012-06-19 | Mitralign, Inc. | Catheter-based annuloplasty using ventricularly positioned catheter |
| US6537300B2 (en) | 2001-05-30 | 2003-03-25 | Scimed Life Systems, Inc. | Implantable obstruction device for septal defects |
| US7338514B2 (en) * | 2001-06-01 | 2008-03-04 | St. Jude Medical, Cardiology Division, Inc. | Closure devices, related delivery methods and tools, and related methods of use |
| AU2002318349A1 (en) * | 2001-06-11 | 2002-12-23 | Ev3 Inc. | A method of training nitinol wire |
| US6712859B2 (en) * | 2001-06-28 | 2004-03-30 | Ethicon, Inc. | Hernia repair prosthesis and methods for making same |
| US8771302B2 (en) | 2001-06-29 | 2014-07-08 | Medtronic, Inc. | Method and apparatus for resecting and replacing an aortic valve |
| US8623077B2 (en) | 2001-06-29 | 2014-01-07 | Medtronic, Inc. | Apparatus for replacing a cardiac valve |
| US7544206B2 (en) | 2001-06-29 | 2009-06-09 | Medtronic, Inc. | Method and apparatus for resecting and replacing an aortic valve |
| FR2826863B1 (en) | 2001-07-04 | 2003-09-26 | Jacques Seguin | ASSEMBLY FOR PLACING A PROSTHETIC VALVE IN A BODY CONDUIT |
| US6626920B2 (en) * | 2001-07-05 | 2003-09-30 | Converge Medical, Inc. | Distal anastomosis system |
| US20030229365A1 (en) * | 2002-06-10 | 2003-12-11 | Whayne James G. | Angled vascular anastomosis system |
| US6858035B2 (en) | 2001-07-05 | 2005-02-22 | Converge Medical, Inc. | Distal anastomosis system |
| US20060064119A9 (en) * | 2001-07-05 | 2006-03-23 | Converge Medical, Inc. | Vascular anastomosis systems |
| US6972023B2 (en) * | 2001-07-05 | 2005-12-06 | Converge Medical, Inc. | Distal anastomosis system |
| US7011671B2 (en) * | 2001-07-18 | 2006-03-14 | Atritech, Inc. | Cardiac implant device tether system and method |
| FR2828091B1 (en) | 2001-07-31 | 2003-11-21 | Seguin Jacques | ASSEMBLY ALLOWING THE PLACEMENT OF A PROTHETIC VALVE IN A BODY DUCT |
| US7288105B2 (en) | 2001-08-01 | 2007-10-30 | Ev3 Endovascular, Inc. | Tissue opening occluder |
| US7485088B2 (en) * | 2001-09-05 | 2009-02-03 | Chase Medical L.P. | Method and device for percutaneous surgical ventricular repair |
| US20040243170A1 (en) * | 2001-09-05 | 2004-12-02 | Mitta Suresh | Method and device for percutaneous surgical ventricular repair |
| US6702835B2 (en) | 2001-09-07 | 2004-03-09 | Core Medical, Inc. | Needle apparatus for closing septal defects and methods for using such apparatus |
| US20060052821A1 (en) | 2001-09-06 | 2006-03-09 | Ovalis, Inc. | Systems and methods for treating septal defects |
| US6776784B2 (en) | 2001-09-06 | 2004-08-17 | Core Medical, Inc. | Clip apparatus for closing septal defects and methods of use |
| US7226466B2 (en) * | 2001-09-06 | 2007-06-05 | Nmt Medical, Inc. | Flexible delivery system |
| US7097659B2 (en) | 2001-09-07 | 2006-08-29 | Medtronic, Inc. | Fixation band for affixing a prosthetic heart valve to tissue |
| EP1423066B1 (en) | 2001-09-07 | 2008-07-16 | Mardil, Inc. | Method and apparatus for external heart stabilization |
| US20030050648A1 (en) | 2001-09-11 | 2003-03-13 | Spiration, Inc. | Removable lung reduction devices, systems, and methods |
| US6596013B2 (en) | 2001-09-20 | 2003-07-22 | Scimed Life Systems, Inc. | Method and apparatus for treating septal defects |
| AU2002347900B8 (en) | 2001-10-11 | 2006-01-12 | Emphasys Medical, Inc. | Bronchial flow control devices and methods of use |
| US6592594B2 (en) * | 2001-10-25 | 2003-07-15 | Spiration, Inc. | Bronchial obstruction device deployment system and method |
| US7318833B2 (en) | 2001-12-19 | 2008-01-15 | Nmt Medical, Inc. | PFO closure device with flexible thrombogenic joint and improved dislodgement resistance |
| US6764510B2 (en) | 2002-01-09 | 2004-07-20 | Myocor, Inc. | Devices and methods for heart valve treatment |
| WO2003059152A2 (en) | 2002-01-14 | 2003-07-24 | Nmt Medical, Inc. | Patent foramen ovale (pfo) closure method and device |
| JP4328209B2 (en) | 2002-01-25 | 2009-09-09 | アトリテック, インコーポレイテッド | Atrial appendage blood filtration system |
| US6869436B2 (en) * | 2002-02-07 | 2005-03-22 | Scimed Life Systems, Inc. | Surgical clip with a self-releasing fluid reservoir |
| US6929637B2 (en) | 2002-02-21 | 2005-08-16 | Spiration, Inc. | Device and method for intra-bronchial provision of a therapeutic agent |
| WO2003075796A2 (en) * | 2002-03-08 | 2003-09-18 | Emphasys Medical, Inc. | Methods and devices for inducing collapse in lung regions fed by collateral pathways |
| US20030216769A1 (en) | 2002-05-17 | 2003-11-20 | Dillard David H. | Removable anchored lung volume reduction devices and methods |
| US20030181922A1 (en) | 2002-03-20 | 2003-09-25 | Spiration, Inc. | Removable anchored lung volume reduction devices and methods |
| US6755868B2 (en) * | 2002-03-22 | 2004-06-29 | Ethicon, Inc. | Hernia repair device |
| EP1487353A4 (en) * | 2002-03-25 | 2008-04-16 | Nmt Medical Inc | Patent foramen ovale (pfo) closure clips |
| US20030195553A1 (en) * | 2002-04-12 | 2003-10-16 | Scimed Life Systems, Inc. | System and method for retaining vaso-occlusive devices within an aneurysm |
| US8721713B2 (en) | 2002-04-23 | 2014-05-13 | Medtronic, Inc. | System for implanting a replacement valve |
| US8241308B2 (en) * | 2002-04-24 | 2012-08-14 | Boston Scientific Scimed, Inc. | Tissue fastening devices and processes that promote tissue adhesion |
| US7976564B2 (en) | 2002-05-06 | 2011-07-12 | St. Jude Medical, Cardiology Division, Inc. | PFO closure devices and related methods of use |
| WO2003099164A1 (en) * | 2002-05-28 | 2003-12-04 | Emphasys Medical, Inc. | Implantable bronchial isolation devices and lung treatment methods |
| EP1509144A4 (en) | 2002-06-03 | 2008-09-03 | Nmt Medical Inc | Device with biological tissue scaffold for intracardiac defect closure |
| WO2003103476A2 (en) | 2002-06-05 | 2003-12-18 | Nmt Medical, Inc. | Patent foramen ovale (pfo) closure device with radial and circumferential support |
| US8348963B2 (en) * | 2002-07-03 | 2013-01-08 | Hlt, Inc. | Leaflet reinforcement for regurgitant valves |
| US20040010209A1 (en) * | 2002-07-15 | 2004-01-15 | Spiration, Inc. | Device and method for measuring the diameter of an air passageway |
| US20040059263A1 (en) * | 2002-09-24 | 2004-03-25 | Spiration, Inc. | Device and method for measuring the diameter of an air passageway |
| DE60323502D1 (en) | 2002-07-26 | 2008-10-23 | Emphasys Medical Inc | BRONCHIAL FLOW DEVICE WITH A MEMBRANE SEAL |
| EP1526810B1 (en) * | 2002-07-31 | 2009-04-15 | Abbott Laboratories Vascular Enterprises Limited | Apparatus for sealing surgical punctures |
| CA2503258C (en) * | 2002-08-28 | 2011-08-16 | Heart Leaflet Technologies, Inc. | Method and device for treating diseased valve |
| US20040127855A1 (en) * | 2002-10-10 | 2004-07-01 | Nmt Medical, Inc. | Hemostasis valve |
| US20050119735A1 (en) | 2002-10-21 | 2005-06-02 | Spence Paul A. | Tissue fastening systems and methods utilizing magnetic guidance |
| CN1705462A (en) | 2002-10-21 | 2005-12-07 | 米特拉利根公司 | Method and apparatus for performing catheter-based annuloplasty using local plications |
| AU2003284976A1 (en) | 2002-10-25 | 2004-05-13 | Nmt Medical, Inc. | Expandable sheath tubing |
| EP1562653A1 (en) * | 2002-11-06 | 2005-08-17 | NMT Medical, Inc. | Medical devices utilizing modified shape memory alloy |
| US7247134B2 (en) | 2002-11-12 | 2007-07-24 | Myocor, Inc. | Devices and methods for heart valve treatment |
| US7112219B2 (en) | 2002-11-12 | 2006-09-26 | Myocor, Inc. | Devices and methods for heart valve treatment |
| US7814912B2 (en) | 2002-11-27 | 2010-10-19 | Pulmonx Corporation | Delivery methods and devices for implantable bronchial isolation devices |
| WO2004049974A2 (en) * | 2002-11-27 | 2004-06-17 | Emphasys Medical, Inc. | Delivery method and device for implantable bronchial isolation devices |
| WO2004052213A1 (en) * | 2002-12-09 | 2004-06-24 | Nmt Medical, Inc. | Septal closure devices |
| US7942884B2 (en) | 2002-12-11 | 2011-05-17 | Usgi Medical, Inc. | Methods for reduction of a gastric lumen |
| US7942898B2 (en) | 2002-12-11 | 2011-05-17 | Usgi Medical, Inc. | Delivery systems and methods for gastric reduction |
| DE10302447B4 (en) * | 2003-01-21 | 2007-12-06 | pfm Produkte für die Medizin AG | Occlusion device, placement system, set of such a placement system and such occlusion device and method for producing an occlusion device |
| US7115135B2 (en) * | 2003-01-22 | 2006-10-03 | Cardia, Inc. | Occlusion device having five or more arms |
| US7780700B2 (en) | 2003-02-04 | 2010-08-24 | ev3 Endovascular, Inc | Patent foramen ovale closure system |
| US8021359B2 (en) | 2003-02-13 | 2011-09-20 | Coaptus Medical Corporation | Transseptal closure of a patent foramen ovale and other cardiac defects |
| US7257450B2 (en) | 2003-02-13 | 2007-08-14 | Coaptus Medical Corporation | Systems and methods for securing cardiovascular tissue |
| RU2221524C1 (en) * | 2003-02-21 | 2004-01-20 | Коков Леонид Сергеевич | Device for correction of heart diseases and covering of lumens of blood vessels |
| US20040176788A1 (en) * | 2003-03-07 | 2004-09-09 | Nmt Medical, Inc. | Vacuum attachment system |
| US7658747B2 (en) | 2003-03-12 | 2010-02-09 | Nmt Medical, Inc. | Medical device for manipulation of a medical implant |
| US7473266B2 (en) | 2003-03-14 | 2009-01-06 | Nmt Medical, Inc. | Collet-based delivery system |
| US7165552B2 (en) | 2003-03-27 | 2007-01-23 | Cierra, Inc. | Methods and apparatus for treatment of patent foramen ovale |
| WO2004087235A2 (en) | 2003-03-27 | 2004-10-14 | Cierra, Inc. | Methods and apparatus for treatment of patent foramen ovale |
| US7972330B2 (en) | 2003-03-27 | 2011-07-05 | Terumo Kabushiki Kaisha | Methods and apparatus for closing a layered tissue defect |
| US7293562B2 (en) | 2003-03-27 | 2007-11-13 | Cierra, Inc. | Energy based devices and methods for treatment of anatomic tissue defects |
| US6939348B2 (en) | 2003-03-27 | 2005-09-06 | Cierra, Inc. | Energy based devices and methods for treatment of patent foramen ovale |
| US8021362B2 (en) | 2003-03-27 | 2011-09-20 | Terumo Kabushiki Kaisha | Methods and apparatus for closing a layered tissue defect |
| US7186251B2 (en) | 2003-03-27 | 2007-03-06 | Cierra, Inc. | Energy based devices and methods for treatment of patent foramen ovale |
| US7100616B2 (en) | 2003-04-08 | 2006-09-05 | Spiration, Inc. | Bronchoscopic lung volume reduction method |
| US20040267306A1 (en) | 2003-04-11 | 2004-12-30 | Velocimed, L.L.C. | Closure devices, related delivery methods, and related methods of use |
| US8372112B2 (en) | 2003-04-11 | 2013-02-12 | St. Jude Medical, Cardiology Division, Inc. | Closure devices, related delivery methods, and related methods of use |
| JP4547381B2 (en) * | 2003-05-19 | 2010-09-22 | セプトアールエックス インコーポレイテッド | Therapeutic tissue expansion device and related methods |
| US7311701B2 (en) | 2003-06-10 | 2007-12-25 | Cierra, Inc. | Methods and apparatus for non-invasively treating atrial fibrillation using high intensity focused ultrasound |
| US7316706B2 (en) * | 2003-06-20 | 2008-01-08 | Medtronic Vascular, Inc. | Tensioning device, system, and method for treating mitral valve regurgitation |
| WO2005006990A2 (en) | 2003-07-14 | 2005-01-27 | Nmt Medical, Inc. | Tubular patent foramen ovale (pfo) closure device with catch system |
| US9861346B2 (en) | 2003-07-14 | 2018-01-09 | W. L. Gore & Associates, Inc. | Patent foramen ovale (PFO) closure device with linearly elongating petals |
| US8480706B2 (en) | 2003-07-14 | 2013-07-09 | W.L. Gore & Associates, Inc. | Tubular patent foramen ovale (PFO) closure device with catch system |
| US20050055050A1 (en) * | 2003-07-24 | 2005-03-10 | Alfaro Arthur A. | Intravascular occlusion device |
| US7533671B2 (en) | 2003-08-08 | 2009-05-19 | Spiration, Inc. | Bronchoscopic repair of air leaks in a lung |
| US8216252B2 (en) | 2004-05-07 | 2012-07-10 | Usgi Medical, Inc. | Tissue manipulation and securement system |
| WO2005018728A2 (en) | 2003-08-19 | 2005-03-03 | Nmt Medical, Inc. | Expandable sheath tubing |
| DE10338702B9 (en) * | 2003-08-22 | 2007-04-26 | Occlutech Gmbh | Occlusioninstrument |
| CA2538476A1 (en) | 2003-09-11 | 2005-04-21 | Nmt Medical, Inc. | Devices, systems, and methods for suturing tissue |
| ATE404126T1 (en) * | 2003-09-11 | 2008-08-15 | Nmt Medical Inc | CUTTING TUBE FOR SURGICAL SEWING THREAD |
| US7144410B2 (en) * | 2003-09-18 | 2006-12-05 | Cardia Inc. | ASD closure device with self centering arm network |
| US7192435B2 (en) * | 2003-09-18 | 2007-03-20 | Cardia, Inc. | Self centering closure device for septal occlusion |
| US9579194B2 (en) | 2003-10-06 | 2017-02-28 | Medtronic ATS Medical, Inc. | Anchoring structure with concave landing zone |
| US20050192627A1 (en) * | 2003-10-10 | 2005-09-01 | Whisenant Brian K. | Patent foramen ovale closure devices, delivery apparatus and related methods and systems |
| US8852229B2 (en) | 2003-10-17 | 2014-10-07 | Cordis Corporation | Locator and closure device and method of use |
| US7361183B2 (en) | 2003-10-17 | 2008-04-22 | Ensure Medical, Inc. | Locator and delivery device and method of use |
| US7419498B2 (en) | 2003-10-21 | 2008-09-02 | Nmt Medical, Inc. | Quick release knot attachment system |
| ATE374575T1 (en) * | 2003-10-24 | 2007-10-15 | Ev3 Endovascular Inc | CLOSURE SYSTEM FOR AN OPEN FORAMEN OVALE |
| US8292910B2 (en) | 2003-11-06 | 2012-10-23 | Pressure Products Medical Supplies, Inc. | Transseptal puncture apparatus |
| CA2542280A1 (en) | 2003-11-06 | 2005-05-26 | Nmt Medical, Inc. | Transseptal puncture apparatus |
| US20050273119A1 (en) | 2003-12-09 | 2005-12-08 | Nmt Medical, Inc. | Double spiral patent foramen ovale closure clamp |
| US7186265B2 (en) | 2003-12-10 | 2007-03-06 | Medtronic, Inc. | Prosthetic cardiac valves and systems and methods for implanting thereof |
| US20050251189A1 (en) | 2004-05-07 | 2005-11-10 | Usgi Medical Inc. | Multi-position tissue manipulation assembly |
| US7347863B2 (en) | 2004-05-07 | 2008-03-25 | Usgi Medical, Inc. | Apparatus and methods for manipulating and securing tissue |
| US7361180B2 (en) | 2004-05-07 | 2008-04-22 | Usgi Medical, Inc. | Apparatus for manipulating and securing tissue |
| US9005273B2 (en) | 2003-12-23 | 2015-04-14 | Sadra Medical, Inc. | Assessing the location and performance of replacement heart valves |
| US8579962B2 (en) | 2003-12-23 | 2013-11-12 | Sadra Medical, Inc. | Methods and apparatus for performing valvuloplasty |
| US7959666B2 (en) | 2003-12-23 | 2011-06-14 | Sadra Medical, Inc. | Methods and apparatus for endovascularly replacing a heart valve |
| US7780725B2 (en) | 2004-06-16 | 2010-08-24 | Sadra Medical, Inc. | Everting heart valve |
| US7824443B2 (en) | 2003-12-23 | 2010-11-02 | Sadra Medical, Inc. | Medical implant delivery and deployment tool |
| US8828078B2 (en) | 2003-12-23 | 2014-09-09 | Sadra Medical, Inc. | Methods and apparatus for endovascular heart valve replacement comprising tissue grasping elements |
| US7166127B2 (en) | 2003-12-23 | 2007-01-23 | Mitralign, Inc. | Tissue fastening systems and methods utilizing magnetic guidance |
| US8182528B2 (en) | 2003-12-23 | 2012-05-22 | Sadra Medical, Inc. | Locking heart valve anchor |
| US7329279B2 (en) | 2003-12-23 | 2008-02-12 | Sadra Medical, Inc. | Methods and apparatus for endovascularly replacing a patient's heart valve |
| US8864822B2 (en) | 2003-12-23 | 2014-10-21 | Mitralign, Inc. | Devices and methods for introducing elements into tissue |
| US11278398B2 (en) | 2003-12-23 | 2022-03-22 | Boston Scientific Scimed, Inc. | Methods and apparatus for endovascular heart valve replacement comprising tissue grasping elements |
| US8343213B2 (en) | 2003-12-23 | 2013-01-01 | Sadra Medical, Inc. | Leaflet engagement elements and methods for use thereof |
| AU2004308508B2 (en) | 2003-12-23 | 2011-03-10 | Sadra Medical, Inc. | Repositionable heart valve |
| US8603160B2 (en) * | 2003-12-23 | 2013-12-10 | Sadra Medical, Inc. | Method of using a retrievable heart valve anchor with a sheath |
| US9526609B2 (en) | 2003-12-23 | 2016-12-27 | Boston Scientific Scimed, Inc. | Methods and apparatus for endovascularly replacing a patient's heart valve |
| US20050137687A1 (en) | 2003-12-23 | 2005-06-23 | Sadra Medical | Heart valve anchor and method |
| US7824442B2 (en) | 2003-12-23 | 2010-11-02 | Sadra Medical, Inc. | Methods and apparatus for endovascularly replacing a heart valve |
| US20120041550A1 (en) | 2003-12-23 | 2012-02-16 | Sadra Medical, Inc. | Methods and Apparatus for Endovascular Heart Valve Replacement Comprising Tissue Grasping Elements |
| US7445631B2 (en) | 2003-12-23 | 2008-11-04 | Sadra Medical, Inc. | Methods and apparatus for endovascularly replacing a patient's heart valve |
| US7381219B2 (en) | 2003-12-23 | 2008-06-03 | Sadra Medical, Inc. | Low profile heart valve and delivery system |
| US20050137694A1 (en) | 2003-12-23 | 2005-06-23 | Haug Ulrich R. | Methods and apparatus for endovascularly replacing a patient's heart valve |
| US7748389B2 (en) | 2003-12-23 | 2010-07-06 | Sadra Medical, Inc. | Leaflet engagement elements and methods for use thereof |
| US8287584B2 (en) | 2005-11-14 | 2012-10-16 | Sadra Medical, Inc. | Medical implant deployment tool |
| US8840663B2 (en) | 2003-12-23 | 2014-09-23 | Sadra Medical, Inc. | Repositionable heart valve method |
| US8262694B2 (en) | 2004-01-30 | 2012-09-11 | W.L. Gore & Associates, Inc. | Devices, systems, and methods for closure of cardiac openings |
| WO2005074517A2 (en) | 2004-01-30 | 2005-08-18 | Nmt Medical, Inc. | Welding systems for closure of cardiac openings |
| US8206684B2 (en) | 2004-02-27 | 2012-06-26 | Pulmonx Corporation | Methods and devices for blocking flow through collateral pathways in the lung |
| ITTO20040135A1 (en) | 2004-03-03 | 2004-06-03 | Sorin Biomedica Cardio Spa | CARDIAC VALVE PROSTHESIS |
| EP1737349A1 (en) | 2004-03-03 | 2007-01-03 | NMT Medical, Inc. | Delivery/recovery system for septal occluder |
| US7976539B2 (en) | 2004-03-05 | 2011-07-12 | Hansen Medical, Inc. | System and method for denaturing and fixing collagenous tissue |
| US7703459B2 (en) | 2004-03-09 | 2010-04-27 | Usgi Medical, Inc. | Apparatus and methods for mapping out endoluminal gastrointestinal surgery |
| EP2308425B2 (en) * | 2004-03-11 | 2023-10-18 | Percutaneous Cardiovascular Solutions Pty Limited | Percutaneous Heart Valve Prosthesis |
| US9039724B2 (en) * | 2004-03-19 | 2015-05-26 | Aga Medical Corporation | Device for occluding vascular defects |
| US8398670B2 (en) | 2004-03-19 | 2013-03-19 | Aga Medical Corporation | Multi-layer braided structures for occluding vascular defects and for occluding fluid flow through portions of the vasculature of the body |
| US8747453B2 (en) * | 2008-02-18 | 2014-06-10 | Aga Medical Corporation | Stent/stent graft for reinforcement of vascular abnormalities and associated method |
| US20050228434A1 (en) * | 2004-03-19 | 2005-10-13 | Aga Medical Corporation | Multi-layer braided structures for occluding vascular defects |
| US8313505B2 (en) * | 2004-03-19 | 2012-11-20 | Aga Medical Corporation | Device for occluding vascular defects |
| US8777974B2 (en) | 2004-03-19 | 2014-07-15 | Aga Medical Corporation | Multi-layer braided structures for occluding vascular defects |
| MXPA06006905A (en) | 2004-04-08 | 2008-02-13 | Aga Medical Corp | EMBROIDERED OCLUSION DEVICE AND METHODS. |
| US20050267524A1 (en) | 2004-04-09 | 2005-12-01 | Nmt Medical, Inc. | Split ends closure device |
| US12303105B2 (en) | 2004-04-12 | 2025-05-20 | Boston Scientific Scimed, Inc. | Luminal structure anchoring devices and methods |
| US8425539B2 (en) | 2004-04-12 | 2013-04-23 | Xlumena, Inc. | Luminal structure anchoring devices and methods |
| US20050228413A1 (en) * | 2004-04-12 | 2005-10-13 | Binmoeller Kenneth F | Automated transluminal tissue targeting and anchoring devices and methods |
| CN101052359A (en) | 2004-04-23 | 2007-10-10 | 3F医疗有限公司 | Implantable prosthetic valve |
| US8361110B2 (en) | 2004-04-26 | 2013-01-29 | W.L. Gore & Associates, Inc. | Heart-shaped PFO closure device |
| US7842053B2 (en) | 2004-05-06 | 2010-11-30 | Nmt Medical, Inc. | Double coil occluder |
| US8308760B2 (en) | 2004-05-06 | 2012-11-13 | W.L. Gore & Associates, Inc. | Delivery systems and methods for PFO closure device with two anchors |
| US7736374B2 (en) | 2004-05-07 | 2010-06-15 | Usgi Medical, Inc. | Tissue manipulation and securement system |
| US7390329B2 (en) | 2004-05-07 | 2008-06-24 | Usgi Medical, Inc. | Methods for grasping and cinching tissue anchors |
| US7842069B2 (en) | 2004-05-07 | 2010-11-30 | Nmt Medical, Inc. | Inflatable occluder |
| US7918869B2 (en) | 2004-05-07 | 2011-04-05 | Usgi Medical, Inc. | Methods and apparatus for performing endoluminal gastroplasty |
| US7704268B2 (en) | 2004-05-07 | 2010-04-27 | Nmt Medical, Inc. | Closure device with hinges |
| WO2005110240A1 (en) | 2004-05-07 | 2005-11-24 | Nmt Medical, Inc. | Catching mechanisms for tubular septal occluder |
| US8057511B2 (en) | 2004-05-07 | 2011-11-15 | Usgi Medical, Inc. | Apparatus and methods for positioning and securing anchors |
| US8444657B2 (en) | 2004-05-07 | 2013-05-21 | Usgi Medical, Inc. | Apparatus and methods for rapid deployment of tissue anchors |
| US8257394B2 (en) | 2004-05-07 | 2012-09-04 | Usgi Medical, Inc. | Apparatus and methods for positioning and securing anchors |
| WO2005112813A1 (en) | 2004-05-17 | 2005-12-01 | C.R. Bard, Inc. | Method and apparatus for mapping and7or ablation of cardiac tissue |
| GB0411348D0 (en) * | 2004-05-21 | 2004-06-23 | Univ Cranfield | Fabrication of polymeric structures using laser initiated polymerisation |
| US8267985B2 (en) | 2005-05-25 | 2012-09-18 | Tyco Healthcare Group Lp | System and method for delivering and deploying an occluding device within a vessel |
| US7678135B2 (en) | 2004-06-09 | 2010-03-16 | Usgi Medical, Inc. | Compressible tissue anchor assemblies |
| US7695493B2 (en) | 2004-06-09 | 2010-04-13 | Usgi Medical, Inc. | System for optimizing anchoring force |
| US7736379B2 (en) | 2004-06-09 | 2010-06-15 | Usgi Medical, Inc. | Compressible tissue anchor assemblies |
| US8206417B2 (en) | 2004-06-09 | 2012-06-26 | Usgi Medical Inc. | Apparatus and methods for optimizing anchoring force |
| US7367975B2 (en) | 2004-06-21 | 2008-05-06 | Cierra, Inc. | Energy based devices and methods for treatment of anatomic tissue defects |
| US20060047337A1 (en) | 2004-08-27 | 2006-03-02 | Brenneman Rodney A | Device and method for establishing an artificial arterio-venous fistula |
| US9706997B2 (en) * | 2004-08-27 | 2017-07-18 | Rox Medical, Inc. | Device and method for establishing an artificial arterio-venous fistula |
| US7828814B2 (en) | 2004-08-27 | 2010-11-09 | Rox Medical, Inc. | Device and method for establishing an artificial arterio-venous fistula |
| US20060052867A1 (en) | 2004-09-07 | 2006-03-09 | Medtronic, Inc | Replacement prosthetic heart valve, system and method of implant |
| US7641688B2 (en) | 2004-09-16 | 2010-01-05 | Evera Medical, Inc. | Tissue augmentation device |
| US7244270B2 (en) | 2004-09-16 | 2007-07-17 | Evera Medical | Systems and devices for soft tissue augmentation |
| EP1827247B8 (en) | 2004-09-24 | 2020-05-06 | W.L. Gore & Associates, Inc. | Occluder device double securement system for delivery/recovery of such occluder device |
| US7473252B2 (en) | 2004-10-07 | 2009-01-06 | Coaptus Medical Corporation | Systems and methods for shrinking and/or securing cardiovascular tissue |
| US20060089711A1 (en) * | 2004-10-27 | 2006-04-27 | Medtronic Vascular, Inc. | Multifilament anchor for reducing a compass of a lumen or structure in mammalian body |
| US7722629B2 (en) * | 2004-10-29 | 2010-05-25 | Jeffrey W. Chambers, M.D. | System and method for catheter-based septal defect repair |
| US8562672B2 (en) | 2004-11-19 | 2013-10-22 | Medtronic, Inc. | Apparatus for treatment of cardiac valves and method of its manufacture |
| US7771472B2 (en) | 2004-11-19 | 2010-08-10 | Pulmonx Corporation | Bronchial flow control devices and methods of use |
| US8328837B2 (en) | 2004-12-08 | 2012-12-11 | Xlumena, Inc. | Method and apparatus for performing needle guided interventions |
| US20080021497A1 (en) | 2005-01-03 | 2008-01-24 | Eric Johnson | Endoluminal filter |
| US20060155323A1 (en) * | 2005-01-07 | 2006-07-13 | Porter Stephen C | Intra-aneurysm devices |
| DE102005003632A1 (en) | 2005-01-20 | 2006-08-17 | Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. | Catheter for the transvascular implantation of heart valve prostheses |
| US8366743B2 (en) * | 2005-01-28 | 2013-02-05 | Lifetech Scientific (Shenzhen) Co., Ltd | Heart septal defect occlusion device |
| CN100389732C (en) * | 2005-01-28 | 2008-05-28 | 先健科技(深圳)有限公司 | Cardiac septal defect occluder with self-adjusting function |
| ITTO20050074A1 (en) | 2005-02-10 | 2006-08-11 | Sorin Biomedica Cardio Srl | CARDIAC VALVE PROSTHESIS |
| US20060259074A1 (en) * | 2005-02-22 | 2006-11-16 | Brian Kelleher | Methods and devices for anchoring to soft tissue |
| US8876791B2 (en) | 2005-02-25 | 2014-11-04 | Pulmonx Corporation | Collateral pathway treatment using agent entrained by aspiration flow current |
| US20060241687A1 (en) * | 2005-03-16 | 2006-10-26 | Glaser Erik N | Septal occluder with pivot arms and articulating joints |
| US20060217760A1 (en) * | 2005-03-17 | 2006-09-28 | Widomski David R | Multi-strand septal occluder |
| WO2006102213A1 (en) | 2005-03-18 | 2006-09-28 | Nmt Medical, Inc. | Catch member for pfo occluder |
| US8372113B2 (en) * | 2005-03-24 | 2013-02-12 | W.L. Gore & Associates, Inc. | Curved arm intracardiac occluder |
| US20060271089A1 (en) | 2005-04-11 | 2006-11-30 | Cierra, Inc. | Methods and apparatus to achieve a closure of a layered tissue defect |
| US7962208B2 (en) | 2005-04-25 | 2011-06-14 | Cardiac Pacemakers, Inc. | Method and apparatus for pacing during revascularization |
| US20060253184A1 (en) * | 2005-05-04 | 2006-11-09 | Kurt Amplatz | System for the controlled delivery of stents and grafts |
| US8088144B2 (en) | 2005-05-04 | 2012-01-03 | Ensure Medical, Inc. | Locator and closure device and method of use |
| US8926654B2 (en) | 2005-05-04 | 2015-01-06 | Cordis Corporation | Locator and closure device and method of use |
| US7914569B2 (en) | 2005-05-13 | 2011-03-29 | Medtronics Corevalve Llc | Heart valve prosthesis and methods of manufacture and use |
| EP1883371B1 (en) | 2005-05-25 | 2015-10-07 | Covidien LP | System and method for delivering and deploying and occluding device within a vessel |
| US8273101B2 (en) | 2005-05-25 | 2012-09-25 | Tyco Healthcare Group Lp | System and method for delivering and deploying an occluding device within a vessel |
| US9585651B2 (en) | 2005-05-26 | 2017-03-07 | Usgi Medical, Inc. | Methods and apparatus for securing and deploying tissue anchors |
| US8298291B2 (en) | 2005-05-26 | 2012-10-30 | Usgi Medical, Inc. | Methods and apparatus for securing and deploying tissue anchors |
| US8784437B2 (en) | 2005-06-09 | 2014-07-22 | Xlumena, Inc. | Methods and devices for endosonography-guided fundoplexy |
| US8777967B2 (en) | 2005-06-09 | 2014-07-15 | Xlumena, Inc. | Methods and devices for anchoring to tissue |
| US8579936B2 (en) | 2005-07-05 | 2013-11-12 | ProMed, Inc. | Centering of delivery devices with respect to a septal defect |
| US8951285B2 (en) | 2005-07-05 | 2015-02-10 | Mitralign, Inc. | Tissue anchor, anchoring system and methods of using the same |
| CN101351242A (en) | 2005-07-19 | 2009-01-21 | 斯托特药物集团公司 | Embolic Filtration Method and Instrument |
| JP4376836B2 (en) * | 2005-07-29 | 2009-12-02 | 富士フイルム株式会社 | Magnetic recording device |
| US8062309B2 (en) * | 2005-08-19 | 2011-11-22 | Boston Scientific Scimed, Inc. | Defect occlusion apparatus, system, and method |
| WO2007022519A2 (en) | 2005-08-19 | 2007-02-22 | Chf Technologies, Inc. | Steerable heart implants for congestive heart failure |
| US7998095B2 (en) * | 2005-08-19 | 2011-08-16 | Boston Scientific Scimed, Inc. | Occlusion device |
| US7824397B2 (en) * | 2005-08-19 | 2010-11-02 | Boston Scientific Scimed, Inc. | Occlusion apparatus |
| US7766906B2 (en) | 2005-08-19 | 2010-08-03 | Boston Scientific Scimed, Inc. | Occlusion apparatus |
| US7837619B2 (en) * | 2005-08-19 | 2010-11-23 | Boston Scientific Scimed, Inc. | Transeptal apparatus, system, and method |
| US20070185530A1 (en) | 2005-09-01 | 2007-08-09 | Chao Chin-Chen | Patent foramen ovale closure method |
| US20080015635A1 (en) | 2006-06-09 | 2008-01-17 | Daniel Olsen | Single disc occlusionary patent foramen ovale closure device |
| US7846179B2 (en) | 2005-09-01 | 2010-12-07 | Ovalis, Inc. | Suture-based systems and methods for treating septal defects |
| US7797056B2 (en) * | 2005-09-06 | 2010-09-14 | Nmt Medical, Inc. | Removable intracardiac RF device |
| US9259267B2 (en) | 2005-09-06 | 2016-02-16 | W.L. Gore & Associates, Inc. | Devices and methods for treating cardiac tissue |
| US7712606B2 (en) | 2005-09-13 | 2010-05-11 | Sadra Medical, Inc. | Two-part package for medical implant |
| US20070088388A1 (en) * | 2005-09-19 | 2007-04-19 | Opolski Steven W | Delivery device for implant with dual attachment sites |
| US20070123934A1 (en) * | 2005-09-26 | 2007-05-31 | Whisenant Brian K | Delivery system for patent foramen ovale closure device |
| WO2007038540A1 (en) | 2005-09-26 | 2007-04-05 | Medtronic, Inc. | Prosthetic cardiac and venous valves |
| CN101355906A (en) * | 2005-11-11 | 2009-01-28 | 奥特鲁泰克有限公司 | Occluder and surgical instrument and implantation/transplantation method thereof |
| US7632308B2 (en) | 2005-11-23 | 2009-12-15 | Didier Loulmet | Methods, devices, and kits for treating mitral valve prolapse |
| WO2007073566A1 (en) | 2005-12-22 | 2007-06-28 | Nmt Medical, Inc. | Catch members for occluder devices |
| US20070213813A1 (en) | 2005-12-22 | 2007-09-13 | Symetis Sa | Stent-valves for valve replacement and associated methods and systems for surgery |
| US9078781B2 (en) | 2006-01-11 | 2015-07-14 | Medtronic, Inc. | Sterile cover for compressible stents used in percutaneous device delivery systems |
| US8726909B2 (en) | 2006-01-27 | 2014-05-20 | Usgi Medical, Inc. | Methods and apparatus for revision of obesity procedures |
| EP1988851A2 (en) | 2006-02-14 | 2008-11-12 | Sadra Medical, Inc. | Systems and methods for delivering a medical implant |
| US20070203391A1 (en) * | 2006-02-24 | 2007-08-30 | Medtronic Vascular, Inc. | System for Treating Mitral Valve Regurgitation |
| DE102006013770A1 (en) * | 2006-03-24 | 2007-09-27 | Occlutech Gmbh | Occlusion instrument and method for its production |
| US8075615B2 (en) | 2006-03-28 | 2011-12-13 | Medtronic, Inc. | Prosthetic cardiac valve formed from pericardium material and methods of making same |
| US8551135B2 (en) | 2006-03-31 | 2013-10-08 | W.L. Gore & Associates, Inc. | Screw catch mechanism for PFO occluder and method of use |
| US7691151B2 (en) * | 2006-03-31 | 2010-04-06 | Spiration, Inc. | Articulable Anchor |
| CA2647505C (en) | 2006-03-31 | 2014-07-29 | Nmt Medical, Inc. | Deformable flap catch mechanism for occluder device |
| US8870913B2 (en) | 2006-03-31 | 2014-10-28 | W.L. Gore & Associates, Inc. | Catch system with locking cap for patent foramen ovale (PFO) occluder |
| CN101049269B (en) * | 2006-04-03 | 2010-12-29 | 孟坚 | Medical use obstruction appliance |
| US7625403B2 (en) | 2006-04-04 | 2009-12-01 | Medtronic Vascular, Inc. | Valved conduit designed for subsequent catheter delivered valve therapy |
| US7740655B2 (en) | 2006-04-06 | 2010-06-22 | Medtronic Vascular, Inc. | Reinforced surgical conduit for implantation of a stented valve therein |
| US7591848B2 (en) | 2006-04-06 | 2009-09-22 | Medtronic Vascular, Inc. | Riveted stent valve for percutaneous use |
| US7524331B2 (en) | 2006-04-06 | 2009-04-28 | Medtronic Vascular, Inc. | Catheter delivered valve having a barrier to provide an enhanced seal |
| ATE524114T1 (en) * | 2006-04-07 | 2011-09-15 | Lifetech Scient Shenzhen Co | SELF-ADAPTABLE CLOSURE DEVICE FOR TREATING CONGENITAL HEART DISEASE |
| US20070244494A1 (en) * | 2006-04-18 | 2007-10-18 | Downing Stephen W | Methods and devices for treating atrial septal defects |
| DE102006036649A1 (en) * | 2006-04-27 | 2007-10-31 | Biophan Europe Gmbh | Occluder for human or animal heart, has intermediate piece eccentrically connected with each closing body in edge area of bodies in closing condition, where occluder or its part forms electrical resonant oscillating circuit |
| US20070265658A1 (en) * | 2006-05-12 | 2007-11-15 | Aga Medical Corporation | Anchoring and tethering system |
| US7927351B2 (en) * | 2006-06-19 | 2011-04-19 | Cardia, Inc. | Occlusion device with flexible wire connector |
| US7691115B2 (en) * | 2006-06-19 | 2010-04-06 | Cardia, Inc. | Occlusion device with flexible fabric connector |
| CN100471468C (en) * | 2006-07-06 | 2009-03-25 | 何健峰 | Occlusive device for treating septal defect of congenital heart disease |
| US8870916B2 (en) * | 2006-07-07 | 2014-10-28 | USGI Medical, Inc | Low profile tissue anchors, tissue anchor systems, and methods for their delivery and use |
| CN101120893B (en) * | 2006-08-08 | 2010-05-12 | 先健科技(深圳)有限公司 | Cardiac Septal Defect Occluder |
| US8840655B2 (en) | 2006-08-09 | 2014-09-23 | Coherex Medical, Inc. | Systems and devices for reducing the size of an internal tissue opening |
| US8529597B2 (en) * | 2006-08-09 | 2013-09-10 | Coherex Medical, Inc. | Devices for reducing the size of an internal tissue opening |
| US20090270840A1 (en) * | 2008-03-28 | 2009-10-29 | Coherex Medical, Inc. | Delivery systems for a medical device and related methods |
| US8979941B2 (en) * | 2006-08-09 | 2015-03-17 | Coherex Medical, Inc. | Devices for reducing the size of an internal tissue opening |
| US20080051830A1 (en) * | 2006-08-24 | 2008-02-28 | Boston Scientific Scimed, Inc. | Occluding device and method |
| US8075576B2 (en) * | 2006-08-24 | 2011-12-13 | Boston Scientific Scimed, Inc. | Closure device, system, and method |
| GB2441589A (en) * | 2006-09-05 | 2008-03-12 | Anthony Walter Anson | Heat treatment method for composite textiles |
| US20080065205A1 (en) * | 2006-09-11 | 2008-03-13 | Duy Nguyen | Retrievable implant and method for treatment of mitral regurgitation |
| US8834564B2 (en) | 2006-09-19 | 2014-09-16 | Medtronic, Inc. | Sinus-engaging valve fixation member |
| US11304800B2 (en) | 2006-09-19 | 2022-04-19 | Medtronic Ventor Technologies Ltd. | Sinus-engaging valve fixation member |
| US8876894B2 (en) | 2006-09-19 | 2014-11-04 | Medtronic Ventor Technologies Ltd. | Leaflet-sensitive valve fixation member |
| DE102006045545A1 (en) * | 2006-09-25 | 2008-04-03 | Peter Osypka Stiftung Stiftung des bürgerlichen Rechts | Medical device |
| US20080077180A1 (en) * | 2006-09-26 | 2008-03-27 | Nmt Medical, Inc. | Scaffold for tubular septal occluder device and techniques for attachment |
| CN101795627A (en) * | 2006-10-04 | 2010-08-04 | 伊西康内外科公司 | Devices and methods for endoluminal gastric restriction tissue manipulation, and drug delivery |
| DK2083901T3 (en) | 2006-10-16 | 2018-02-26 | Medtronic Ventor Tech Ltd | TRANSAPICAL DELIVERY SYSTEM WITH VENTRICULO-ARTERIAL OVERFLOW BYPASS |
| US8876881B2 (en) | 2006-10-22 | 2014-11-04 | Idev Technologies, Inc. | Devices for stent advancement |
| EP3329882B1 (en) | 2006-10-22 | 2023-09-20 | IDEV Technologies, INC. | Methods for securing strand ends and the resulting devices |
| US10413284B2 (en) | 2006-11-07 | 2019-09-17 | Corvia Medical, Inc. | Atrial pressure regulation with control, sensing, monitoring and therapy delivery |
| US9232997B2 (en) | 2006-11-07 | 2016-01-12 | Corvia Medical, Inc. | Devices and methods for retrievable intra-atrial implants |
| US20110257723A1 (en) | 2006-11-07 | 2011-10-20 | Dc Devices, Inc. | Devices and methods for coronary sinus pressure relief |
| CA2664557C (en) | 2006-11-07 | 2015-05-26 | Corvia Medical, Inc. | Devices and methods for the treatment of heart failure |
| EP1982655B2 (en) | 2007-04-16 | 2022-12-07 | Occlutech Holding AG | Occluder to seal an atrial appendage and method of manufacture thereof |
| EP1923019B1 (en) | 2006-11-20 | 2010-10-20 | SeptRx, Inc. | Device for preventing the undesired passage of emboli from a venous blood pool to an arterial blood pool |
| JP5593545B2 (en) | 2006-12-06 | 2014-09-24 | メドトロニック シーブイ ルクセンブルク エス.アー.エール.エル. | System and method for transapical delivery of a self-expanding valve secured to an annulus |
| US20080140069A1 (en) * | 2006-12-07 | 2008-06-12 | Cierra, Inc. | Multi-electrode apparatus for tissue welding and ablation |
| WO2008094706A2 (en) * | 2007-02-01 | 2008-08-07 | Cook Incorporated | Closure device and method of closing a bodily opening |
| US8617205B2 (en) | 2007-02-01 | 2013-12-31 | Cook Medical Technologies Llc | Closure device |
| US20080188892A1 (en) * | 2007-02-01 | 2008-08-07 | Cook Incorporated | Vascular occlusion device |
| CA2677648C (en) | 2007-02-16 | 2015-10-27 | Medtronic, Inc. | Replacement prosthetic heart valves and methods of implantation |
| US20080228256A1 (en) * | 2007-03-13 | 2008-09-18 | Medtronic Vascular, Inc. | Braided Flange Branch Graft for Branch Vessel |
| US8911461B2 (en) * | 2007-03-13 | 2014-12-16 | Mitralign, Inc. | Suture cutter and method of cutting suture |
| US11660190B2 (en) | 2007-03-13 | 2023-05-30 | Edwards Lifesciences Corporation | Tissue anchors, systems and methods, and devices |
| US20080228265A1 (en) | 2007-03-13 | 2008-09-18 | Mitralign, Inc. | Tissue anchors, systems and methods, and devices |
| WO2008124603A1 (en) | 2007-04-05 | 2008-10-16 | Nmt Medical, Inc. | Septal closure device with centering mechanism |
| US7896915B2 (en) | 2007-04-13 | 2011-03-01 | Jenavalve Technology, Inc. | Medical device for treating a heart valve insufficiency |
| US9138562B2 (en) | 2007-04-18 | 2015-09-22 | W.L. Gore & Associates, Inc. | Flexible catheter system |
| FR2915087B1 (en) | 2007-04-20 | 2021-11-26 | Corevalve Inc | IMPLANT FOR TREATMENT OF A HEART VALVE, IN PARTICULAR OF A MITRAL VALVE, EQUIPMENT INCLUDING THIS IMPLANT AND MATERIAL FOR PLACING THIS IMPLANT. |
| EP2157937B1 (en) | 2007-06-04 | 2017-03-22 | Sequent Medical, Inc. | Devices for treatment of vascular defects |
| EP2157916A2 (en) * | 2007-06-04 | 2010-03-03 | Mor Research Applications Ltd. | Cardiac valve leaflet augmentation |
| US8034061B2 (en) * | 2007-07-12 | 2011-10-11 | Aga Medical Corporation | Percutaneous catheter directed intravascular occlusion devices |
| AU2013270508B2 (en) * | 2007-07-12 | 2015-09-03 | St. Jude Medical, Cardiology Division, Inc. | Percutaneous catheter directed intravascular occlusion devices |
| US20090112251A1 (en) * | 2007-07-25 | 2009-04-30 | Aga Medical Corporation | Braided occlusion device having repeating expanded volume segments separated by articulation segments |
| US8361138B2 (en) * | 2007-07-25 | 2013-01-29 | Aga Medical Corporation | Braided occlusion device having repeating expanded volume segments separated by articulation segments |
| EP2182852A2 (en) | 2007-08-02 | 2010-05-12 | Occlutech GmbH | Method of producing a medical implantable device and medical implantable device |
| US8747458B2 (en) | 2007-08-20 | 2014-06-10 | Medtronic Ventor Technologies Ltd. | Stent loading tool and method for use thereof |
| US8308752B2 (en) * | 2007-08-27 | 2012-11-13 | Cook Medical Technologies Llc | Barrel occlusion device |
| US8734483B2 (en) * | 2007-08-27 | 2014-05-27 | Cook Medical Technologies Llc | Spider PFO closure device |
| US20090062838A1 (en) * | 2007-08-27 | 2009-03-05 | Cook Incorporated | Spider device with occlusive barrier |
| US8025495B2 (en) * | 2007-08-27 | 2011-09-27 | Cook Medical Technologies Llc | Apparatus and method for making a spider occlusion device |
| US8366741B2 (en) | 2007-09-13 | 2013-02-05 | Cardia, Inc. | Occlusion device with centering arm |
| US20090084386A1 (en) * | 2007-10-01 | 2009-04-02 | Mcclellan Annette M L | Tubal ligation |
| US20090118726A1 (en) * | 2007-10-05 | 2009-05-07 | Coaptus Medical Corporation | Systems and Methods for Transeptal Cardiac Procedures, Including Tissue Sealing Members Associated Methods |
| US10856970B2 (en) | 2007-10-10 | 2020-12-08 | Medtronic Ventor Technologies Ltd. | Prosthetic heart valve for transfemoral delivery |
| US9848981B2 (en) | 2007-10-12 | 2017-12-26 | Mayo Foundation For Medical Education And Research | Expandable valve prosthesis with sealing mechanism |
| US8043301B2 (en) | 2007-10-12 | 2011-10-25 | Spiration, Inc. | Valve loader method, system, and apparatus |
| US9414842B2 (en) * | 2007-10-12 | 2016-08-16 | St. Jude Medical, Cardiology Division, Inc. | Multi-component vascular device |
| US8136230B2 (en) | 2007-10-12 | 2012-03-20 | Spiration, Inc. | Valve loader method, system, and apparatus |
| US20090118745A1 (en) * | 2007-11-06 | 2009-05-07 | Cook Incorporated | Patent foramen ovale closure apparatus and method |
| CN101450013B (en) * | 2007-11-28 | 2011-03-23 | 王涛 | Blocking device of heart atrial, ventricular septal defect and patent oval foramen |
| US9492263B2 (en) * | 2007-12-10 | 2016-11-15 | Incept, Llc | Retrieval apparatus and methods for use |
| US20090171386A1 (en) * | 2007-12-28 | 2009-07-02 | Aga Medical Corporation | Percutaneous catheter directed intravascular occlusion devices |
| US9743918B2 (en) * | 2008-01-18 | 2017-08-29 | St. Jude Medical, Cardiology Division, Inc. | Percutaneous catheter directed intravascular occlusion device |
| US9393115B2 (en) | 2008-01-24 | 2016-07-19 | Medtronic, Inc. | Delivery systems and methods of implantation for prosthetic heart valves |
| EP3449875B1 (en) | 2008-01-24 | 2025-10-15 | Medtronic, Inc. | Stents for prosthetic heart valves |
| US8157853B2 (en) | 2008-01-24 | 2012-04-17 | Medtronic, Inc. | Delivery systems and methods of implantation for prosthetic heart valves |
| EP2254512B1 (en) | 2008-01-24 | 2016-01-06 | Medtronic, Inc. | Markers for prosthetic heart valves |
| US9149358B2 (en) | 2008-01-24 | 2015-10-06 | Medtronic, Inc. | Delivery systems for prosthetic heart valves |
| US20090198329A1 (en) | 2008-02-01 | 2009-08-06 | Kesten Randy J | Breast implant with internal flow dampening |
| US20090209999A1 (en) * | 2008-02-14 | 2009-08-20 | Michael Afremov | Device and Method for Closure of Atrial Septal Defects |
| AU2013273779B2 (en) * | 2008-02-19 | 2015-09-24 | St. Jude Medical, Cardiology Division, Inc. | Medical devices for treating a target site and associated method |
| US9259225B2 (en) * | 2008-02-19 | 2016-02-16 | St. Jude Medical, Cardiology Division, Inc. | Medical devices for treating a target site and associated method |
| US9044318B2 (en) | 2008-02-26 | 2015-06-02 | Jenavalve Technology Gmbh | Stent for the positioning and anchoring of a valvular prosthesis |
| WO2011104269A1 (en) | 2008-02-26 | 2011-09-01 | Jenavalve Technology Inc. | Stent for the positioning and anchoring of a valvular prosthesis in an implantation site in the heart of a patient |
| WO2009108355A1 (en) | 2008-02-28 | 2009-09-03 | Medtronic, Inc. | Prosthetic heart valve systems |
| US8828008B2 (en) | 2008-03-05 | 2014-09-09 | Allston J. Stubbs | Apparatus for arthroscopic assisted arthroplasty of the hip joint |
| US20090227938A1 (en) * | 2008-03-05 | 2009-09-10 | Insitu Therapeutics, Inc. | Wound Closure Devices, Methods of Use, and Kits |
| US20130165967A1 (en) | 2008-03-07 | 2013-06-27 | W.L. Gore & Associates, Inc. | Heart occlusion devices |
| US8313525B2 (en) | 2008-03-18 | 2012-11-20 | Medtronic Ventor Technologies, Ltd. | Valve suturing and implantation procedures |
| DE102008015781B4 (en) * | 2008-03-26 | 2011-09-29 | Malte Neuss | Device for sealing defects in the vascular system |
| WO2009124058A1 (en) * | 2008-03-31 | 2009-10-08 | Alejandro Berenstein | Catheter-based septal occlusion device and adhesive delivery system |
| US8430927B2 (en) | 2008-04-08 | 2013-04-30 | Medtronic, Inc. | Multiple orifice implantable heart valve and methods of implantation |
| JP5610542B2 (en) | 2008-04-21 | 2014-10-22 | コヴィディエン リミテッド パートナーシップ | Blade ball embolization device and delivery system |
| CN106974691A (en) | 2008-05-02 | 2017-07-25 | 斯昆特医疗公司 | Thread device for treating vascular defects |
| WO2009137755A2 (en) * | 2008-05-09 | 2009-11-12 | University Of Pittsburgh- Commonwealth System Of Higher Education | Biologic matrix for cardiac repair |
| US20090281379A1 (en) | 2008-05-12 | 2009-11-12 | Xlumena, Inc. | System and method for transluminal access |
| US8454632B2 (en) | 2008-05-12 | 2013-06-04 | Xlumena, Inc. | Tissue anchor for securing tissue layers |
| WO2009140437A1 (en) | 2008-05-13 | 2009-11-19 | Nfocus Neuromedical, Inc. | Braid implant delivery systems |
| US8840661B2 (en) | 2008-05-16 | 2014-09-23 | Sorin Group Italia S.R.L. | Atraumatic prosthetic heart valve prosthesis |
| US20100016885A1 (en) * | 2008-07-21 | 2010-01-21 | Eidenschink Tracee E J | Device to close openings in body tissue |
| US9179918B2 (en) | 2008-07-22 | 2015-11-10 | Covidien Lp | Vascular remodeling device |
| US9232992B2 (en) * | 2008-07-24 | 2016-01-12 | Aga Medical Corporation | Multi-layered medical device for treating a target site and associated method |
| US9351715B2 (en) * | 2008-07-24 | 2016-05-31 | St. Jude Medical, Cardiology Division, Inc. | Multi-layered medical device for treating a target site and associated method |
| US8652202B2 (en) | 2008-08-22 | 2014-02-18 | Edwards Lifesciences Corporation | Prosthetic heart valve and delivery apparatus |
| US8945211B2 (en) | 2008-09-12 | 2015-02-03 | Mitralign, Inc. | Tissue plication device and method for its use |
| US8998981B2 (en) | 2008-09-15 | 2015-04-07 | Medtronic, Inc. | Prosthetic heart valve having identifiers for aiding in radiographic positioning |
| US8721714B2 (en) | 2008-09-17 | 2014-05-13 | Medtronic Corevalve Llc | Delivery system for deployment of medical devices |
| JP5607639B2 (en) | 2008-10-10 | 2014-10-15 | サドラ メディカル インコーポレイテッド | Medical devices and systems |
| US8137398B2 (en) | 2008-10-13 | 2012-03-20 | Medtronic Ventor Technologies Ltd | Prosthetic valve having tapered tip when compressed for delivery |
| US8163022B2 (en) | 2008-10-14 | 2012-04-24 | Anulex Technologies, Inc. | Method and apparatus for the treatment of the intervertebral disc annulus |
| US8986361B2 (en) | 2008-10-17 | 2015-03-24 | Medtronic Corevalve, Inc. | Delivery system for deployment of medical devices |
| US20100160862A1 (en) * | 2008-12-22 | 2010-06-24 | Cook Incorporated | Variable stiffness introducer sheath with transition zone |
| US10517719B2 (en) | 2008-12-22 | 2019-12-31 | Valtech Cardio, Ltd. | Implantation of repair devices in the heart |
| EP2201911B1 (en) | 2008-12-23 | 2015-09-30 | Sorin Group Italia S.r.l. | Expandable prosthetic valve having anchoring appendages |
| US10702275B2 (en) * | 2009-02-18 | 2020-07-07 | St. Jude Medical Cardiology Division, Inc. | Medical device with stiffener wire for occluding vascular defects |
| US8029534B2 (en) | 2009-03-16 | 2011-10-04 | Cook Medical Technologies Llc | Closure device with string retractable umbrella |
| US9636204B2 (en) | 2009-04-16 | 2017-05-02 | Cvdevices, Llc | Deflection devices, systems and methods for the prevention of stroke |
| WO2010121192A1 (en) | 2009-04-16 | 2010-10-21 | Cvdevices, Llc | Devices, systems, and methods for the prevention of stroke |
| US9681967B2 (en) | 2009-04-16 | 2017-06-20 | Cvdevices, Llc | Linked deflection devices, systems and methods for the prevention of stroke |
| US9364259B2 (en) | 2009-04-21 | 2016-06-14 | Xlumena, Inc. | System and method for delivering expanding trocar through a sheath |
| US20110137394A1 (en) * | 2009-05-29 | 2011-06-09 | Xlumena, Inc. | Methods and systems for penetrating adjacent tissue layers |
| ES2523218T3 (en) | 2009-04-27 | 2014-11-24 | Sorin Group Italia S.R.L. | Prosthetic vascular duct |
| US9968452B2 (en) | 2009-05-04 | 2018-05-15 | Valtech Cardio, Ltd. | Annuloplasty ring delivery cathethers |
| EP2434961B1 (en) | 2009-05-29 | 2015-01-14 | Xlumena, Inc. | Apparatus and method for deploying stent across adjacent tissue layers |
| US9636094B2 (en) | 2009-06-22 | 2017-05-02 | W. L. Gore & Associates, Inc. | Sealing device and delivery system |
| US9381006B2 (en) | 2009-06-22 | 2016-07-05 | W. L. Gore & Associates, Inc. | Sealing device and delivery system |
| US20120029556A1 (en) | 2009-06-22 | 2012-02-02 | Masters Steven J | Sealing device and delivery system |
| US9757107B2 (en) | 2009-09-04 | 2017-09-12 | Corvia Medical, Inc. | Methods and devices for intra-atrial shunts having adjustable sizes |
| US8808369B2 (en) | 2009-10-05 | 2014-08-19 | Mayo Foundation For Medical Education And Research | Minimally invasive aortic valve replacement |
| BR112012010758A2 (en) | 2009-11-05 | 2019-09-24 | Sequent Medical Inc | multilayer filament devices for treatment of vascular defects |
| US9095342B2 (en) | 2009-11-09 | 2015-08-04 | Covidien Lp | Braid ball embolic device features |
| US8449599B2 (en) | 2009-12-04 | 2013-05-28 | Edwards Lifesciences Corporation | Prosthetic valve for replacing mitral valve |
| US8460319B2 (en) | 2010-01-11 | 2013-06-11 | Anulex Technologies, Inc. | Intervertebral disc annulus repair system and method |
| WO2011094634A1 (en) | 2010-01-28 | 2011-08-04 | Micro Therapeutics, Inc. | Vascular remodeling device |
| EP2528542A4 (en) | 2010-01-28 | 2013-07-03 | Covidien Lp | Vascular remodeling device |
| WO2011094521A2 (en) | 2010-01-29 | 2011-08-04 | Dc Devices, Inc. | Devices and methods for reducing venous pressure |
| CA2786575A1 (en) | 2010-01-29 | 2011-08-04 | Dc Devices, Inc. | Devices and systems for treating heart failure |
| US8500776B2 (en) | 2010-02-08 | 2013-08-06 | Covidien Lp | Vacuum patch for rapid wound closure |
| US9226826B2 (en) | 2010-02-24 | 2016-01-05 | Medtronic, Inc. | Transcatheter valve structure and methods for valve delivery |
| US8652204B2 (en) | 2010-04-01 | 2014-02-18 | Medtronic, Inc. | Transcatheter valve with torsion spring fixation and related systems and methods |
| US9795482B2 (en) * | 2010-04-27 | 2017-10-24 | Medtronic, Inc. | Prosthetic heart valve devices and methods of valve repair |
| US20180049731A1 (en) * | 2010-04-29 | 2018-02-22 | Muffin Incorporated | Closing device for tissue openings |
| US10568628B2 (en) | 2017-05-23 | 2020-02-25 | Muffin Incorporated | Closing device for tissue openings |
| US8419767B2 (en) * | 2010-05-04 | 2013-04-16 | Mustafa H. Al-Qbandi | Steerable atrial septal occluder implantation device with flexible neck |
| US10856978B2 (en) | 2010-05-20 | 2020-12-08 | Jenavalve Technology, Inc. | Catheter system |
| IT1400327B1 (en) | 2010-05-21 | 2013-05-24 | Sorin Biomedica Cardio Srl | SUPPORT DEVICE FOR VALVULAR PROSTHESIS AND CORRESPONDING CORRESPONDENT. |
| CN103002833B (en) | 2010-05-25 | 2016-05-11 | 耶拿阀门科技公司 | Artificial heart valve and comprise artificial heart valve and support through conduit carry interior prosthese |
| US9023095B2 (en) | 2010-05-27 | 2015-05-05 | Idev Technologies, Inc. | Stent delivery system with pusher assembly |
| EP2399524A1 (en) | 2010-06-22 | 2011-12-28 | Occlutech Holding AG | Medical implant and manufacturing method thereof |
| US9247942B2 (en) | 2010-06-29 | 2016-02-02 | Artventive Medical Group, Inc. | Reversible tubal contraceptive device |
| EP2588042A4 (en) | 2010-06-29 | 2015-03-18 | Artventive Medical Group Inc | Reducing flow through a tubular structure |
| US8828051B2 (en) | 2010-07-02 | 2014-09-09 | Pfm Medical Ag | Left atrial appendage occlusion device |
| WO2012030598A2 (en) | 2010-09-01 | 2012-03-08 | Medtronic Vascular Galway Limited | Prosthetic valve support structure |
| JP6087281B2 (en) | 2010-09-10 | 2017-03-01 | メディナ メディカル,インコーポレイテッド | Device and method for treating vascular abnormalities |
| US8998947B2 (en) | 2010-09-10 | 2015-04-07 | Medina Medical, Inc. | Devices and methods for the treatment of vascular defects |
| AU2011300644B2 (en) | 2010-09-10 | 2015-08-20 | Symetis Sa | Valve replacement devices and a system comprising the valve replacement device and a delivery device therefor |
| WO2012051489A2 (en) | 2010-10-15 | 2012-04-19 | Cook Medical Technologies Llc | Occlusion device for blocking fluid flow through bodily passages |
| US9149277B2 (en) | 2010-10-18 | 2015-10-06 | Artventive Medical Group, Inc. | Expandable device delivery |
| EP2632530B1 (en) | 2010-10-25 | 2018-01-17 | Boston Scientific Scimed, Inc. | Apparatus for penetrating and enlarging adjacent tissue layers |
| US12303119B2 (en) | 2011-02-10 | 2025-05-20 | Corvia Medical, Inc. | Apparatus and methods to create and maintain an intra-atrial pressure relief opening |
| AU2012214279A1 (en) | 2011-02-10 | 2013-08-22 | Corvia Medical, Inc. | Apparatus and methods to create and maintain an intra-atrial pressure relief opening |
| AU2012214240B2 (en) | 2011-02-11 | 2015-03-12 | Covidien Lp | Two-stage deployment aneurysm embolization devices |
| EP2486893B1 (en) | 2011-02-14 | 2017-07-05 | Sorin Group Italia S.r.l. | Sutureless anchoring device for cardiac valve prostheses |
| EP2486894B1 (en) | 2011-02-14 | 2021-06-09 | Sorin Group Italia S.r.l. | Sutureless anchoring device for cardiac valve prostheses |
| EP4119095A1 (en) | 2011-03-21 | 2023-01-18 | Cephea Valve Technologies, Inc. | Disk-based valve apparatus |
| US10201336B2 (en) | 2011-03-25 | 2019-02-12 | St. Jude Medical, Cardiology Division, Inc. | Device and method for delivering a vascular device |
| US8821529B2 (en) | 2011-03-25 | 2014-09-02 | Aga Medical Corporation | Device and method for occluding a septal defect |
| US20120245674A1 (en) | 2011-03-25 | 2012-09-27 | Tyco Healthcare Group Lp | Vascular remodeling device |
| US8562643B2 (en) | 2011-04-21 | 2013-10-22 | Cook Medical Technologies Llc | Self closing occulsion device with a twist |
| EP2520251A1 (en) | 2011-05-05 | 2012-11-07 | Symetis SA | Method and Apparatus for Compressing Stent-Valves |
| US8795241B2 (en) | 2011-05-13 | 2014-08-05 | Spiration, Inc. | Deployment catheter |
| EP2723274B1 (en) | 2011-06-23 | 2017-12-27 | Valtech Cardio, Ltd. | Closure element for use with annuloplasty structure |
| JP2014527425A (en) | 2011-07-12 | 2014-10-16 | ボストン サイエンティフィック サイムド,インコーポレイテッドBoston Scientific Scimed,Inc. | Linkage system for medical devices |
| US9770232B2 (en) | 2011-08-12 | 2017-09-26 | W. L. Gore & Associates, Inc. | Heart occlusion devices |
| EP2796103B1 (en) | 2011-08-25 | 2017-02-22 | Covidien LP | Systems and devices for treatment of luminal tissue |
| EP2572644A1 (en) | 2011-09-22 | 2013-03-27 | Occlutech Holding AG | Medical implantable occlusion device |
| WO2013044267A1 (en) | 2011-09-23 | 2013-03-28 | Pulmonx, Inc. | Implant loading device and system |
| WO2013049448A1 (en) | 2011-09-29 | 2013-04-04 | Covidien Lp | Vascular remodeling device |
| WO2013058889A2 (en) | 2011-10-17 | 2013-04-25 | Sequent Medical Inc. | Braiding mechanism and methods of use |
| US8261648B1 (en) | 2011-10-17 | 2012-09-11 | Sequent Medical Inc. | Braiding mechanism and methods of use |
| US9474516B2 (en) | 2011-11-08 | 2016-10-25 | Boston Scientific Scimed, Inc. | Handle assembly for a left atrial appendage occlusion device |
| CN104254285B (en) * | 2011-11-09 | 2017-07-28 | 伊兹诺茨有限公司 | Blocking device |
| US9131926B2 (en) | 2011-11-10 | 2015-09-15 | Boston Scientific Scimed, Inc. | Direct connect flush system |
| US8940014B2 (en) | 2011-11-15 | 2015-01-27 | Boston Scientific Scimed, Inc. | Bond between components of a medical device |
| US8758389B2 (en) | 2011-11-18 | 2014-06-24 | Aga Medical Corporation | Devices and methods for occluding abnormal openings in a patient's vasculature |
| US8951243B2 (en) | 2011-12-03 | 2015-02-10 | Boston Scientific Scimed, Inc. | Medical device handle |
| US9510945B2 (en) | 2011-12-20 | 2016-12-06 | Boston Scientific Scimed Inc. | Medical device handle |
| EP3581152B1 (en) | 2011-12-21 | 2025-09-24 | Majoro Cardiac Innovations, LLC | Platforms for mitral valve replacement |
| US9205236B2 (en) | 2011-12-22 | 2015-12-08 | Corvia Medical, Inc. | Methods, systems, and devices for resizable intra-atrial shunts |
| EP2609893B1 (en) | 2011-12-29 | 2014-09-03 | Sorin Group Italia S.r.l. | A kit for implanting prosthetic vascular conduits |
| US10548706B2 (en) | 2012-01-13 | 2020-02-04 | Volcano Corporation | Retrieval snare device and method |
| US10426501B2 (en) | 2012-01-13 | 2019-10-01 | Crux Biomedical, Inc. | Retrieval snare device and method |
| WO2013112547A1 (en) | 2012-01-25 | 2013-08-01 | Boston Scientific Scimed, Inc. | Valve assembly with a bioabsorbable gasket and a replaceable valve implant |
| WO2013119332A2 (en) | 2012-02-09 | 2013-08-15 | Stout Medical Group, L.P. | Embolic device and methods of use |
| WO2013120082A1 (en) | 2012-02-10 | 2013-08-15 | Kassab Ghassan S | Methods and uses of biological tissues for various stent and other medical applications |
| US10213288B2 (en) | 2012-03-06 | 2019-02-26 | Crux Biomedical, Inc. | Distal protection filter |
| US9821145B2 (en) | 2012-03-23 | 2017-11-21 | Pressure Products Medical Supplies Inc. | Transseptal puncture apparatus and method for using the same |
| US9265514B2 (en) | 2012-04-17 | 2016-02-23 | Miteas Ltd. | Manipulator for grasping tissue |
| EP2854654B1 (en) | 2012-05-17 | 2019-11-06 | Boston Scientific Scimed, Inc. | Devices for access across adjacent tissue layers |
| US9883941B2 (en) | 2012-06-19 | 2018-02-06 | Boston Scientific Scimed, Inc. | Replacement heart valve |
| US9155647B2 (en) | 2012-07-18 | 2015-10-13 | Covidien Lp | Methods and apparatus for luminal stenting |
| US9056002B2 (en) | 2012-10-18 | 2015-06-16 | Medtronic, Inc. | Stent-graft and method for percutaneous access and closure of vessels |
| US20140114346A1 (en) * | 2012-10-23 | 2014-04-24 | Medtronic, Inc. | Transapical Entry Point Closure Device |
| US9314248B2 (en) | 2012-11-06 | 2016-04-19 | Covidien Lp | Multi-pivot thrombectomy device |
| CN108354645B (en) | 2012-11-13 | 2026-03-13 | 柯惠有限合伙公司 | Sealing device |
| US9295571B2 (en) | 2013-01-17 | 2016-03-29 | Covidien Lp | Methods and apparatus for luminal stenting |
| US10828019B2 (en) * | 2013-01-18 | 2020-11-10 | W.L. Gore & Associates, Inc. | Sealing device and delivery system |
| US9737294B2 (en) | 2013-01-28 | 2017-08-22 | Cartiva, Inc. | Method and system for orthopedic repair |
| AU2014209124A1 (en) | 2013-01-28 | 2015-09-17 | Cartiva, Inc. | Systems and methods for orthopedic repair |
| US9439763B2 (en) | 2013-02-04 | 2016-09-13 | Edwards Lifesciences Corporation | Prosthetic valve for replacing mitral valve |
| US9095344B2 (en) | 2013-02-05 | 2015-08-04 | Artventive Medical Group, Inc. | Methods and apparatuses for blood vessel occlusion |
| US8984733B2 (en) | 2013-02-05 | 2015-03-24 | Artventive Medical Group, Inc. | Bodily lumen occlusion |
| AU2014214700B2 (en) | 2013-02-11 | 2018-01-18 | Cook Medical Technologies Llc | Expandable support frame and medical device |
| EP4360570A3 (en) | 2013-02-21 | 2024-07-17 | Boston Scientific Scimed, Inc. | Devices and methods for forming an anastomosis |
| US20160030151A1 (en) | 2013-03-14 | 2016-02-04 | Volcano Corporation | Filters with echogenic characteristics |
| US10219887B2 (en) | 2013-03-14 | 2019-03-05 | Volcano Corporation | Filters with echogenic characteristics |
| US10292677B2 (en) | 2013-03-14 | 2019-05-21 | Volcano Corporation | Endoluminal filter having enhanced echogenic properties |
| US9463105B2 (en) | 2013-03-14 | 2016-10-11 | Covidien Lp | Methods and apparatus for luminal stenting |
| US10736758B2 (en) | 2013-03-15 | 2020-08-11 | Covidien | Occlusive device |
| US20140309684A1 (en) * | 2013-04-10 | 2014-10-16 | Mustafa H. Al-Qbandi | Atrial septal occluder device and method |
| WO2014179763A1 (en) | 2013-05-03 | 2014-11-06 | Medtronic Inc. | Valve delivery tool |
| CN103284772B (en) * | 2013-05-03 | 2016-02-03 | 广东省心血管病研究所 | A kind of adjustable tracheo esophageal fistula locking device |
| PL3038537T3 (en) | 2013-05-30 | 2025-12-15 | Occlutech Gmbh | ASYMMETRIC OCCLUDER DEVICE |
| US9636116B2 (en) | 2013-06-14 | 2017-05-02 | Artventive Medical Group, Inc. | Implantable luminal devices |
| US9737308B2 (en) | 2013-06-14 | 2017-08-22 | Artventive Medical Group, Inc. | Catheter-assisted tumor treatment |
| US9737306B2 (en) | 2013-06-14 | 2017-08-22 | Artventive Medical Group, Inc. | Implantable luminal devices |
| US10149968B2 (en) | 2013-06-14 | 2018-12-11 | Artventive Medical Group, Inc. | Catheter-assisted tumor treatment |
| US8870948B1 (en) | 2013-07-17 | 2014-10-28 | Cephea Valve Technologies, Inc. | System and method for cardiac valve repair and replacement |
| US10010328B2 (en) | 2013-07-31 | 2018-07-03 | NeuVT Limited | Endovascular occlusion device with hemodynamically enhanced sealing and anchoring |
| CN105899150B (en) | 2013-07-31 | 2018-07-27 | Neuvt 有限公司 | Method and apparatus for Endovascular Embolization |
| US9955976B2 (en) | 2013-08-16 | 2018-05-01 | Sequent Medical, Inc. | Filamentary devices for treatment of vascular defects |
| US9078658B2 (en) | 2013-08-16 | 2015-07-14 | Sequent Medical, Inc. | Filamentary devices for treatment of vascular defects |
| WO2015028209A1 (en) | 2013-08-30 | 2015-03-05 | Jenavalve Technology Gmbh | Radially collapsible frame for a prosthetic valve and method for manufacturing such a frame |
| US10070857B2 (en) | 2013-08-31 | 2018-09-11 | Mitralign, Inc. | Devices and methods for locating and implanting tissue anchors at mitral valve commissure |
| US9622863B2 (en) | 2013-11-22 | 2017-04-18 | Edwards Lifesciences Corporation | Aortic insufficiency repair device and method |
| JP6661539B2 (en) | 2013-12-20 | 2020-03-11 | テルモ株式会社 | Vessel closure |
| US10350098B2 (en) | 2013-12-20 | 2019-07-16 | Volcano Corporation | Devices and methods for controlled endoluminal filter deployment |
| US9730701B2 (en) | 2014-01-16 | 2017-08-15 | Boston Scientific Scimed, Inc. | Retrieval wire centering device |
| CN103845096B (en) * | 2014-03-10 | 2016-05-04 | 上海形状记忆合金材料有限公司 | Left atrial appendage occlusion device and preparation method thereof |
| US10675450B2 (en) | 2014-03-12 | 2020-06-09 | Corvia Medical, Inc. | Devices and methods for treating heart failure |
| JP6640829B2 (en) * | 2014-03-27 | 2020-02-05 | ラフィー・ナッサーRAFIEE, Nasser | Apparatus and method for closure of a transvascular or transventricular access port |
| US10058315B2 (en) | 2014-03-27 | 2018-08-28 | Transmural Systems Llc | Devices and methods for closure of transvascular or transcameral access ports |
| WO2017185082A1 (en) * | 2016-04-23 | 2017-10-26 | Nasser Rafiee | Devices and methods for closure of transvascular or transcameral access ports |
| US9629635B2 (en) | 2014-04-14 | 2017-04-25 | Sequent Medical, Inc. | Devices for therapeutic vascular procedures |
| US9913744B2 (en) | 2014-04-30 | 2018-03-13 | Lean Medical Technologies, Inc. | Gastrointestinal device |
| US10363043B2 (en) | 2014-05-01 | 2019-07-30 | Artventive Medical Group, Inc. | Treatment of incompetent vessels |
| US9060777B1 (en) | 2014-05-28 | 2015-06-23 | Tw Medical Technologies, Llc | Vaso-occlusive devices and methods of use |
| CN106413631B (en) | 2014-05-28 | 2018-08-17 | 波士顿科学国际有限公司 | Catheter with radiofrequency cutting tip and heated balloon |
| WO2015184075A1 (en) | 2014-05-28 | 2015-12-03 | Stryker European Holdings I, Llc | Vaso-occlusive devices and methods of use |
| US9808230B2 (en) | 2014-06-06 | 2017-11-07 | W. L. Gore & Associates, Inc. | Sealing device and delivery system |
| WO2016014821A1 (en) | 2014-07-23 | 2016-01-28 | Corvia Medical, Inc. | Devices and methods for treating heart failure |
| CN105455922B (en) * | 2014-09-09 | 2018-09-14 | 先健科技(深圳)有限公司 | Plugging device and preparation method thereof |
| CN104173120A (en) * | 2014-09-11 | 2014-12-03 | 山东省立医院 | Postoperation perivalvular leakage plugging device |
| CN104173122A (en) * | 2014-09-11 | 2014-12-03 | 山东省立医院 | Plugging device suitable for postoperation perivalvular leakage |
| US9901445B2 (en) | 2014-11-21 | 2018-02-27 | Boston Scientific Scimed, Inc. | Valve locking mechanism |
| CN111437068B (en) | 2014-12-04 | 2023-01-17 | 爱德华兹生命科学公司 | Percutaneous clamp for repairing heart valve |
| WO2016093877A1 (en) | 2014-12-09 | 2016-06-16 | Cephea Valve Technologies, Inc. | Replacement cardiac valves and methods of use and manufacture |
| US10449043B2 (en) | 2015-01-16 | 2019-10-22 | Boston Scientific Scimed, Inc. | Displacement based lock and release mechanism |
| CN104546054B (en) * | 2015-01-19 | 2017-02-22 | 上海形状记忆合金材料有限公司 | Adjustable plugging device and release method |
| US9861477B2 (en) | 2015-01-26 | 2018-01-09 | Boston Scientific Scimed Inc. | Prosthetic heart valve square leaflet-leaflet stitch |
| US9788942B2 (en) | 2015-02-03 | 2017-10-17 | Boston Scientific Scimed Inc. | Prosthetic heart valve having tubular seal |
| WO2016126524A1 (en) | 2015-02-03 | 2016-08-11 | Boston Scientific Scimed, Inc. | Prosthetic heart valve having tubular seal |
| US10285809B2 (en) | 2015-03-06 | 2019-05-14 | Boston Scientific Scimed Inc. | TAVI anchoring assist device |
| US9375333B1 (en) | 2015-03-06 | 2016-06-28 | Covidien Lp | Implantable device detachment systems and associated devices and methods |
| US10426617B2 (en) | 2015-03-06 | 2019-10-01 | Boston Scientific Scimed, Inc. | Low profile valve locking mechanism and commissure assembly |
| US10080652B2 (en) | 2015-03-13 | 2018-09-25 | Boston Scientific Scimed, Inc. | Prosthetic heart valve having an improved tubular seal |
| WO2016150806A1 (en) | 2015-03-20 | 2016-09-29 | Jenavalve Technology, Inc. | Heart valve prosthesis delivery system and method for delivery of heart valve prosthesis with introducer sheath |
| GB2550099B (en) | 2015-03-24 | 2020-09-02 | Gyrus Acmi Inc | Airway stent |
| US20160287228A1 (en) * | 2015-03-31 | 2016-10-06 | Ruben Quintero | Amnio opening occlusion device |
| CN107530168B (en) | 2015-05-01 | 2020-06-09 | 耶拿阀门科技股份有限公司 | Device and method with reduced pacemaker ratio in heart valve replacement |
| WO2016182949A1 (en) | 2015-05-08 | 2016-11-17 | Stryker European Holdings I, Llc | Vaso-occlusive devices |
| WO2016183526A1 (en) | 2015-05-14 | 2016-11-17 | Cephea Valve Technologies, Inc. | Replacement mitral valves |
| ES3001450T3 (en) | 2015-05-14 | 2025-03-05 | Edwards Lifesciences Corp | Heart valve sealing devices and delivery devices therefor |
| WO2016183523A1 (en) | 2015-05-14 | 2016-11-17 | Cephea Valve Technologies, Inc. | Cardiac valve delivery devices and systems |
| US10195392B2 (en) | 2015-07-02 | 2019-02-05 | Boston Scientific Scimed, Inc. | Clip-on catheter |
| US10335277B2 (en) | 2015-07-02 | 2019-07-02 | Boston Scientific Scimed Inc. | Adjustable nosecone |
| US10136991B2 (en) | 2015-08-12 | 2018-11-27 | Boston Scientific Scimed Inc. | Replacement heart valve implant |
| US10179041B2 (en) | 2015-08-12 | 2019-01-15 | Boston Scientific Scimed Icn. | Pinless release mechanism |
| WO2017046811A2 (en) * | 2015-09-18 | 2017-03-23 | Nageswara Rao Koneti | Multi-functional occluder |
| US12310568B2 (en) * | 2015-09-18 | 2025-05-27 | Nageswara Rao Koneti | Multi-functional occluder |
| US10478194B2 (en) | 2015-09-23 | 2019-11-19 | Covidien Lp | Occlusive devices |
| WO2017083660A1 (en) | 2015-11-13 | 2017-05-18 | Cardiac Pacemakers, Inc. | Bioabsorbable left atrial appendage closure with endothelialization promoting surface |
| CN106923886B (en) * | 2015-12-31 | 2022-04-22 | 先健科技(深圳)有限公司 | Left atrial appendage occluder |
| US10342660B2 (en) | 2016-02-02 | 2019-07-09 | Boston Scientific Inc. | Tensioned sheathing aids |
| CN109069160B (en) | 2016-03-17 | 2022-05-17 | S·珍耶那曼 | occlusion anatomy |
| US12232737B2 (en) | 2016-03-17 | 2025-02-25 | Eclipse Medical Limited | Occluding anatomical structures |
| US10799675B2 (en) | 2016-03-21 | 2020-10-13 | Edwards Lifesciences Corporation | Cam controlled multi-direction steerable handles |
| US10835714B2 (en) | 2016-03-21 | 2020-11-17 | Edwards Lifesciences Corporation | Multi-direction steerable handles for steering catheters |
| US11219746B2 (en) | 2016-03-21 | 2022-01-11 | Edwards Lifesciences Corporation | Multi-direction steerable handles for steering catheters |
| US10799676B2 (en) | 2016-03-21 | 2020-10-13 | Edwards Lifesciences Corporation | Multi-direction steerable handles for steering catheters |
| US10799677B2 (en) | 2016-03-21 | 2020-10-13 | Edwards Lifesciences Corporation | Multi-direction steerable handles for steering catheters |
| US10813644B2 (en) | 2016-04-01 | 2020-10-27 | Artventive Medical Group, Inc. | Occlusive implant and delivery system |
| CN105997304B (en) * | 2016-04-29 | 2017-11-28 | 肖书娜 | Heart valve annulus compression apparatus |
| CN109475419B (en) | 2016-05-13 | 2021-11-09 | 耶拿阀门科技股份有限公司 | Heart valve prosthesis delivery systems and methods for delivering heart valve prostheses through guide sheaths and loading systems |
| US10245136B2 (en) | 2016-05-13 | 2019-04-02 | Boston Scientific Scimed Inc. | Containment vessel with implant sheathing guide |
| US10583005B2 (en) | 2016-05-13 | 2020-03-10 | Boston Scientific Scimed, Inc. | Medical device handle |
| US10201416B2 (en) | 2016-05-16 | 2019-02-12 | Boston Scientific Scimed, Inc. | Replacement heart valve implant with invertible leaflets |
| AU2016408266B2 (en) * | 2016-05-25 | 2021-02-18 | Coramaze Technologies Gmbh | Heart implant |
| WO2017218877A1 (en) | 2016-06-17 | 2017-12-21 | Cephea Valve Technologies, Inc. | Cardiac valve delivery devices and systems |
| US10973638B2 (en) | 2016-07-07 | 2021-04-13 | Edwards Lifesciences Corporation | Device and method for treating vascular insufficiency |
| US10478195B2 (en) | 2016-08-04 | 2019-11-19 | Covidien Lp | Devices, systems, and methods for the treatment of vascular defects |
| WO2018035105A1 (en) | 2016-08-15 | 2018-02-22 | The Cleveland Clinic Foundation | Apparatuses and methods for at least partially supporting a valve leaflet of a regurgitant heart valve |
| US12011352B2 (en) | 2016-08-15 | 2024-06-18 | The Cleveland Clinic Foundation | Apparatuses and methods for at least partially supporting a valve leaflet of a regurgitant heart valve |
| RU2648344C2 (en) * | 2016-08-24 | 2018-03-23 | Общество с ограниченной ответственностью "Эндоваскулярная исследовательская лаборатория" | Method of manufacture of the framework of the aortal heart valve endovascular prosthesis |
| CN106419973A (en) * | 2016-10-12 | 2017-02-22 | 上海形状记忆合金材料有限公司 | Using method of spring suturing device |
| DE102016012395A1 (en) * | 2016-10-13 | 2018-05-03 | Cormos Medical Gmbh | LAA occluder for closing the left atrial appendage |
| JP7062303B2 (en) | 2016-10-14 | 2022-05-06 | インセプタス メディカル, エルエルシー | Braiding machine and usage |
| US10576099B2 (en) | 2016-10-21 | 2020-03-03 | Covidien Lp | Injectable scaffold for treatment of intracranial aneurysms and related technology |
| US10653862B2 (en) | 2016-11-07 | 2020-05-19 | Edwards Lifesciences Corporation | Apparatus for the introduction and manipulation of multiple telescoping catheters |
| US10905554B2 (en) | 2017-01-05 | 2021-02-02 | Edwards Lifesciences Corporation | Heart valve coaptation device |
| AU2018203053B2 (en) | 2017-01-23 | 2020-03-05 | Cephea Valve Technologies, Inc. | Replacement mitral valves |
| CA3051272C (en) | 2017-01-23 | 2023-08-22 | Cephea Valve Technologies, Inc. | Replacement mitral valves |
| CN110392557A (en) | 2017-01-27 | 2019-10-29 | 耶拿阀门科技股份有限公司 | Heart valve simulation |
| WO2018156897A1 (en) | 2017-02-24 | 2018-08-30 | Tc1 Llc | Minimally invasive methods and devices for ventricular assist device implantation |
| CN110573092B (en) | 2017-02-24 | 2023-04-18 | 因赛普特斯医学有限责任公司 | Vasoocclusive devices and methods |
| US11224511B2 (en) | 2017-04-18 | 2022-01-18 | Edwards Lifesciences Corporation | Heart valve sealing devices and delivery devices therefor |
| PL3558169T3 (en) | 2017-04-18 | 2022-04-04 | Edwards Lifesciences Corporation | DEVICES FOR SEALING THE HEART VALVE AND DEVICES FOR THEIR DELIVERY |
| WO2018200891A1 (en) | 2017-04-27 | 2018-11-01 | Boston Scientific Scimed, Inc. | Occlusive medical device with fabric retention barb |
| US10799312B2 (en) | 2017-04-28 | 2020-10-13 | Edwards Lifesciences Corporation | Medical device stabilizing apparatus and method of use |
| US10959846B2 (en) | 2017-05-10 | 2021-03-30 | Edwards Lifesciences Corporation | Mitral valve spacer device |
| JP7293132B2 (en) | 2017-05-25 | 2023-06-19 | テルモ株式会社 | adhesive occlusion system |
| EP3634311B1 (en) | 2017-06-08 | 2025-07-30 | Boston Scientific Scimed, Inc. | Heart valve implant commissure support structure |
| WO2019028161A1 (en) | 2017-08-01 | 2019-02-07 | Boston Scientific Scimed, Inc. | Medical implant locking mechanism |
| AU2018316225B2 (en) * | 2017-08-10 | 2023-09-28 | St. Jude Medical, Cardiology Division, Inc. | Collapsible medical device for atrial sealing and trans-septal access |
| WO2019035966A1 (en) | 2017-08-16 | 2019-02-21 | Boston Scientific Scimed, Inc. | Replacement heart valve commissure assembly |
| US10675036B2 (en) | 2017-08-22 | 2020-06-09 | Covidien Lp | Devices, systems, and methods for the treatment of vascular defects |
| US11051940B2 (en) | 2017-09-07 | 2021-07-06 | Edwards Lifesciences Corporation | Prosthetic spacer device for heart valve |
| US11065117B2 (en) | 2017-09-08 | 2021-07-20 | Edwards Lifesciences Corporation | Axisymmetric adjustable device for treating mitral regurgitation |
| US11110251B2 (en) | 2017-09-19 | 2021-09-07 | Edwards Lifesciences Corporation | Multi-direction steerable handles for steering catheters |
| JP7429187B2 (en) | 2017-10-14 | 2024-02-07 | インセプタス メディカル リミテッド ライアビリティ カンパニー | Braiding machine and usage |
| US10993807B2 (en) | 2017-11-16 | 2021-05-04 | Medtronic Vascular, Inc. | Systems and methods for percutaneously supporting and manipulating a septal wall |
| EP4338688B1 (en) | 2017-12-18 | 2026-04-15 | Boston Scientific Scimed, Inc. | Occlusive device with expandable member |
| US10111751B1 (en) | 2018-01-09 | 2018-10-30 | Edwards Lifesciences Corporation | Native valve repair devices and procedures |
| US10076415B1 (en) | 2018-01-09 | 2018-09-18 | Edwards Lifesciences Corporation | Native valve repair devices and procedures |
| US10973639B2 (en) | 2018-01-09 | 2021-04-13 | Edwards Lifesciences Corporation | Native valve repair devices and procedures |
| US10123873B1 (en) | 2018-01-09 | 2018-11-13 | Edwards Lifesciences Corporation | Native valve repair devices and procedures |
| US10231837B1 (en) | 2018-01-09 | 2019-03-19 | Edwards Lifesciences Corporation | Native valve repair devices and procedures |
| US10159570B1 (en) | 2018-01-09 | 2018-12-25 | Edwards Lifesciences Corporation | Native valve repair devices and procedures |
| US10105222B1 (en) | 2018-01-09 | 2018-10-23 | Edwards Lifesciences Corporation | Native valve repair devices and procedures |
| US10130475B1 (en) | 2018-01-09 | 2018-11-20 | Edwards Lifesciences Corporation | Native valve repair devices and procedures |
| US10136993B1 (en) | 2018-01-09 | 2018-11-27 | Edwards Lifesciences Corporation | Native valve repair devices and procedures |
| JP7343393B2 (en) | 2018-01-09 | 2023-09-12 | エドワーズ ライフサイエンシーズ コーポレイション | Natural heart valve repair devices and procedures |
| US10507109B2 (en) | 2018-01-09 | 2019-12-17 | Edwards Lifesciences Corporation | Native valve repair devices and procedures |
| US10245144B1 (en) | 2018-01-09 | 2019-04-02 | Edwards Lifesciences Corporation | Native valve repair devices and procedures |
| US10238493B1 (en) | 2018-01-09 | 2019-03-26 | Edwards Lifesciences Corporation | Native valve repair devices and procedures |
| WO2019144071A1 (en) | 2018-01-19 | 2019-07-25 | Boston Scientific Scimed, Inc. | Medical device delivery system with feedback loop |
| WO2019144069A2 (en) | 2018-01-19 | 2019-07-25 | Boston Scientific Scimed, Inc. | Inductance mode deployment sensors for transcatheter valve system |
| EP3740139A1 (en) | 2018-01-19 | 2020-11-25 | Boston Scientific Scimed Inc. | Occlusive medical device with delivery system |
| US11185335B2 (en) * | 2018-01-19 | 2021-11-30 | Galaxy Therapeutics Inc. | System for and method of treating aneurysms |
| WO2019157156A1 (en) | 2018-02-07 | 2019-08-15 | Boston Scientific Scimed, Inc. | Medical device delivery system with alignment feature |
| WO2019165394A1 (en) | 2018-02-26 | 2019-08-29 | Boston Scientific Scimed, Inc. | Embedded radiopaque marker in adaptive seal |
| US11389297B2 (en) | 2018-04-12 | 2022-07-19 | Edwards Lifesciences Corporation | Mitral valve spacer device |
| US11207181B2 (en) | 2018-04-18 | 2021-12-28 | Edwards Lifesciences Corporation | Heart valve sealing devices and delivery devices therefor |
| US11331104B2 (en) | 2018-05-02 | 2022-05-17 | Boston Scientific Scimed, Inc. | Occlusive sealing sensor system |
| CN112399836B (en) | 2018-05-15 | 2024-10-15 | 波士顿科学国际有限公司 | Replacement heart valve commissure assembly |
| EP3793450B1 (en) | 2018-05-15 | 2024-06-26 | Boston Scientific Scimed, Inc. | Occlusive medical device with charged polymer coating |
| CN112437649B (en) | 2018-05-23 | 2024-10-11 | 恪心有限责任公司 | Heart valve prosthesis |
| EP3796872B1 (en) | 2018-05-23 | 2022-07-20 | Corcym S.r.l. | A device for the in-situ delivery of heart valve prostheses |
| US11672541B2 (en) | 2018-06-08 | 2023-06-13 | Boston Scientific Scimed, Inc. | Medical device with occlusive member |
| US11123079B2 (en) | 2018-06-08 | 2021-09-21 | Boston Scientific Scimed, Inc. | Occlusive device with actuatable fixation members |
| WO2019241477A1 (en) | 2018-06-13 | 2019-12-19 | Boston Scientific Scimed, Inc. | Replacement heart valve delivery device |
| CN112566566B (en) | 2018-07-06 | 2025-01-14 | 波士顿科学医学有限公司 | Closed medical devices |
| JP7322133B2 (en) * | 2018-07-18 | 2023-08-07 | ダブリュ.エル.ゴア アンド アソシエイツ,インコーポレイティド | Medical devices for shunts, occluders, fenestrations and related systems and methods |
| CA3105224A1 (en) | 2018-07-18 | 2020-01-23 | W. L. Gore & Associates, Inc. | Implantable medical device deployment system |
| EP3840670B1 (en) | 2018-08-21 | 2023-11-15 | Boston Scientific Scimed, Inc. | Projecting member with barb for cardiovascular devices |
| US12390332B2 (en) | 2018-08-28 | 2025-08-19 | Edwards Lifesciences Corporation | Methods and devices for ventricular reshaping and heart valve reshaping |
| US10945844B2 (en) | 2018-10-10 | 2021-03-16 | Edwards Lifesciences Corporation | Heart valve sealing devices and delivery devices therefor |
| US11564692B2 (en) | 2018-11-01 | 2023-01-31 | Terumo Corporation | Occlusion systems |
| EP3883500B1 (en) | 2018-11-20 | 2024-11-06 | Edwards Lifesciences Corporation | Deployment tools for delivering a device to a native heart valve |
| CN113301869A (en) | 2018-11-21 | 2021-08-24 | 爱德华兹生命科学公司 | Heart valve sealing device, delivery device and retrieval device thereof |
| CR20210312A (en) | 2018-11-29 | 2021-09-14 | Edwards Lifesciences Corp | Catheterization method and apparatus |
| WO2020123486A1 (en) | 2018-12-10 | 2020-06-18 | Boston Scientific Scimed, Inc. | Medical device delivery system including a resistance member |
| WO2020131976A2 (en) | 2018-12-17 | 2020-06-25 | Covidien Lp | Devices, systems, and methods for the treatment of vascular defects |
| AU2019404586B2 (en) | 2018-12-21 | 2023-02-02 | W. L. Gore & Associates, Inc. | Implantable cardiac sensors |
| IT201800020707A1 (en) * | 2018-12-21 | 2020-06-21 | Eustaquio Maria Onorato | Patent foramen ovale occlusion device. |
| CN109745094B (en) * | 2018-12-29 | 2021-09-03 | 先健科技(深圳)有限公司 | Plugging device |
| WO2020150557A1 (en) * | 2019-01-18 | 2020-07-23 | W. L. Gore & Associates, Inc. | Bioabsorbable medical devices |
| CN113747858B (en) | 2019-02-11 | 2024-11-01 | 爱德华兹生命科学公司 | Heart valve sealing device and delivery device therefor |
| WO2020168081A1 (en) | 2019-02-14 | 2020-08-20 | Edwards Lifesciences Corporation | Heart valve sealing devices and delivery devices therefor |
| SG11202108606PA (en) | 2019-02-25 | 2021-09-29 | Edwards Lifesciences Corp | Heart valve sealing devices |
| CN119214724A (en) | 2019-03-15 | 2024-12-31 | 美科微先股份有限公司 | Silk device for treating vascular defects |
| CN113573650B (en) | 2019-03-15 | 2024-05-28 | 后续医疗股份有限公司 | Silk device with flexible connector for treating vascular defects |
| CN113573765B (en) | 2019-03-15 | 2024-08-13 | 美科微先股份有限公司 | Silk device for treating vascular defects |
| US11439504B2 (en) | 2019-05-10 | 2022-09-13 | Boston Scientific Scimed, Inc. | Replacement heart valve with improved cusp washout and reduced loading |
| EP3998962B1 (en) | 2019-07-17 | 2024-05-08 | Boston Scientific Scimed, Inc. | Left atrial appendage implant with continuous covering |
| BR112022002912A2 (en) * | 2019-08-20 | 2022-05-10 | Holistick Medical | Medical implant and delivery device for a medical implant |
| WO2021034537A1 (en) | 2019-08-22 | 2021-02-25 | Edwards Lifesciences Corporation | Puncture needles |
| EP3986284B1 (en) | 2019-08-30 | 2025-05-14 | Boston Scientific Scimed, Inc. | Left atrial appendage implant with sealing disk |
| CA3143014A1 (en) | 2019-10-15 | 2021-04-22 | Edwards Lifesciences Corporation | Heart valve sealing devices and delivery devices therefor |
| US11498165B2 (en) | 2019-11-04 | 2022-11-15 | Covidien Lp | Systems and methods for treating aneurysms |
| JP2023502077A (en) | 2019-11-14 | 2023-01-20 | エドワーズ ライフサイエンシーズ コーポレイション | Transcatheter medical implant delivery |
| AU2021207486B2 (en) | 2020-01-17 | 2024-03-28 | W. L. Gore & Associates, Inc. | Medical implant comprising two frame components and pairs of eyelets |
| US20210282789A1 (en) | 2020-03-11 | 2021-09-16 | Microvention, Inc. | Multiple layer devices for treatment of vascular defects |
| US12070220B2 (en) | 2020-03-11 | 2024-08-27 | Microvention, Inc. | Devices having multiple permeable shells for treatment of vascular defects |
| US12023034B2 (en) | 2020-03-11 | 2024-07-02 | Microvention, Inc. | Devices for treatment of vascular defects |
| EP4609806A3 (en) | 2020-03-24 | 2025-11-26 | Boston Scientific Scimed, Inc. | Medical system for treating a left atrial appendage |
| EP4142622A4 (en) | 2020-04-28 | 2024-05-01 | Terumo Corporation | Occlusion systems |
| US11931041B2 (en) | 2020-05-12 | 2024-03-19 | Covidien Lp | Devices, systems, and methods for the treatment of vascular defects |
| EP4420618A3 (en) * | 2020-08-03 | 2024-09-25 | St. Jude Medical, Cardiology Division, Inc. | Devices for the treatment of vascular abnormalities |
| WO2022051241A1 (en) | 2020-09-01 | 2022-03-10 | Edwards Lifesciences Corporation | Medical device stabilizing systems |
| CN116685276A (en) | 2020-11-30 | 2023-09-01 | 波士顿科学医学有限公司 | Implantable passive average pressure sensor |
| WO2022133250A1 (en) | 2020-12-18 | 2022-06-23 | Boston Scientific Scimed, Inc. | Occlusive medical device having sensing capabilities |
| WO2022155344A1 (en) | 2021-01-14 | 2022-07-21 | Boston Scientific Scimed, Inc. | Medical system for treating a left atrial appendage |
| US12527942B2 (en) | 2021-02-01 | 2026-01-20 | Edwards Lifesciences Corporation | Pulmonary vein shunting |
| US12383201B2 (en) | 2021-02-03 | 2025-08-12 | Boston Scientific Scimed, Inc. | Medical system for treating a left atrial appendage |
| EP4059445A1 (en) * | 2021-03-18 | 2022-09-21 | HoliStick Medical | Medical implant and catheter device for a medical implant |
| US12485008B2 (en) | 2021-04-09 | 2025-12-02 | Boston Scientific Scimed, Inc. | Rotational alignment of medical implant |
| WO2022271832A1 (en) | 2021-06-22 | 2022-12-29 | Boston Scientific Scimed, Inc. | Left atrial appendage implant |
| JP7690067B2 (en) | 2021-07-08 | 2025-06-09 | ボストン サイエンティフィック サイムド,インコーポレイテッド | Left atrial appendage closure device |
| US12446891B2 (en) | 2021-08-30 | 2025-10-21 | Microvention, Inc. | Devices for treatment of vascular defects |
| WO2023038929A1 (en) | 2021-09-08 | 2023-03-16 | Boston Scientific Scimed, Inc. | Occlusive implant with multi-sharpness split tip soft tissue anchors |
| WO2023140833A1 (en) | 2022-01-19 | 2023-07-27 | Bard Peripheral Vascular, Inc. | Occlusion devices and methods of use thereof |
| US12502178B2 (en) | 2022-08-16 | 2025-12-23 | Boston Scientific Scimed, Inc. | Medical device for occluding a left atrial appendage |
| CN120152682A (en) | 2022-11-09 | 2025-06-13 | 耶拿阀门科技公司 | Catheter system for sequential deployment of expandable implants |
| CN115919380B (en) * | 2022-12-06 | 2025-08-05 | 先健科技(深圳)有限公司 | Occluders and occlusion systems |
| CN115998348A (en) * | 2023-01-18 | 2023-04-25 | 上海普实医疗器械股份有限公司 | Patent foramen ovale plugging device |
| USD1071198S1 (en) | 2023-06-28 | 2025-04-15 | Edwards Lifesciences Corporation | Cradle |
| US12178420B1 (en) | 2023-10-19 | 2024-12-31 | Atheart Medical Ag | Systems and methods for delivering implantable occluder devices for treating atrial septal defects |
Family Cites Families (31)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3874388A (en) * | 1973-02-12 | 1975-04-01 | Ochsner Med Found Alton | Shunt defect closure system |
| US4007743A (en) * | 1975-10-20 | 1977-02-15 | American Hospital Supply Corporation | Opening mechanism for umbrella-like intravascular shunt defect closure device |
| US5190546A (en) * | 1983-10-14 | 1993-03-02 | Raychem Corporation | Medical devices incorporating SIM alloy elements |
| US5067957A (en) * | 1983-10-14 | 1991-11-26 | Raychem Corporation | Method of inserting medical devices incorporating SIM alloy elements |
| US4665906A (en) * | 1983-10-14 | 1987-05-19 | Raychem Corporation | Medical devices incorporating sim alloy elements |
| US4836204A (en) * | 1987-07-06 | 1989-06-06 | Landymore Roderick W | Method for effecting closure of a perforation in the septum of the heart |
| US5067489A (en) | 1988-08-16 | 1991-11-26 | Flexmedics Corporation | Flexible guide with safety tip |
| US4917089A (en) * | 1988-08-29 | 1990-04-17 | Sideris Eleftherios B | Buttoned device for the transvenous occlusion of intracardiac defects |
| FR2641692A1 (en) | 1989-01-17 | 1990-07-20 | Nippon Zeon Co | Plug for closing an opening for a medical application, and device for the closure plug making use thereof |
| US4991602A (en) | 1989-06-27 | 1991-02-12 | Flexmedics Corporation | Flexible guide wire with safety tip |
| EP0510007B1 (en) * | 1990-01-08 | 1996-05-08 | Health Research, Inc. | A submersible lens fiberoptic assembly |
| ATE107150T1 (en) * | 1990-04-02 | 1994-07-15 | Kanji Inoue | DEVICE FOR CLOSING A SHUTTLE OPENING BY A NON-OPERATIONAL METHOD. |
| IL94138A (en) * | 1990-04-19 | 1997-03-18 | Instent Inc | Device for the treatment of constricted fluid conducting ducts |
| US5108420A (en) * | 1991-02-01 | 1992-04-28 | Temple University | Aperture occlusion device |
| DE69229539T2 (en) * | 1991-11-05 | 2000-02-17 | Children's Medical Center Corp., Boston | Occlusion device for repairing heart and vascular defects |
| CA2082090C (en) | 1991-11-05 | 2004-04-27 | Jack Fagan | Improved occluder for repair of cardiac and vascular defects |
| ES2133382T3 (en) * | 1992-01-21 | 1999-09-16 | Univ Minnesota | DEVICE FOR THE CLOSURE OF SEPTAL DEFECTS. |
| DE4222291C1 (en) * | 1992-07-07 | 1994-01-20 | Krmek Mirko | Prosthesis for closing atrial or ventricular-septal defect - comprises two equally shaped units of elastic sprung material with six radially running arms spaced apart by equal edges |
| US5527338A (en) * | 1992-09-02 | 1996-06-18 | Board Of Regents, The University Of Texas System | Intravascular device |
| WO1994006460A1 (en) * | 1992-09-21 | 1994-03-31 | Vitaphore Corporation | Embolization plugs for blood vessels |
| US5382259A (en) * | 1992-10-26 | 1995-01-17 | Target Therapeutics, Inc. | Vasoocclusion coil with attached tubular woven or braided fibrous covering |
| US5466242A (en) * | 1994-02-02 | 1995-11-14 | Mori; Katsushi | Stent for biliary, urinary or vascular system |
| US5725552A (en) * | 1994-07-08 | 1998-03-10 | Aga Medical Corporation | Percutaneous catheter directed intravascular occlusion devices |
| US6123715A (en) * | 1994-07-08 | 2000-09-26 | Amplatz; Curtis | Method of forming medical devices; intravascular occlusion devices |
| US5702421A (en) * | 1995-01-11 | 1997-12-30 | Schneidt; Bernhard | Closure device for closing a vascular opening, such as patent ductus arteriosus |
| US5634936A (en) * | 1995-02-06 | 1997-06-03 | Scimed Life Systems, Inc. | Device for closing a septal defect |
| US5645558A (en) * | 1995-04-20 | 1997-07-08 | Medical University Of South Carolina | Anatomically shaped vasoocclusive device and method of making the same |
| WO1997016119A1 (en) * | 1995-10-30 | 1997-05-09 | Children's Medical Center Corporation | Self-centering umbrella-type septal closure device |
| DE19604817C2 (en) * | 1996-02-09 | 2003-06-12 | Pfm Prod Fuer Die Med Ag | Device for closing defect openings in the human or animal body |
| US5733294A (en) * | 1996-02-28 | 1998-03-31 | B. Braun Medical, Inc. | Self expanding cardiovascular occlusion device, method of using and method of making the same |
| GB9614950D0 (en) | 1996-07-16 | 1996-09-04 | Anson Medical Ltd | A ductus stent and delivery catheter |
-
1998
- 1998-02-06 US US09/019,620 patent/US5944738A/en not_active Expired - Lifetime
- 1998-10-12 DK DK98953347T patent/DK1052944T3/en active
- 1998-10-12 CA CA002319521A patent/CA2319521C/en not_active Expired - Lifetime
- 1998-10-12 EP EP98953347A patent/EP1052944B1/en not_active Expired - Lifetime
- 1998-10-12 ES ES07014279T patent/ES2431563T3/en not_active Expired - Lifetime
- 1998-10-12 AT AT98953347T patent/ATE372727T1/en active
- 1998-10-12 ES ES98953347T patent/ES2294820T3/en not_active Expired - Lifetime
- 1998-10-12 EP EP10075489A patent/EP2263569A1/en not_active Withdrawn
- 1998-10-12 PT PT98953347T patent/PT1052944E/en unknown
- 1998-10-12 WO PCT/US1998/021342 patent/WO1999039646A1/en not_active Ceased
- 1998-10-12 DE DE69838436T patent/DE69838436T2/en not_active Expired - Lifetime
- 1998-10-12 JP JP2000530153A patent/JP3524494B2/en not_active Expired - Lifetime
- 1998-10-12 CN CN98813470A patent/CN1102373C/en not_active Expired - Lifetime
- 1998-10-12 EA EA200000739A patent/EA002106B1/en not_active IP Right Cessation
- 1998-10-12 KR KR10-2000-7008508A patent/KR100400506B1/en not_active Expired - Lifetime
- 1998-10-12 EP EP07014279.9A patent/EP1844717B1/en not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| EP2263569A1 (en) | 2010-12-22 |
| CN1283973A (en) | 2001-02-14 |
| DE69838436T2 (en) | 2008-06-12 |
| ATE372727T1 (en) | 2007-09-15 |
| KR20010040637A (en) | 2001-05-15 |
| DK1052944T3 (en) | 2007-11-05 |
| AU1074899A (en) | 1999-08-23 |
| EP1052944A4 (en) | 2006-06-14 |
| PT1052944E (en) | 2007-10-12 |
| EP1844717A2 (en) | 2007-10-17 |
| EP1844717A3 (en) | 2008-09-24 |
| JP2002502625A (en) | 2002-01-29 |
| AU737934B2 (en) | 2001-09-06 |
| EP1844717B1 (en) | 2013-08-28 |
| CN1102373C (en) | 2003-03-05 |
| DE69838436D1 (en) | 2007-10-25 |
| US5944738A (en) | 1999-08-31 |
| EA200000739A1 (en) | 2001-04-23 |
| WO1999039646A1 (en) | 1999-08-12 |
| EA002106B1 (en) | 2001-12-24 |
| ES2431563T3 (en) | 2013-11-27 |
| KR100400506B1 (en) | 2003-10-08 |
| CA2319521A1 (en) | 1999-08-12 |
| EP1052944A1 (en) | 2000-11-22 |
| EP1052944B1 (en) | 2007-09-12 |
| CA2319521C (en) | 2004-05-04 |
| JP3524494B2 (en) | 2004-05-10 |
| HK1032892A1 (en) | 2001-08-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2294820T3 (en) | DECLARATION DEVICE FOR CONSTRUCTION CONDUCTED BY PERCUTANEOUS CATETER | |
| ES2395213T3 (en) | Intravascular occlusion devices guided by a percutaneous catheter | |
| ES2308396T3 (en) | MULTI-PAPER FABRIC STRUCTURES TO OCCUR VASCULAR DEFECTS. | |
| ES3015572T3 (en) | Device for occluding abnormal openings in a patient's vasculature | |
| US11134933B2 (en) | Multi-layer braided structures for occluding vascular defects | |
| ES2394958T5 (en) | Repositionable and recoverable vascular graft / stent | |
| ES2487515T3 (en) | Procedure for the formation of medical devices; intravascular occlusion devices | |
| ES2330389T3 (en) | DECLARATION AND PROCEDURE DEVICE FOR MANUFACTURING. | |
| ES2718481T3 (en) | Intravascular occlusion devices directed by percutaneous catheter | |
| ES2428967T3 (en) | Oval foramen tubular permeable closure device (FOP) with retention system | |
| AU2001249146B2 (en) | Retrievable self expanding shunt | |
| ES2424655T3 (en) | Permeable oval foramen closure device (FOP) with petals that lengthen linearly | |
| ES2203680T3 (en) | ANEURISM OCLUSION DEVICE. | |
| ES2334372T3 (en) | A SET TO HERMETICALLY CLOSE A DUCT AND A HEART. | |
| ES2202627T3 (en) | SURGICAL IMPLANTS AND DELIVERY SYSTEMS FOR THEM. | |
| EP1011469B1 (en) | Percutaneous catheter directed occlusion devices | |
| ES2394959T3 (en) | Intravascular occlusion devices directed by percutaneous catheter | |
| ES3054071T3 (en) | Devices and methods for occlusion of vascular system abnormalities | |
| ES2371026T3 (en) | ADJUSTABLE OCLUSION DEVICE IN THE LEFT HEADPHONE OREJUELA. |